Notice of Extraordinary General Meeting in Getinge AB

The shareholders of Getinge AB (publ) are hereby invited to attend the Extraordinary General Meeting (the “EGM”) to be held on Tuesday August 15, 2017 at 11.00 CEST, at Clarion Hotel Post, Drottningtorget 10 in Gothenburg, Sweden. Right to attend Shareholders who wish to attend the EGM must: – be recorded in the share register kept by Euroclear Sweden AB (the Swedish Central Securities Depository), on Wednesday 9 August 2017, and – notify the company of their intention to attend the EGM by Wednesday 9 August 2017, preferably before 4.00 p.m. CET. In order to participate in the EGM, shareholders with nominee-registered shares should request their bank or broker to have the shares temporarily owner-registered with Euroclear Sweden AB by Wednesday 9 August 2017. Therefore, shareholders are requested to notify their nominees in due time before the said date. Notice of attendance Notice of attendance shall be made in writing to Getinge AB, “EGM”, P.O. Box 7841, SE-103 98 Stockholm, Sweden, or by telephone +46 10 335 08 18, or on the company’s website, www.getinge.com. The notice of attendance shall state name, personal (or corporate) identity number, shareholding, telephone number and name of advisor, if any. An entrance card to be shown when registering for the EGM will be sent in confirmation of the notice of attendance. Shareholders represented by proxy should submit a power of attorney to the company before the EGM. A proxy form is available at the company and on the company’s website, www.getinge.com. Representatives of a legal entity shall present a copy of the certificate of registration or similar document of authorisation. Proposal for agenda 1. Opening of the Meeting 2. Election of Chairman of the Meeting 3. Preparation and approval of the voting list 4. Approval of the agenda 5. Election of person(s) to approve the minutes 6. Determination of compliance with the rules of convocation 7. Resolution regarding amendment of the Articles of Association by including a conversion provision 8. Resolution regarding authorisation of the Board to resolve on a new issue of shares 9. Closing of the Meeting The Board’s proposal for amendment of the Articles of Association (Item 7) The Board of Directors proposes the EGM to resolve to include a conversion provision as a new seventh paragraph of § 5 of the Articles of Association, in accordance with the below. Proposed wordingNew seventh paragraph of § 5At the request from a   shareholder, share of Series A (one or more) belongingto that shareholder   shall be converted to share of Series B. The request ofconversion, which   shall be in writing and state the number of shares to beconverted, shall be   addressed to the Board. The conversion shall thereafterwithout delay be   filed for registration with the Swedish CompaniesRegistration Office (Sw. Bolagsverket) and shall be executed   when registeredin the companies’ register and recorded in the share register   kept byEuroclear Sweden AB (the   Swedish Central Securities Depository). The resolution by the Meeting requires the support of shareholders representing at least two-thirds of both the votes cast and the shares represented at the Meeting. The Board’s proposal for resolution on authorization of the Board to resolve on a new issue of shares (item 8) The Board of Directors proposes the EGM to authorise the Board to resolve on the issue of new shares with preferential right for the company’s shareholders during the period up to the company’s Annual General Meeting 2018. The total number of shares that may be issued by virtue of the authorisation shall amount to the number of shares corresponding to issue proceeds of approximately SEK 4 billion, and shall be within the limits of the share capital. Other terms and conditions for the new share issue shall be determined by the Board. Documents and other information The complete proposals for the resolutions under item 7 and 8 will be available at the company and on the company’s website, www.getinge.com, from Tuesday 25 July 2017 at the latest and will be sent to shareholders upon request. Copies will also be available at the EGM. The Board and the CEO shall at the EGM, if any shareholder so requests and the Board believes that it can be done without significant harm to the company, provide information regarding circumstances that may affect the assessment of an item on the agenda. The total number of shares in the company amounts to 238,323,377, whereof 15,940,050 shares of series A and 222,383,327 shares of series B. The total number of votes in the company amounts to 381,783,827. ————————————  Gothenburg in July 2017The Board of Directors of Getinge AB (publ)   Contacts: Jeanette Hedén CarlssonEVP Communications & Brand ManagementPhone: +46 (0)10 335 1003Email: jeanette.hedencarlsson@getinge.com Lars MattssonHead of Investor RelationsPhone: +46 (0)10 335 0043Email: lars.mattsson@getinge.com   About Getinge Getinge is a global provider of innovative solutions for operating rooms, intensive care units, sterilization departments and for life science companies and institutions. Based on our firsthand experience and close partnerships with clinical experts, healthcare professionals and medtech specialists, we are improving the everyday life for people - today and tomorrow.

Sales development in June 2017

The H&M group’s sales including VAT increased by 7 percent in local currencies in June 2017 compared to the same month the previous year. Converted into SEK sales increased by 10 percent. The total number of stores in the group amounted to 4,517 on 30 June 2017 compared to 4,095 stores on30 June 2016. The H&M group has decided to arrange Capital Markets Days during which more in-depth information about the business will be given and has also decided – in consultation with its large institutional shareholders – to publish the group’s sales development per quarter instead of per month. Just as previously, sales for the quarter will be published ahead of each interim report as the percentage change in local currencies and in Swedish kronor as well as in absolute figures in Swedish kronor, both including and excluding VAT.  The reasoning is that a month is far too short a period over which to assess how sales are developing; in fact, a single month’s sales can actually be misleading, since calendar and weather effects – among other things – may significantly affect the outcome. Instead sales development should be viewed over a longer period of time, such as over a season or a quarter. This is also the reason why the majority of companies in fashion retail currently report their sales quarterly rather than monthly.   Following the publication of sales development for June 2017, the H&M group will typically publish quarterly sales figures on the 15th of the month in which an interim report is presented. Third quarter sales will therefore be published on 15 September 2017. Sales figures for the fourth quarter will be published on 15 December 2017. More information on Capital Markets Days will be provided at a later date.  Karl-Johan Persson, CEO

Pandox AB (publ) acquires Hilton London Heathrow Airport for MGBP 80

“Great Britain is a prioritised market and we are delighted over the acquisition of Hilton London Heathrow Airport at Europe’s largest and the third largest airport in the world. The hotel is large, profitable and has a strong location at London-Heathrow Terminal 4, which the guests reach by a covered walkway. At the terminal swift access to London via underground is available, which makes the hotel attractive to all types of guests. The hotel is operated by Hilton under a long-term revenue-based lease agreement in a sub-market with high occupancy and good average rates and contributes to a further diversification of our portfolio.”, says Anders Nissen, CEO of Pandox. The acquisition of the hotel property is made by acquisition of shares in a company owned by an institutional investor with an underlying property value of MGBP 80, corresponding to approximately MSEK 865 at current exchange rate, on a debt free basis. The acquired hotel property has a yield of 5.5 percent. The hotel is operated by Adda Hotels – a subsidiary of Hilton Worldwide Holdings – under a revenue-based lease agreement with a remaining average maturity (WAULT) of 26 years where the tenant has a far-reaching responsibility for maintenance, repair and investments in the property. The hotel property is consistently in good condition and all rooms and conference areas have been renovated the past five years. Renovation of restaurant, bar, lobby and gym is planned 2018-2019. Hilton London Heathrow Airport has 398 rooms, large meeting facilities and a strategic airport location in close proximity to London-Heathrow Terminal 4 where nearly 50 airlines are operating. Within a radius of 20 km from the airport many of Britain's largest companies are also represented. Hilton London Heathrow Airport has via a covered walkway (10-minute walk) direct access to Terminal 4. Terminal 4 offers good communications to London, giving the hotel city near features. FOR MORE INFORMATION, PLEASE CONTACT:Anders Nissen, CEO, +46 (0) 708 46 02 02Liia Nõu, CFO, +46 (0) 702 37 44 04Anders Berg, Head of Communications and IR, +46 (0) 760 95 19 40 This information is information that Pandox AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 08:00 CEST on 17 July 2017. About PandoxPandox is a leading owner of hotel properties in Northern Europe with a focus on sizeable hotels in key leisure and corporate destinations. Pandox’s hotel property portfolio currently comprises 121 hotels with more than 26,000 hotel rooms in ten countries. Pandox’s business is organised into Property management, which comprises hotel properties leased on a long-term basis to market leading regional hotel operators and leading international hotel operators, and Operator activities, which comprises hotel operations executed by Pandox in its owner-occupied hotel properties. Pandox was founded in 1995 and the company’s B shares are listed on Nasdaq Stockholm. www.pandox.se

Interim Report January – June 2017

April – June 2017 in brief ·  Order intake increased by 1.1% to SEK 7,539 M (7,460). The order intake declined organically by 3.8%.   ·  Net sales rose by 4.5% to SEK 7,241 M (6,927). Net sales decreased organically by 0.5%.  ·  Cash flow from operations declined 51.8% to SEK 223 M (463). The cash conversion amounted to 29.1% (44.7).  ·  EBITA 1* increased 9.6% to SEK 864 M (788).  ·  Restructuring and integration costs amounted to SEK 524 M (133), of which SEK 488 M comprised a provision for improvements in Hechingen in accordance with the Consent Decree with the FDA.  ·  Profit after financial items fell to SEK 9 M (311).  ·  Earnings per share declined to SEK 0.01 (0.93).  ·  Savings of slightly more than SEK 100 M were achieved via the Big 5 efficiency-enhancement program.   ·  Plan for guaranteed rights issue of approximately SEK 4 billion.   ·  A minor acquisition within Surgical Workflows  ·  After the quarter: Lars Sandström was appointed CFO and the notice of the EGM for the proposed Rights Issue was published. January – June 2017 in brief ·  Order intake increased by 2.8% to SEK 14,788 M (14,384). The order intake declined organically by 1.6%.   ·  Net sales increased by 4.5% to SEK 13,905 M (13,304), corresponding to an organic change of 0.0%.  ·  Cash flow from operations fell by 6.2% to SEK 1,091 M (1,163). The cash conversion amounted to 55.3% (59.2).  ·  EBITA 1* improved by 19.5% to SEK 1,682 M (1,408).  ·  Restructuring and integration costs amounted to SEK 620 M (260).   ·  Profit after financial items decreased to SEK 392 M (468).  ·  Earnings per share declined to SEK 1.17 (1.39).  ·  Savings of slightly more than SEK 200 M were achieved via the Big 5 efficiency-enhancement program.  Financial summary  Quarter Quarter Jan Jan-Jun Rolling Full year 2 2017  2  -Jun  2016     2016  2016  2017   12M  Order intake,   SEK M  7,539  7,460  14,788  14,384  30,546  30,142 Net sales, SEK   M  7,241  6,927  13,905  13,304  30,357  29,756 Gross profit,   SEK M  3,449  3,167  6,744  6,178  14,406  13,840 Gross margin, %  47.6  45.7  48.5  46.4  47.5  46.5 EBITA 1*, SEK   M  864  788  1,682  1,408  4,615  4,341 EBITA 1*   margin, %  11.9  11.4  12.1  10.6  15.2  14.6 Operating   profit 162  473  702  789  2,200  2,287 (EBIT), SEK M Profit after   9  311  392  468  1,574  1,650 financial items, SEKNet profit,   SEK M  7  227  288  342  1,159  1,213 Earnings per   share, 0.01  0.93  1.17  1.39  4.77  4.98 SEK Cash flow from   223  463  1,091  1,163  3,599  3,671 operating activities,SEK M  * EBITA 1: EBITA before acquisition, restructuring and integration costs. For further information, please contact:Jeanette Hedén CarlssonEVP Communications & Brand ManagementPhone: +46 (0)10 335 1003Email: jeanette.hedencarlsson@getinge.com  Lars MattssonHead of Investor RelationsPhone: +46 (0)10 335 0043Email: lars.mattsson@getinge.com  This information is information that Getinge AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 08:00 CET on July 17, 2017.About GetingeGetinge is a global provider of innovative solutions for operating rooms, intensive care units, sterilization departments and for life science companies and institutions. Based on our firsthand experience and close partnerships with clinical experts, healthcare professionals and medtech specialists, we are improving the everyday life for people - today and tomorrow.

Getinge has replanned the remediation in Hechingen (DE) related to the Consent Decree with FDA and makes a provision of additional SEK 488 M

As previously communicated the remediation program has continued at the Getinge production sites under the Consent Decree with FDA. A replanning of the ongoing remediation program has been conducted in Hechingen, Germany, and the Group has decided to make an additional provision of SEK 488 M to make the necessary changes. The costs are primarily attributable to increased staffing and process validation. After the decided provision the Group has a total remaining provision of SEK 710 M. As previously announced a US federal judge approved the terms of a Consent Decree between Getinge’s former Medical Systems business area (corresponding to Acute Care Therapies today) and the FDA on February 3, 2015. The Consent Decree establishes a framework that provides assurances to the FDA that Getinge will complete the improvements to strengthen the quality management system. The Consent Decree originally encompasses four legal entities: Atrium Medical Corporation in Hudson (New Hampshire, USA), Wayne (New Jersey, USA), Rastatt (Germany) and Hechingen (Germany). Media contacts: Jeanette Hedén CarlssonEVP Communications & Brand ManagementPhone: +46 (0)10 335 1003Email: jeanette.hedencarlsson@getinge.com Anna Appelqvist,Head of Media RelationsPhone: +46 (0)10 335 5906Email: anna.appelqvist@getinge.com This information is information that Getinge AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:00 CEST on July 17, 2017.    About GetingeGetinge is a global provider of innovative solutions for operating rooms, intensive care units, sterilization departments and for life science companies and institutions. Based on our firsthand experience and close partnerships with clinical experts, healthcare professionals and medtech specialists, we are improving the everyday life for people - today and tomorrow.  

Sandvik divests conveyor components as the final step in exiting Mining Systems

Sandvik has signed an agreement to divest the conveyor components’ parts of the Mining Systems business, including the closely related specialist conveyor systems business in Hollola (Finland), to NEPEAN Conveyors Pty Ltd, a privately owned Australian based company. As announced on 12 July 2017, Sandvik signed an agreement to divest the project business in Mining Systems to FLSmidth. By divesting also the conveyor components’ operations the exit from Mining Systems will be fully executed.  “I am pleased that we now have completed our plan enabling us to further focus on Sandvik’s core businesses. NEPEAN is a truly suitable new owner as they have an ambition to continue to develop this offering”, says Björn Rosengren, President and CEO of Sandvik. Mining Systems is a supplier of design and engineering of material handling systems with annual sales 2016 of 2.9 billion SEK, of which the conveyor components’ parts corresponded to about 20%. The closing of the transaction is expected by the end of 2017 and is subject to regulatory approvals. Mining Systems will continue to be reported in discontinued operations. The transaction will have no or limited impact on earnings per share. For further information, contact Ann-Sofie Nordh, Vice President Investor Relations, phone: +46 8 456 1494 or Pär Altan, Vice President External Communications, phone: +46 70 616 2024. Stockholm, 17 July, 2017 Sandvik AB

Getinge appoints Lars Sandström as CFO and member of Getinge Executive Team

Lars Sandström has been appointed Chief Financial Officer (CFO) and member of Getinge Executive Team. He has held several senior positions within the Finance organization in Scania and most recently served as Senior Vice President, Group reporting, Tax & Control in the Volvo Group. “I am very pleased that Lars has accepted the CFO role and that he will join the Getinge team. Lars has a long and broad experience from the finance area in public listed companies with global businesses. He will bring knowledge and experience both from a head office and a market perspective that will benefit Getinge”, says Mattias Perjos, President and CEO Getinge. During 1998-2010 Lars Sandstöm held various senior finance positions in Scania; Financial Manager Scania Finance Deutschland 2002-2004, Head of Group Financial reporting 2005-2007, Head of Group Reporting and Control 2007-2010 followed by a position as CFO in Swedish Orphan Biovitrum AB 2010-2012. Lars Sandström most recently held the position as Senior Vice President, Group reporting, Tax & Control in the Volvo Group. He holds a Master of Science in Business Administration from the University of Halmstad, Sweden. Lars Sandström will be a member of the Getinge Executive Team and report to Mattias Perjos, President and CEO Getinge. He takes up the position latest January 2018. Lars succeeds Reinhard Mayer who, as earlier communicated, will leave Getinge for personal reasons. Media contacts: Jeanette Hedén CarlssonEVP Communications & Brand ManagementPhone: +46 (0)10 335 1003Email: jeanette.hedencarlsson@getinge.com Anna AppelqvistHead of Media RelationsPhone: +46 (0)10 335 5906Email: anna.appelqvist@getinge.com This information is information that Getinge AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:00 CEST on July 17, 2017.  About GetingeGetinge is a global provider of innovative solutions for operating rooms, intensive care units, sterilization departments and for life science companies and institutions. Based on our firsthand experience and close partnerships with clinical experts, healthcare professionals and medtech specialists, we are improving the everyday life for people - today and tomorrow.

INTERIM REPORT 1 JANUARY – 30 JUNE 2017

"A strong start of the year"1 APRIL – 30 JUNE 2017 (3 MONTHS) · Net sales rose by 23 percent to SEK 572 million (465), of which organic growth totalled 3 percent and acquired growth totalled 17 percent. · EBITA rose by 25 percent to SEK 57 million (47), corresponding to an EBITA-margin of 10.1 percent (10.0). · Profit after tax rose by 12 percent and amounted to SEK 29 million (26). · Cash flow from operating activities amounted to SEK 37 million (-6). 1 JANUARY – 30 JUNE 2017 (6 MONTHS) · Net sales rose by 25 percent to SEK 1,148 million (918), of which organic growth totalled 7 percent and acquired growth totalled 15 percent. · EBITA rose by 37 percent to SEK 111 million (82), corresponding to an EBITA-margin of 9.7 percent (8.9). · Profit after tax rose by 30 percent and amounted to SEK 58 million (45). · Earnings per share amounted to SEK 2.39 (2.11). For the 12-month period, earnings per share amounted to SEK 5.12 (3.99). · Cash flow from operating activities amounted to SEK 84 million (9). · The equity ratio amounted to 40 percent (50). · Return on working capital (P/WC) amounted to 64 percent (57). · Two acquisitions have been carried out during the interim period, TM Techno Medica AB and Hepro AS, with a combined annual sale of about SEK 195 million. · After the reporting period Krabat AS has been acquired, with an annual sales of about SEK 30 million. Stockholm, July 17, 2017AddLife AB (publ) For more information, contact;Kristina Willgård, CEO, kristina.willgard@add.life, +46 70 510 12 23Martin Almgren, CFO, martin.almgren@add.life, +46 70 228 15 45www.add.lifeTeleconferenceInvestors. analysts and the media are invited to a teleconference at which CEO Kristina Willgård and CFO Martin Almgren will present the interim report. The presentation will be given in Swedish and take about 20 minutes. after which there will be an opportunity to ask questions.The teleconference will be at 10:00 a.m. on 17 July 2017The presentation will be available via the following link: https://5569958126.globalmeet.com/MartinAlmgrenPlease call on: +46 8 22 90 90 code: 113242 AddLife is an independent player in the Life Science sector, offering high-quality products, services and advice to the private and public sectors, above all in the Nordic region. AddLife has about 600 employees in some 35 subsidiaries that operate under their own brands. The Group has annual sales of about SEK 2.0 billion. AddLife shares are listed on Nasdaq Stockholm.This information is information that AddLife AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 08:00 a.m. CET on July 17.

NOTE’s Interim Report January–June 2017

Financial performance April–June• Sales increased by 9% to SEK 308.4 (282.4) million. Excluding divestments, sales increased by 12%.• Operating profit rose to SEK 20.3 (15.4) million.• Operating margin expanded by 1.1 percentage points to 6.6% (5.5%).• Profit after financial items increased to SEK 19.3 (13.6) million.• Profit after tax rose to SEK 11.6 (11.0) million, corresponding to SEK 0.40 (0.38) per share, of which SEK -0.14 (-) consisted of write-down of foreign deferred taxes.• Cash flow after investments amounted to SEK 1.3 (4.1) million, or SEK 0.05 (0.14) per share.Financial performance January–June• Sales increased by 4% to SEK 585.5 (561.5) million. Excluding divestments, sales increased by 8%.• Operating profit rose to SEK 50.7 (29.6) million, and adjusted for non-recurring items in the first quarter, operating profit increased to SEK 35.0 (29.6) million.• Operating margin was 8.7% (5.3%), adjusted for non-recurring items in the first quarter, operating margin expanded by 0.7 percentage points to 6.0% (5.3%).• Profit after financial items increased to SEK 48.4 (26.5) million.• Profit after tax was up to SEK 38.5 (21.2) million, corresponding to SEK 1.33 (0.73) per share.• Cash flow after investments amounted to SEK 79.1 (31.2) million, or SEK 2.74 (1.08) per share.CEO’s comment"I am delighted that our market efforts start to show results–in Q2 sales in our units increased by 12%. We still win new customers' confidence and new exciting projects to our already strong customer base. Our recently announced collaboration with innovator myFC, as well as several ongoing projects in the Internet of Things, represent great growth opportunities for us. Growth combined with cost reductions means that we will continue to strengthen our profitability. During the second quarter, our operating margin improved by 1.1 percentage points to 6.6%. We are financially well-equipped for the future–our balance sheet is one of the strongest in the industry with an equity ratio of just over 46%," says Per Ovrén, CEO and President.NOTE’s Interim Report for January–June is now available in PDF format on the corporate web site, www.note.eu, and attached to this message. The Interim Report for January–September will be published on 17 October.For more information, please contact:Per Ovrén, CEO and President, tel. +46 (0)73 440 7727Henrik Nygren, CFO, tel. +46 (0)70 977 0686About NOTENOTE is one of the leading Northern European manufacturing and logistics partners for production of electronics-based products. NOTE produces PCBAs, subassemblies and box build products. NOTE's offering covers the complete product lifecycle, from design to after-sales. NOTE has a presence in Sweden, Finland, the UK, Estonia and China. Net sales in the last 12 months were SEK 1,122 million; the group has approximately 900 employees. NOTE is listed on Nasdaq Stockholm. For more information, please go to www.note.eu.This information is information that NOTE AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of Per Ovrén, at 8:30 a.m. CET on 17 July 2017.   

ExpreS2ion enters multi-product agreement with US-based Integrated BioTherapeutics for expansion of their commercial reagents portfolio

Master Services Agreement (MSA) and Research & Commercial License Agreement (RCLA) The MSA enables IBT to retain ExpreS2ion services and products for IBT research programs in a predefined and simple manner, according to the terms and conditions stipulated in the agreement. The agreement is made based on a common understanding by the parties that such services and products will be required. ExpreS2ion’s overall role will be development and manufacturing of selected protein antigens based on the efficient proprietary technology, ExpreS2. The RCLA grants IBT the research and commercial rights to develop and market proteins made with the ExpreS2 technology. The RCLA contains an annual Research License Fee as well as Royalty of Net Sales to be paid by IBT to ExpreS2ion for such license grant. The Royalty of Net Sales is a two-digit percentage. IBT expects to expand their unique research proteins franchise annually with up to five products developed with ExpreS2.  ExpreS2ion and IBT do not disclose the financial terms of the Agreements, which constitutes a part of both companies’ general business models, however, when the collaboration is fully implemented, ExpreS2ion expects to generate annual revenues of up to 1.0 million SEK as a result of these agreements. Integrated Biotherapeutics, Inc. Integrated BioTherapeutics, Inc. (“IBT”) is a biotechnology company focused on the discovery of novel vaccines and therapeutics for emerging infectious diseases. IBT's pipeline includes promising product candidates for bacterial and viral infections. IBT's antiviral pipeline includes unique pan-filovirus antibody candidates, vaccines and a variety of other product candidates for emerging viruses, such as Zika, Ebola, dengue, Marburg, and others.  IBT is located in Rockville, Maryland, USA, and has a close working relationship with United States Government agencies including the National Institute of Allergy and Infectious Diseases (NIAID/NIH), National Cancer Institute (NCI), United States Army Medical Research Institute of Infectious Diseases (USAMRIID), and many biotechnology and pharmaceutical companies and academic laboratories.  IBT’s service and reagent division doing business as IBT Bioservices (www.ibtbioservices.com) produces and markets high quality recombinant proteins and antibodies primarily for infectious disease research.   CEO Dr. Steen Klysner comments “I am pleased that we have established our first broad commercial agreement in reagent supply with IBT, which has direct sales and distribution to the market for high quality proteins used in research. This expands our near-term revenue business model and demonstrates the value of the ExpreS2 platform in this and related commercial segments. We look forward to this mutually beneficial collaboration with IBT and continued work in the future.” Certified Adviser Sedermera Fondkommission is appointed as Certified Adviser for ExpreS2ion.

Presentation of Probi’s Q2 report 2017

Probi’s report for the second quarter 2017 will be published on Wednesday, 19 July at 8.00 a.m. CET In conjunction with this, analysts, investors and media are invited to an audiocast telephone conference on the same day at 10.00 a.m., where CEO Peter Nählstedt and CFO Jörn Andreas will present and comment on the report. The presentation and presentation material can be obtained via www.probi.se or http://www.financialhearings.com/event/10013  The presentation can also be followed via a telephone conference on the following telephone number:Sweden: +46 8 56 64 26 91UK: +44 20 30 08 98 02US: +1 85 57 53 22 36 After the presentation, conference participants will be able to ask questions. Questions can also be asked via the audiocast. An on-demand version of the presentation will be available at the addresses given above following the presentation. FOR FURTHER INFORMATION, CONTACT:Peter Nählstedt, CEO, Probi, tel +46 46 286 89 23, e-mail: peter.nahlstedt@probi.comJörn Andreas, CFO, Probi, tel +46 46 286 89 41, e-mail: jorn.andreas@probi.com ABOUT PROBIProbi AB is a Swedish publicly traded bioengineering company. The vision of Probi is to help people live healthier lives by delivering effective and well-documented probiotics, with proven health benefits based on scientific research. Founded by scientists in Sweden in 1991, Probi is a multinational company with four centers of excellence, active in more than 40 markets around the world and holding over 400 patents worldwide. In 2016, Probi had net sales of MSEK 444. The Probi share is listed on Nasdaq Stockholm, Mid Cap. Probi has about 5,000 shareholders. Read more at www.probi.se. 

Bravida takes on large coordination project when Region Kronoberg builds new psychiatry facilities

The new premises of 16,000 square meters will contain elderly, psychosis, addictive and general psychiatry, as well as an psychiatric emergency room. That means high demands on the technical installations. Håkan Stjernqvist, CEO of Dynacon Construction AB: – This kind of medical activity put high demands on the technical solutions, where the installations plays an essential part. We have worked with Bravida before and they presented a good and flexible solution to this project. Therefore, the choice fell on them. I feel confident with Bravida coordinating and performing all installations. Bravida has an important role in the stage of projection as well as performing all installations of electrics, heating & plumbing, HVAC, sprinkler and control solutions in the new, installation dense, facilities. – This is one of the largest projects Bravida Växjö has received. We have the skills and resources so it feels both safe and exiting. The timetable of this project is, like for many others, very tight. This requires good coordination which is one of our strengths, says Niclas Johansson, Project Manager, Bravida Region Jönköping. The project starts in august 2017 and is estimated to be completed during the fall 2019. Bravida will have 50 employees involved in the project and it will also open up for new recruitments. For further information, please contact:Niclas Johansson, Project Manager, Bravida Region Jönköping. Phone: +46 725-38 86 06Henrik Ekelöf, Deputy Project Manager, Bravida Växjö. Phone: +46 470-377 09

Chelsea Football Club appoints Ericsson as Connected Venue Partner

Ericsson (NASDAQ: ERIC) has been unveiled as the connectivity partner for Stamford Bridge – Chelsea Football Club’s home stadium in Fulham, London. Free Wi-Fi coverage will be provided via the Small Cell as a Service connected venue business model whereby Ericsson designs, builds and operates the network on the customer’s behalf. As a result, Chelsea FC will be able to provide fans throughout the stadium with a richer experience that enables them to interact digitally with each other, the club, friends and family. In winning their fifth Premier League title in 2016/2017, Chelsea FC sold out every home match day at Stamford Bridge. Many fans used their smartphones to share photos and videos via social media, often stretching cellular networks to the limit. To ensure visitors can enjoy a seamless digital experience, Ericsson will design, build and operate a carrier-grade Wi-Fi access network and then manage it on Chelsea FC’s behalf. Chris Townsend, Chelsea FC commercial director, says: “We look forward to a rich partnership with Ericsson which will directly assist the thousands of fans who come regularly to Stamford Bridge. Ericsson leads the way in providing innovative digital solutions and we welcome them to the Chelsea family.” Arun Bansal, Senior Vice President, Europe & Latin America, Ericsson, says: “Our research indicates that people want to use their digital devices wherever they go – and the urge to connect is even greater at a Chelsea FC home game. Through this partnership, we will ensure the connectivity at Stamford Bridge matches the quality of the football and look forward to exploring further options that will enable Chelsea FC to take the digital experience to the next level.” Small Cell as a Service supports service providers’ cellular go-to-market models, enables businesses to monetize Wi-Fi, provides a business case for network build-out and improves end-user experience. In 2015, Legia Warsaw became the first football club in Europe to sign a Small Cell as a Service contract with Ericsson. In 2016, Ericsson became the connectivity partner for the Ricoh Arena stadium in Coventry, England, home to Aviva Premiership rugby team Wasps and Wasps Netball. Through four weeks of football mania in Brazil in 2014, the Nordic World Ski Championships in Sweden in 2015, the 2016 European football tournament in France, and the 2016 summer sports event in Rio, Ericsson ensured the networks kept pace with the fans. Click here  to read how we connect the most popular venues around the world. NOTES TO EDITORS About Chelsea Football Club Chelsea Football Club is one of the world’s top football clubs and current Premier league champions. UEFA Champions League winners in 2012, the club followed that success by lifting the UEFA Europa League trophy in 2013. Founded in 1905, Chelsea is London’s most central football club, based at the iconic 42,000-capacity Stamford Bridge stadium. Nicknamed ‘the Blues’, Chelsea are five-time English Premier League champions and have also lifted the FA Cup seven times, the Football League Cup five times, the UEFA Cup Winners’ Cup twice, the UEFA Super Cup once and the Football League Championship once, in 1955. The Europa League triumph saw Chelsea become the first English club to win all three major UEFA competitions, and the first club ever to hold both the Champions League and Europa League at the same time. In addition to possessing some of the world’s most recognisable players and head coach Antonio Conte, the club has also invested in its future with a state-of-the-art Academy and training centre in Cobham, Surrey. Since its opening in 2007, Chelsea have lifted the FA Youth Cup trophy six times and the UEFA Youth League twice. The Chelsea Ladies team also won the FA Women’s Super League and FA Women’s Cup Double in 2015, adding the Spring Series in 2017. Additionally, the Chelsea Foundation boasts one of the most extensive community initiatives in sport, working in 30 countries around the world, helping improve the lives of more than 900,000 children and young people each year. For media kits, backgrounders and high-resolution photos, please visit www.ericsson.com/press FOLLOW US: www.twitter.com/ericssonwww.facebook.com/ericssonwww.linkedin.com/company/ericssonwww.youtube.com/ericsson  MORE INFORMATION AT: News Center  media.relations@ericsson.com(+46 10 719 69 92) investor.relations@ericsson.com(+46 10 719 00 00) Ericsson is a world leader in communications technology and services with headquarters in Stockholm, Sweden. Our organization consists of more than 111,000 experts who provide customers in 180 countries with innovative solutions and services. Together we are building a more connected future where anyone and any industry is empowered to reach their full potential. Net sales in 2016 were SEK 222.6 billion (USD 24.5 billion). The Ericsson stock is listed on Nasdaq Stockholm and on NASDAQ in New York. Read more on www.ericsson.com.

STRONG MOMENTUM IN RAYSTATION PROTON THERAPY SALES

These eight centers represent a variety of hospital environments and machine types. RayStation will be used together with the IBA Proteus Plus and Proteus One systems, Mevion systems with HYPERSCAN, and Hitachi ProBeat systems. The centers will receive the latest version of RayStation, which includes innovative features such as fast Monte Carlo pencil beam scanning (PBS) optimization and dose calculation, use of PBS with apertures, and robust optimization/4D-CT optimization for proton and carbon ion planning. All purchases include both clinical and research licenses. RayStation has a wide range of features of value to researchers at academic centers. A few examples are LET and RBE calculations for proton and carbon PBS planning, interplay evaluation from machine delivery log files, PET-based range verification, proton and carbon planning on virtual CBCT(CT) images, and small animal X-ray irradiator planning. The clinical and research configurations of RayStation will be on show at the upcoming AAPM Annual Meeting in Denver, Colorado, 30 July–2 August 2017. Attendees are welcome to visit RaySearch at booth #5079 and demonstrations can be booked now at www.raysearchlabs.com. About RayStationRayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon ion therapy. The system is built on the latest software architecture and features a graphical user interface with state-of-the-art usability. About RaySearchRaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved radiation therapy of cancer. RaySearch markets the RayStation treatment planning system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. The company is also developing the next-generation oncology information system, RayCare®*, which comprises a new product area for RaySearch, and which will be launched in December 2017. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the share has been listed on NASDAQ Stockholm since November 2003. * Subject to regulatory clearance in some markets For further information, please contact:Johan Löf, President and CEO, RaySearch Laboratories AB (publ)Telephone: +46 (0)8-510 530 00johan.lof@raysearchlabs.com 

FreiLacke implements IFS Applications 9 to support international growth

IFS , the global enterprise applications company, announces that FreiLacke , a leading provider of system coatings with headquarter in Doeggingen, Germany, has decided to implement IFS Applications™ 9 . With the new solution, the company modernizes its software landscape, which will support its international expansion plans. Family-owned business FreiLacke has already been internationally active with locations in the UK, Sweden, Russia and China and is experiencing global expansion. As this undertaking cannot be realized targeted and efficient with its existing software landscape, the company has decided to implement IFS Applications 9. Apart from optimal support of international processes, FreiLacke can now create an integrated comprehensive solution that replaces many of the legacy systems. Thus the company can reduce interface complexity significantly and ensure transparent and holistic data. FreiLacke will use the following components from IFS Applications: finance, HR, project management, product design, production, supply chain, sales and service, maintenance, quality management as well as business process management. After the initial go-live of the solution in Germany, FreiLacke plans to roll out IFS Applications at all its international locations in 2019. During the implementation of the software, IFS will be supported by its implementation partner syscon. IFS Applications prevailed in an extensive and demanding selection process that started with 20 providers and also comprised replying to specification sheets and various process workshops but also visits to current customers. “IFS Applications has the most modern architecture of all ERP-solutions we evaluated and offers an outstanding user experience”, Karl Fritschi notes, Assistant to the Commercial Manager of FreiLacke and Director of the project “ERP live”. “The IFS team has shown a deep understanding for our business requirements and processes and always reacted in a solution-oriented manner to our questions. Having the right team to support our implementation was particularly important to us.” “The process industry and especially the paints and coatings segment is one of our most important target markets”, says Peter Höhne, Vice President Sales & Marketing at IFS Europe Central. “FreiLacke is another leading company from that industry, so we are pleased that the company has decided to implement IFS Applications 9. This is testament to our commitment in this market and our comprehensive investments into the process industry.” Read more about the IFS solutions for the process industry: http://www.ifsworld.com/corp/industries/process-manufacturing/.

AAK’s Interim report for the second quarter 2017 – all-time high operating profit for a second quarter

· Operating profit reached SEK 409 million (368), an improvement of 11 percent. The currency translation impact was SEK 6 million, entirely related to Chocolate & Confectionery Fats.- Ramp-up costs for the greenfield projects in Brazil and China have, according to plan, been absorbed in the reported profit. · Total volumes continued to grow nicely and were up 11 percent (6). Organic volume growth was 5 percent (1). The demand for speciality and semi-speciality products continued to be strong and generated organic volume growth of 5 percent (5). · Food Ingredients improved by 14 percent, reaching SEK 271 million (238). It was a strong quarter with double-digit profit growth due to a continued improved product mix, including a higher portion of customer co-developed solutions. However, the picture between the different segments was mixed:- The Dairy segment continued the strong trend from 2016 and once again reported high double-digit organic volume growth. All regions showed very strong growth except the Nordics where the development was modest.- The Bakery segment had a slightly challenging quarter. The European market remained a challenge and the development in North Latin America was slightly weaker in the second quarter. There was, however, good growth in Asia and South Latin America.- Special Nutrition reported high double-digit volume growth with a significantly better product mix compared to the corresponding quarter last year. This was driven by a double-digit volume growth for our Infant Nutrition product range Akonino®. Our other Infant Nutrition product range InFat®, sold through Advanced Lipids AB, a joint venture of AAK and Enzymotec, also showed double-digit volume growth in the quarter.- Foodservice reported declining volumes in the quarter. This was mainly due to continued challenging market conditions in the Nordics. · Chocolate & Confectionery Fats reported a result of SEK 165 million (146), another impressive quarter with double-digit organic volume growth and profit growth of 13 percent. Both total volume growth and organic volume growth was 14 percent in the quarter. There was continued strong organic volume growth for both speciality and semi-speciality products, with several showing exceptional volume growth – in mature as well as in emerging markets. · Technical Products & Feed reached SEK 9 million (23) and had a more challenging quarter due to an extended, but planned, maintenance stop in our crushing operation with continued pressure from higher raw material prices for the fatty acids business. However, we expect this pressure to gradually decrease over the coming quarters. · Earnings per share increased by 14 percent, to SEK 6.25 (5.47), despite increased earnings in countries with high tax rates. · Operating cash flow including changes in working capital amounted to SEK 171 million (520). As earlier communicated, cash flow from working capital was negative, amounting to SEK 66 million (positive 158). Increased raw material prices, strong organic volume growth and working capital tied up for the two greenfield investments, continued to have a negative impact on working capital. Inventory management has been good and volumes in stock have decreased. There has been a decrease in raw material prices since mid-first quarter which will have a positive impact on cash flow with a time lag of 6–9 months. · Calculated on a rolling 12 months basis, Return on Capital Employed (ROCE) was 15.3 percent (15.8 at December 31, 2016). · Our greenfield project in Brazil is progressing according to plan with volumes increasing quarter by quarter. · Our greenfield project in China is also progressing according to plan. To be able to deliver the whole product range a gradual ramp-up will continue during the upcoming quarters. · Our new company program, The AAK Way, will guide us up through 2019. Our key focus with the program is to enable the company to continue to deliver strong organic growth. This will be achieved by focusing on five priority areas: Go to Market, Operational Excellence, Special Focus Areas, Innovation and People. The implementation of the program is developing according to plan. - During the second quarter we delivered our first volumes of Akovita®, AAK’s new product range for the senior nutrition market. This is an important milestone within The AAK Way. AAK’s tailor-made speciality blend Akovita® will be used in a powder product for the European market. · As communicated in a press release on May 8, 2017, AAK’s CEO Arne Frank has been undergoing medical treatment. The rehabilitation is continuing but will be somewhat longer than earlier predicted. Fredrik Nilsson will continue as acting CEO until Arne Frank returns to full employment. Concluding remarks:“Based on AAK’s customer value propositions for health and reduced costs, and our customer product co-development and solutions approach, we continue to remain prudently optimistic about the future. The main drivers are the continued positive underlying development in Food Ingredients and the continued improvement in Chocolate & Confectionery Fats.” The Interim report for the second quarter 2017 will be presented today, July 17, 2017 at 1 p.m. CET at a Press & Analyst telephone conference. For participation, please see instructions under the Investor tab at the AAK website, www.aak.com. For further information, please contact:Fredrik NilssonCFO and acting CEO                                   Mobile: +46 708 95 22 21                 E-mail: fredrik.nilsson@aak.comThis information is information that AAK AB (publ.) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Act. The information was submitted for publication, through the agency of the contact person set out above, at 10:20 a.m. CET on July 17, 2017. AAK is a leading provider of value-adding vegetable oils & fats. Our expertise in lipid technology within foods and special nutrition applications, our wide range of raw materials and our broad process capabilities enable us to develop innovative and value-adding solutions across many industries – Chocolate & Confectionery, Bakery, Dairy, Special Nutrition, Foodservice, Personal Care, and more. AAK’s proven expertise is based on more than 140 years of experience within oils & fats. Our unique co-development approach brings our customers’ skills and know-how together with our own capabilities and mindset for lasting results. Listed on the NASDAQ OMX Stockholm and with our headquarters in Malmö, Sweden, AAK has 20 different production facilities, sales offices in more than 25 countries and more than 3,000 employees. We are AAK – The Co-Development Company. 

Bormioli Luigi and Triton partnered to acquire the Bormioli Rocco tableware and pharma businesses respectively

Milan / Fidenza (Italy), 17 July 2017 – Bormioli Luigi S.p.A. has partnered with Funds advised by Triton (“Triton”) to purchase the Pharma and Tableware business divisions of the Bormioli Rocco group. Both business divisions will be owned and run independently of each other, as Bormioli Luigi will acquire the Tableware division and Triton will acquire the Pharma division. Bormioli Rocco is a leading Italian tableware and pharma primary packaging manufacturer currently owned by Vision Capital. The transactions are subject to regulatory approval in the relevant jurisdictions. Any necessary employee information and/or consultation procedures will occur in France and Italy at the appropriate time.  “With the historical acquisition of Bormioli Rocco Tableware, Bormioli Luigi will expand the perimeters of its organizational and material resources in order to develop original and virtuous ways of doing business in glass, to the advantage of client's interests leveraging on both Companies’ knowledge, culture and capabilities”, said Alberto Bormioli the President of Bormioli Luigi, the majority shareholders and founder’s son. “We look forward to supporting Bormioli Pharma’s management and employees as new owner by investing in and supporting the growth and development of the business. Our strong industry expertise, gained through other investments in this business area and strengthened by senior industry experts, will contribute in taking Bormioli Pharma to the next level. We look forward to working together with the management team and the Board of Directors in building a stronger company”, said Peder Prahl, Director of the General Partner for the Triton funds. “Bormioli Rocco, as one of the European market leaders active in the tableware and pharmaceutical packaging businesses, has been building its current presence over the last decades. These transactions are an important milestone since, on top of allowing us to pay off all financial debt, they are enabling us to continue with our strategic efforts with a more focused approach on the two respective single divisions. We welcome the new majority owners respectively, as investors who will support us in executing our plans and continuing to be the leaders in each of our industries”, said Riccardo Garrè, Executive Chairman of Bormioli Rocco. About Bormioli Rocco Established in 1825, the Bormioli Rocco is leading Italian pharma primary packaging and glass tableware manufacturer. Organized in two Business Units: Home and Pharma, Bormioli Rocco has eight manufacturing plants, two decoration ateliers, several subsidiaries and seven mono-brand stores featuring tableware products. The Group exports its products to more than 100 countries worldwide and represents one of the most important industrial realities on the international scenario. Bormioli Rocco employees over 2,000 people and has an annual turnover of € 440 million. About Bormioli Luigi Bormioli Luigi is a specialized glass company with a world-class image of excellence in the manufacturing of high quality containers for perfume and spirits bottles, as well as tableware in superior crystal glass. Following the timeless tradition, Alberto Bormioli in collaboration with the CEO, Vincenzo Di Giuseppantonio, and a dedicated, professional and enthusiastic team, will continue to uphold the ever topical and fascinating challenge inspired by the art of glass-making. For further information: http://www.bormioliluigi.com  About Triton The Triton funds invest in and support the positive development of medium-sized businesses headquartered in Europe, focusing on businesses in the Industrial, Business Services and Consumer/Health sectors.  Triton seeks to contribute to the building of better businesses for the longer term. Triton and its executives wish to be agents of positive change towards sustainable operational improvements and growth. The 30 companies currently in Triton's portfolio have combined sales of around €14 billion and around 86,000 employees. The Triton funds are advised by dedicated teams of professionals based in Germany, Sweden, Norway, Finland, Denmark, Italy, the United Kingdom, the United States, China, Luxembourg and Jersey. For further information: www.triton-partners.com  Press Contacts: Bormioli LuigiCamilla ReggianiPhone: +39 0521 793214 TritonMarcus BransPhone: +49 69 921 02204  Bormioli RoccoElisa Lavagna, Brunswick Group+39 02 9288 6200 Vision CapitalAlison Kay/Miranda Ward, Brunswick GroupPhone: +44(0) 20 7404 5959 

Axel Johnson International acquires IOW Group

IOW Group was established in 1993 and has a long-term relationship with its customers and suppliers. The customers are mainly Original Equipment Manufacturers (OEMs) within Mechanical Engineering, Construction Equipment, Machines in Mining and Agriculture as well as Railway Equipment. The current owners of the IOW Group will remain as minority shareholders and will continue to lead the businesses going forward. “To become a part of Axel Johnson International will allow us to continue to develop the product and service offerings in our home markets. IOW´s experience and technical know-how, combined with Axel Johnson International´s financial strength and long-term perspective, will provide a strong support to our future development, this will guarantee also for our customers and suppliers a continuation and a stable perspective for the future”, says Mr Jürgen Dückert, Chairman and current majority owner of the IOW Group.   With the acquisition of the IOW Group, Axel Johnson International strengthens its’ European market position as distributor and service provider of mobile drive trains solutions in Europe. The IOW Group will become part of Axel Johnson International’s business group “Industrial solutions” and a sister company to Trans-Auto AB, which is active in distribution and service of mobile and marine drivetrains in the Nordic markets and in Russia.  “IOW group, the market leader in their geographic markets in Central and Eastern Europe fits very well with Axel Johnson International and Trans-Auto AB. The acquisition of the IOW group provides a platform for expanding our activities in Central and Eastern Europe. We look forward to growing our business together with the IOW team” says Martin Malmvik, President and CEO of Axel Johnson International. The transaction is expected to close later in Q3 2017, awaiting necessary approval by relevant government authorities. For further information, please contact: · Martin Malmvik, CEO and President, Axel Johnson International, +46 (0)8 453 77 14, martin.malmvik@axinter.com · Hans Glemstedt, Head of Strategy and M&A, Axel Johnson International, +46 (0)8 453 77 41, hans.glemstedt@axinter.com · Ola Sjölin, Managing Director, Industrial Solutions, +46 (0)8 453 77 25, ola.sjolin@axinter.com · Jan Brattberg, Managing Director, Trans-Auto, +46 (0)8 554 240 24, jan.brattberg@transauto.se · Jürgen Dückert, Chairman of IOW Group of companies, + 49 -661 777071, Juergen.dueckert@iow.de · Ryszard Mazurek, CEO, IOW Trade, +48 – 22 512 56 60, ryszard.mazurek@iow.pl · Andrzej Karpiak, CEO, IOW service, +48- 76 852 21 17, Andrzej.karpiak@iow.pl · Krassen Milev, CEO, IOW Bulgaria, +359 2 99 28 443, krassen.milev@iow.bg  

Interim Report Second Quarter 2017

Second quarter 2017 Continuing operations   · Order intake 24,533 million SEK · Revenues 23,553 million SEK · Operating profit 3,271  million SEK · Operating margin 13.9% · Adjusted operating profit 3,721 million SEK · Adjusted operating margin 15.8% · Profit after financial items 3,045 million SEK · Earnings per share 1.75 SEK · Cash flow from operations 2,493 million SEK Discontinued operations · Order intake 407 million SEK · Revenues 893 million SEK · Operating profit 13 million SEK Group Total · Order intake 24,940 million SEK · Revenues 24,446 million SEK · Operating profit 3,284 million SEK · Operating margin 13.4% · Adjusted operating profit 3,734 million SEK · Adjusted operating margin 15.3% · Earnings per share 1.76 SEK · Cash flow from operations 2,225 million SEK Additional information may be obtained from Sandvik Investor Relations, phone +46 8 456 14 94 (Ann-Sofie Nordh), +46 8 456 11 94 (Anna Vilogorac) or e-mailing info.ir@sandvik.com A presentation and teleconference will be held on 17 July 2017 at 13:00 CET. Information is available at home.sandvik/investors   Stockholm, 17 July 2017 Sandvik Aktiebolag (publ) Björn Rosengren President and CEO This information is information that Sandvik AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at about 11.30 CET on 17 July 2017.

Mats Rahmström comments on Atlas Copco’s Q2 2017

Orders received in the second quarter grew to MSEK 30 797 (25 207), an organic increase of 11%. Revenues were MSEK 29 030 (24 565), and the adjusted operating profit margin was 21.5% (19.6). Growth was especially strong in Asia where all the business areas grew significantly. Among segments, the semiconductor industry continued to show robust demand for vacuum solutions, and orders for mining equipment rose significantly from a year earlier due to expansions of existing mines as well as investments to replace aging equipment.   “We had a strong quarter thanks to our competent people, innovative products and services, and favorable business climate in most regions,” said Mats Rahmström, President and CEO of the Atlas Copco Group. “We offer what customers need to be productive and energy efficient - by using our solutions they buy their own success.” Innovative products launched in the quarter include a new range of energy-efficient dryers with low noise level, a cost-efficient abatement system, a small and flexible system for tightening applications, a powerful drill bit range for increased productivity in mining and rock excavation, and LED-powered light towers with high performance and long lifetime. Mats Rahmström began his new role on April 27, becoming Atlas Copco’s 12th President and CEO since its foundation in 1873. “I am proud to get the opportunity to lead this fantastic company,” Mats Rahmström said. “I believe in building passionate teams that develop innovative solutions and constantly challenge themselves so that we create value for our customers.” Other important events or announcements in the quarter included:    · Epiroc AB will be the name of the company to be dividended out in 2018; focus is on customers in the mining, infrastructure and natural resources industries. · The Construction Technique business area has changed name to Power Technique to better reflect the current products and customer segments. · Vagner Rego was appointed President Compressor Technique, effectiveAugust 1, 2017. · Cecilia Sandberg was appointed Senior Vice President Human Resources, effective October 1, 2017. 

Alfa Laval AB (publ) Interim report April 1 - June 30, 2017

Summary: second quarterOrder intake increased by 14 percent* to SEK 9,629 (8,101) million.Net sales decreased by 4 percent* to SEK 8,907 (8,950) million.Adjusted EBITA**: SEK 1,410 (1,393) million.Adjusted EBITA margin**: 15.8 (15.6) percent.Result after financial items: SEK 733 (1,265) million.Net income: SEK 479 (931) million.Earnings per share: SEK 1.14 (2.21). Cash flow from operating activities: SEK 1,042 (1,233) million.Impact on adjusted EBITA of foreign exchange effects: SEK 96 (137) million. Summary: first six monthsOrder intake increased by 11 percent* to SEK 18,430 (15,811) million.Net sales decreased by 5 percent* to SEK 17,033 (17,149) million.Adjusted EBITA**: SEK 2,689 (2,726) million.Adjusted EBITA margin**: 15.8 (15.9) percent.Result after financial items: SEK 2,001 (2,355) million.Net income: SEK 1,255 (1,802) million.Earnings per share: SEK 2.98 (4.27). Cash flow from operating activities: SEK 1,846 (2,143) million.Impact on adjusted EBITA of foreign exchange effects: SEK 171 (230) million. * Excluding currency effects.** Alternative performance measures, defined on page 23. Outlook for the third quarter:“We expect that demand during the third quarter 2017 will be lower than in the second quarter.”Earlier published outlook (April 26, 2017): “We expect that demand during the second quarter 2017 will be in line with or somewhat lower than in the first quarter.” The interim report has not been subject to review by the company’s auditors. For more information, please contact:Peter Torstensson, Senior Vice President, CommunicationsPhone: +46 46 36 72 31Mobile: +46 709 33 72 31 peter.torstensson@alfalaval.comGabriella Grotte, Investor Relations Manager Phone: +46 46 36 74 82Mobile: +46 709 78 74 82gabriella.grotte@alfalaval.com Alfa Laval AB (publ) PO Box 73 SE-221 00 Lund SwedenCorporate registration number: 556587-8054 This information is information that Alfa Laval AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at CET 11.45 on July 17, 2017.

Stena makes substantial investment in Superfast VII and Superfast VIII

The ships currently operate under a charter contract agreement with AS Tallink Grupp and have done since they were deployed on the Belfast – Cairnryan route when it opened in November 2011.  Since then the vessels have proved to be both highly reliable and extremely popular with Stena Line customers, hence the acquisition.     Paul Grant, Stena Line’s Trade Director (Irish Sea North) said: “We are delighted to confirm that we have now acquired the highly successful Superfast VII and VIII vessels.  Since their arrival the ships have proved to be perfectly suited to our 2hr 15 min service between Belfast and Cairnryan and appeal equally well to our freight and travel customer segments.  Belfast is a key European business hub for Stena Line and this latest investment signifies Stena’s commitment to developing the region further in the years ahead.”  To date on the route the Superfast vessels have made a total of 23 000 trips and carried 6.4m passengers, 1.4m cars and 1m freight units.  Stena will take over formal ownership of the vessels in December 2017. The purchase of the Superfast vessels is part of Stena Line's ambitious development plan.  This plan also involves the construction of new vessels which will be built at the AVIC Shipyard in China. Stena Line is the largest ferry operator on the Irish Sea, offering the biggest fleet and the widest choice of routes between Britain and Ireland including Belfast to Liverpool and Heysham, Belfast to Cairnryan, Dublin to Holyhead and Rosslare to Fishguard routes, a total of 228 weekly sailing options between Britain and Ireland. Stena Line also offers a direct service from Rosslare to Cherbourg with three return crossings a week. 

TerraNet and Orange Labs in joint trial of TerraNet’s patented service platform for mobile data sharing

TerraNet and Orange Labs have jointly established a test-bed at Warsaw University of Technology, Faculty of Electronics and Information Technology, letting students validate the solution and define usage scenarios of the service. The order has an initial value of 30,000 EUR with the trial running for six months. "GriDD is a very interesting and innovative new feature. To be the first operator testing the functionality of GriDD is very compelling." says Sebastian Grabowski, Director of Research and Development Center at Orange Polska S.A. The GriDD-technology is creating a digital spot-market for the resale of gigabytes between smartphone users. The service opens up for people to always stay connected. When coverage is limited, the GriDD-app will use proximal connectivity to extend network reach by using a standardized underlying protocol for discovery and synchronization. "GriDD is a powerful service for mobile phone users, which gives them the freedom to always stay connected and the possibility to communicate independently of the size of their data subscription plan or them being within reach of a hotspot or other operator networks. To that end, GriDD is truly a transformative feature and a service with potential to be a game-changer.” says Pär-Olof Johannesson, CEO at TerraNet.  Orange is one of the world’s leading telecommunications operators in Europe and Africa, and is a global leader in corporate telecommunication services. Orange Polska is Poland’s leading telecommunication provider, operating in all segments of the Polish Telecom market and is part of Orange Group. Orange is present in 29 countries with a total customer base of 263 million people worldwide in 2016, including 202 million mobile customers and 18 million fixed broadband customers. In March 2015, the Group presented its new strategic plan “Essentials2020,” which places customer experience at the heart of its strategy with the aim of allowing them to benefit fully from the digital universe and the power of its next generation networks. Orange is listed on Euronext Paris and on the New York Stock Exchange. Press and IR contact:Pär-Olof Johannesson, CEOinvestorrelations@terranet.semobile +46 70 332 32 62 ABOUT TERRANETTerraNet delivers a unique patented software technology that enables intelligent machine-to-machine communication and streaming of data, including broadband demanding HD media, regardless of any mobile network or other hot spot-dependent networks. TerraNet is headquartered in Lund, Sweden with established sales and marketing agents in San Jose, Silicon Valley, Hyderabad, India, and Taipei, Taiwan. TerraNet Holding AB (publ) is listed on Nasdaq First North Premier.Visit: www.terranet.se  FNCA Sweden AB is the Certified Adviser to TerraNet Holding AB (publ).

Agricultural Bank of China Co. Ltd. Signs Bank-Enterprise Comprehensive Agreement with Jiangman Yili Fisheries

GUANGZHOU, China-- Sino Agro Food, Inc. (OTCQX: SIAF | OSE: SIAF-ME), a specialized investment company focused on protein food including seafood and cattle, wishes to announce a key agreement toward the financing and spinoff of its former subsidiary, Tri-way Industries, in which Sino Agro Food, Inc. holds a 36.6% ownership interest. Agricultural Bank of China (“ABC”) and Jiangman Yili Fisheries Co. Ltd. China (“JFD”), a fully owned subsidiary of Tri-way Industries Ltd. (“TW”) have signed a Bank-Enterprise Comprehensive Strategic Cooperation Agreement (“BECSCA”) this past week in Guangzhou. JFD is one of the select companies afforded this level of partnership with ABC in the Guangdong region. ABC is providing a revolving credit facility to TW/JFD, which is eligible to be drawn incrementally up to its maximum line of RMB 100 million, with the maximum line intermittently increased as experience and corollaries between ABC and TW/JFD materialize. The monetary amount designated for each draw and its use will be determined in consultation between both parties. A rolling audit of TW/JFD by ABC is one of the conditions that must be met satisfactorily to permit continued use and increase of the revolving credit facility. In addition to the revolving credit facility, the other major provisions of the agreement include: · Personal banking VIP channel, which provides one-on-one consultation and expedited services to its clients; · Bond and debt advisory, including bond underwriting, debt financing, and/or direct (equity) investment in the Company; · Foreign lending and/or foreign investment facilitation, utilizing ABC’s international network of investors and lenders to obtain outside funding sources in addition to those provided by ABC. According to the BECSCA, these and other provisions afforded TW/JFD culminate in what best can be described as a “win-win” joint venture. Agricultural Bank of China Co., Ltd., the world’s third largest bank based on reported assets, is oriented to create partnerships with well-vetted corporations with an international focus. TW plans to develop an aggressive export sales side to complement its already strong domestic sales operations. This is one of the primary reasons ABC has requested the Company to become an Enterprise Partner during the build-out phase of its development. CEO and CFO Commentary  Mr. Solomon Lee, interim Chairman of TW as well as Chairman and CEO of Sino Agro Food, Inc., extended his sincere appreciation to the collective management of ABC for their high level of trust and confidence expressed in TW/JFD’s current operations, and its future impact, both locally and internationally. Mr. Lee stated, “the ‘win-win’ partnership signed today with ABC, increases TW/JFD’s capacity to meet its development goals while enhancing its status as an economic driver throughout the region. Along with its recent 5A-1 rating by Dun and Bradstreet, the BECSCA arrangement provides further testament to JFD’s parent, TW, providing additional merit to the Company’s overall standing and expanded opportunities within the banking and business communities.” SIAF CFO Dan Ritchey elaborated, “ABC is perhaps uniquely well-suited to help Tri-Way meet its aims, through not only financial commitment, but also direct strategic communication, and what it says to partners, customers, and other constituents about Tri-Way. As communicated previously, Tri-way is in discussions with financial institutions in other Asian countries.”

Handelsbanken’s Interim Report January – June 2017

Summary January – June 2017, compared with January – June 2016 · Operating profit rose by 4% to SEK 10,604m (10,244) · The period’s profit after tax for total operations decreased by 1% to SEK 8,167m (8,237) · Earnings per share for total operations decreased to SEK 4.20 (4.31) · Return on equity for total operations declined to 12.6% (13.7) · Income increased by 1% to SEK 20,274m (20,165) and by 5% after adjustment for capital gains in the period of comparison · Net interest income rose by 6% to SEK 14,402m (13,603) · Net fee and commission income rose by 9% to SEK 4,862m (4,450) · The C/I ratio decreased to 45.8% (47.2) · The loan loss ratio was unchanged at 0.04% (0.04) · The common equity tier 1 ratio increased to 23.4% (23.0) and the total capital ratio was 29.0% (28.9) Summary of Q2 2017, compared with Q1 2017 · Operating profit fell by 2% to SEK 5,257m (5,347), but increased by 3% after adjustments for non-recurring items in the quarter of comparison · The period’s profit after tax for total operations decreased by 1% to SEK 4,056m (4,111), and earnings per share were SEK 2.09 (2.11) · Return on equity for total operations rose to 12.9% (12.4) · Income increased by 2% to SEK 10,238m (10,036) · Net interest income increased by 3% to SEK 7,321m (7,081) · The loan loss ratio was 0.04% (0.04) The slide presentation for today’s press conference will be available at 07.00 CET at handelsbanken.se/ireng For further information, please contact:Anders Bouvin, President and Group Chief ExecutiveTel: +46 (0)8 22 92 20 Rolf Marquardt, CFOTel: +46 (0)8 22 92 20 Mikael Hallåker, Head of Investor RelationsTel: +46 (0)8 701 29 95, miha11@handelsbanken.se This information is of the type that Handelsbanken is obliged to make public pursuant to the EU Market Abuse Regulation and the Swedish Securities Markets Act. The information was submitted for publication through the agency of the contact person set out above, at 07.00 CET on 18 July 2017.  For more information about Handelsbanken, please go to: handelsbanken.com

BillerudKorsnäs CEO to leave early 2018

”Per Lindberg has during several years very successfully contributed to the development of Billerud and later BillerudKorsnäs. The company has under Per’s leadership more than tripled the turnover and has fivefolded its market capitalization, and now has a world-leading position in its segments for innovative, sustainable packaging materials and solutions. BillerudKorsnäs has established a solid forward-looking strategy, it is operating within attractive and growing product areas, and it is led by a strong management team. We are therefore well prepared for the next phase of expansion and development, which will be led by a new President and CEO. We extend our sincere thanks to Per for his contributions and wish him good luck in his new challenges at Epiroc”, says Lennart Holm, Chairman of the Board at BillerudKorsnäs. ”It has been several fantastic years at BillerudKorsnäs, and the decision to leave the team and the company has not been easy. But I have worked in the constellation BillerudKorsnäs over many years and I now feel it is time to move on to new challenges. The company has a strong management team and is well positioned for the future, and I am convinced that the company will continue its positive development. Therefore, I feel confident to move on and look very much forward to working with the team at Epiroc”, says Per Lindberg. Per Lindberg has been President and CEO of Billerud and later BillerudKorsnäs since 2005. For further information, please contact: Lennart Holm, Chairman of the Board, BillerudKorsnäs AB (publ), +46 70 630 8562 Per Lindberg, President and CEO, BillerudKorsnäs AB (publ), +46 8 553 335 00, per.lindberg@billerudkorsnas.com   This information constituted inside information before publication. This is information that BillerudKorsnäs AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 07:00 CET on 18 July 2017.

INTERIM REPORT January–June 2017

(Tables included in attached PDF) Q2 2017 · Net sales SEK 5 600 m · EBITDA SEK 863 m · EBITDA margin 15% · Earnings per share SEK 1.72 KEY HIGHLIGHTS · Net sales increased by 3% compared with the same period last year as a result of local price increases and changes in exchange rates. · EBITDA was in line with the corresponding period last year. EBITDA was affected by SEK 55 million as a result of non-recurring costs for a pulp mill breakdown at Gruvön and additional costs related to Rockhammar. · EBITDA was affected by SEK 230 million in costs for maintenance shutdowns, which is SEK 155 million more than the previous quarter and SEK 25 million more than estimated. · Earnings per share for the quarter amounted to SEK 1.72 (1.93). OUTLOOK · Demand and order situation are expected to be strong in the third quarter with normal seasonal variances for all business areas. · The Packaging Paper and Corrugated Solutions business areas see opportunities for local price increases in the next quarter. · Longer transportation of wood is expected to have a 3% negative effect on wood costs in Q3 compared with Q2. · The situation at the Port of Gothenburg could have an impact on the Group's delivery capacity and costs during Q3. · Costs for planned maintenance shutdowns in the third quarter are estimated at SEK 215 million Comments by BillerudKorsnäs’ CEO Per Lindberg: Good prospects “The market for sustainable packaging materials and solutions remains very encouraging. We delivered a stable result in the second quarter, despite the pressure from costs of external factors and the major disruption at Gruvön, which was communicated in May. Looking ahead, we see that the path we have chosen is the right one. Markets are performing strongly over the short term, and in the long term the trend points to companies being ambitious in their sustainability efforts both in their business operations and their products. The prospects for growth are good.”     THE RESULT We delivered solid operating profit of SEK 489 million. Production was relatively stable and we had planned maintenance shutdowns at three of our production units over the quarter, which cost SEK 25 million more than we had estimated. In addition, we had SEK 25 million in costs for the shutdown of the pulp line for the fluting machine at Gruvön, which we communicated separately, as well as additional costs related to Rockhammar of approximately SEK 30 million. Our results were also negatively affected by increased costs of deliveries due to the strike at the Port of Gothenburg. The business areas showed stable performance over the quarter on a strong market and we see some positive development in local prices. Consumer Board is showing volume growth of around 6% compared with the first half of last year. MARKET OUTLOOK The strong performance in the market by all business areas is expected to continue over the next quarter. The outlook is good and there are opportunities for further price increases, particularly in the Packaging Paper and Corrugated Solutions business areas. Primary fibre-based material with high sustainability performance is our core business, but alongside this, our solutions-based offerings are growing rapidly. This is being driven by both demand for a comprehensive offering in which the material is a key component, and by other types of solutions and packaging services. We are seeing a trend of packaging gaining an increasingly important role in many brand owners’ efforts to make their products more competitive. The sustainability performance of packaging is particularly important. This continues to give us great confidence in our products and our development. STRATEGY We are continually reviewing and updating our growth strategy, but our chosen approach remains in place and we are firm in our belief in our clear focus on the effectiveness, sustainability and innovation of both new materials and new solutions and offerings. Achieving long-term growth requires resources and investments, along with a balance between a strong proactive approach and a focus on the right initiatives.Packaging generates significant value for virtually all product value chains, and BillerudKorsnäs aims to shift its position forward in these chains. These efforts have created opportunities to develop new end-to-end solutions together with other companies such as our cooperation with Bosch on Axello Zap. This solution, which has only been in place for a year, is an example of where we see growing interest in end-to-end solutions with the potential to replace conventional packaging with more sustainable options. Also, it recently won a prize at Packaging Europe’s Sustainability Awards in the Bio-based Packaging category. BillerudKorsnäs’ President and CEO Per Lindberg and CFO Susanne Lithander will present the interim report at a press and analyst conference at 10.00 CET on Tuesday 18 July 2017.Venue: BillerudKorsnäs’ head office, Frösundaleden 2B, Solna, StockholmThe press and analyst conference can also be viewed live on BillerudKorsnäs’ website www.billerudkorsnas.com. For further information, please contact:Per Lindberg, President and CEO +46 (0)8 553 335 00Susanne Lithander, CFO, +46 (0)8 553 335 00 This information constituted insider information prior to publication. This is information that BillerudKorsnäs AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Swedish Securities Market Act. The information was submitted for publication, through the agency of the contact persons set out above, at 07.00 CET on 18 July 2017. BillerudKorsnäs provides packaging materials and solutions that challenge conventional packaging for a sustainable future. We are a world leading provider of primary fiber based packaging materials and have customers in over 100 countries. The company has 7 production sites in Sweden, Finland and the UK and about 4 300 employees in over 13 countries. BillerudKorsnäs has an annual turnover of about SEK 22 billion and is listed on Nasdaq Stockholm. www.billerudkorsnas.com

Panoro Announces Final Investment Decision on the Development of the Dussafu oilfields

Oslo, 18 July 2017 – Panoro Energy ASA (the “Company” or “Panoro” with OSE ticker: “PEN”) is pleased to announce that Pan Petroleum Gabon B.V. (a fully owned subsidiary of Panoro) has  approved the operator’s proposed work program and budget to move forward at full speed with the development of the Dussafu oilfields, offshore Gabon. The development plan will consist of two initial horizontal wells at Tortue in the Gamba and Dentale reservoirs. An appraisal side-track will also be drilled in the northwest of the Tortue field. The two production wells will be tied back to a leased FPSO via subsea trees and flowlines. The Dussafu joint venture partners are currently commissioning an independent review by Netherland Sewell and Associates to update the estimates and to move these contingent resources to reserves further to the recent FID. John Hamilton CEO of Panoro, said “The FID is a very important milestone for Panoro and first oil at Dussafu remains on track to be achieved during the second half of 2018. It is a significant step in the execution of Panoro’s strategy to realize Dussafu’s true potential and to continue unlocking value for our shareholders”. Enquiries:  Panoro Energy ASA                                       +44 203 405 1060John Hamilton, Chief Executive Officer          info@panoroenergy.com About Panoro Energy Panoro Energy ASA is an independent E&P company based in London and listed on the Oslo Stock Exchange with ticker PEN. The Company holds production, exploration and development assets in West Africa, namely the Dussafu License offshore southern Gabon and OML 113 offshore western Nigeria. In addition to discovered hydrocarbon resources and reserves, both assets also hold significant exploration potential. For more information, please visit the Company’s website at www.panoroenergy.com.

Good prospects

“The market for sustainable packaging materials and solutions remains very encouraging. We delivered a stable result in the second quarter, despite the pressure from costs of external factors and the major disruption at Gruvön, which was communicated in May. Looking ahead, we see that the path we have chosen is the right one. Markets are performing strongly over the short term, and in the long term the trend points to companies being ambitious in their sustainability efforts both in their business operations and their products. The prospects for growth are good.”     THE RESULT We delivered solid operating profit of SEK 489 million. Production was relatively stable and we had planned maintenance shutdowns at three of our production units over the quarter, which cost SEK 25 million more than we had estimated. In addition, we had SEK 25 million in costs for the shutdown of the pulp line for the fluting machine at Gruvön, which we communicated separately, as well as additional costs related to Rockhammar of approximately SEK 30 million. Our results were also negatively affected by increased costs of deliveries due to the strike at the Port of Gothenburg. The business areas showed stable performance over the quarter on a strong market and we see some positive development in local prices. Consumer Board is showing volume growth of around 6% compared with the first half of last year. MARKET OUTLOOK The strong performance in the market by all business areas is expected to continue over the next quarter. The outlook is good and there are opportunities for further price increases, particularly in the Packaging Paper and Corrugated Solutions business areas. Primary fibre-based material with high sustainability performance is our core business, but alongside this, our solutions-based offerings are growing rapidly. This is being driven by both demand for a comprehensive offering in which the material is a key component, and by other types of solutions and packaging services. We are seeing a trend of packaging gaining an increasingly important role in many brand owners’ efforts to make their products more competitive. The sustainability performance of packaging is particularly important. This continues to give us great confidence in our products and our development. STRATEGY We are continually reviewing and updating our growth strategy, but our chosen approach remains in place and we are firm in our belief in our clear focus on the effectiveness, sustainability and innovation of both new materials and new solutions and offerings. Achieving long-term growth requires resources and investments, along with a balance between a strong proactive approach and a focus on the right initiatives. Packaging generates significant value for virtually all product value chains, and BillerudKorsnäs aims to shift its position forward in these chains. These efforts have created opportunities to develop new end-to-end solutions together with other companies such as our cooperation with Bosch on Axello Zap. This solution, which has only been in place for a year, is an example of where we see growing interest in end-to-end solutions with the potential to replace conventional packaging with more sustainable options. Also, it recently won a prize at Packaging Europe’s Sustainability Awards in the Bio-based Packaging category. For further information, please contact: Per Lindberg, President and CEO +46 (0)8 553 335 00Susanne Lithander, CFO, +46 (0)8 553 335 00 This information constituted inside information before publication. This is information that BillerudKorsnäs AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 07.02 CET on 18 July 2017.

Haldex interim report, January - June 2017: A quarter with slightly weaker growth than the market

Net sales for Q2 totaled SEK 1,184 (1,147) m, which corresponds to a 3 percent increase compared with the same period of the previous year. After currency adjustments, net sales decreased by 2 percent. Net sales for the first six months of the year totaled SEK 2,332 (2,244) m, which is equivalent to a currency-adjusted decrease of 1 percent. Operating income excluding one-off items totaled SEK 78 (87) m for Q2 and SEK 159 (164) m for the first six months of the year, which corresponds to an operating margin of 6.6 (7.6) per cent for Q2 and 6.8 (7.3) per cent for the first six months of the year. The operating margin including one-off items totaled SEK 2.6 (7.6) percent for Q2 and SEK 2.9 (7.3) for the first six months of the year. One-off items for Q2 amounted to SEK 47 (0) m net and for the first six months of the year to SEK 91 (0) m net. Net income after tax for Q2 totaled SEK 10 (62) m and earnings per share for Q2 totaled SEK 0.22 (1.39). The corresponding figures for the first six months of the year are SEK 39 (110) m for net income before tax and SEK 0.86 (2.47) for earnings per share. Cash flow from operating activities totaled SEK 39 (61) m in Q2 and SEK 58 (103) m for the first six months of the year. A bidding process for Haldex was initiated on July 14, 2016, and is still ongoing. Knorr-Bremse’s bid of SEK 125 m is conditional and dependent on authorization from relevant competition authorities. On June 29, 2017, the board of directors announced withdrawn support for the bid from Knorr-Bremse due to the very low probability that it will be approved by the competition authorities. Key figures for April - June 2017(same period previous year in brackets) ·  Net sales, SEK m   1,184 (1,147) ·  Operating income, excl. one-off items, SEK m   78 (87) ·  Operating income, SEK m   31 (87) ·  Operating margin, excl. one-off items, %   6.6 (7.6) ·  Operating margin, %   2.6 (7.6) ·  Return on capital employed, excl. one-off items,%1    12.2 (17.3) ·  Return on capital employed,%1   4.6 (11.7) ·  Net income, SEK m   10 (62) ·  Earnings per share, SEK   0.22 (1.39) ·  Cash flow, operating activities, SEK m   39 (61) 1)    Rolling twelve months Key figures for January - June 2017(same period previous year in brackets) ·  Net sales, SEK m   2,332 (2,244) ·  Operating income, excl. one-off items, SEK m   159 (164) ·  Operating income, SEK m   68 (164) ·  Operating margin, excl. one-off items, %   6.8 (7.3) ·  Operating margin, %   2.9 (7.3) ·  Return on capital employed, excl. one-off items,%1    12.2 (17.3) ·  Return on capital employed,%1   4.6 (11.7) ·  Net income, SEK m   39 (110) ·  Earnings per share, SEK   0.86 (2.47) ·  Cash flow, operating activities, SEK m   58 (103) 2)    Rolling twelve months Comment from Åke Bengtsson, Acting President and CEO:  “The market has gradually improved during the first two quarters. During Q1 we performed better than the market in general, but we were not quite as successful in Q2. One exception is Europe, and we have been winning market shares in several products in this geographical region thanks to sales of disc brakes, which are continuing to rise. North America, which represents half of our sales, continues to be a challenge. The market in North America has improved, but Haldex has not been able to fully benefit from this upswing, primarily due to the uncertainty surrounding Haldex’ situation. Disc brake contract in USA The disc brake was re-introduced in the USA at the beginning of last year, and we have been working intensively to secure new contracts. We are pleased to present a disc brake contract in the USA in Q2 where the fleet placed an order for a number of trailers with one of the large axle manufacturers and specified Haldex disc brakes in the vehicles. This customer is one of the customers who was previously affected by the quality problems with our actuator, and we have worked hard to regain their confidence. We are very pleased that they are now choosing Haldex for this emerging technology in the USA. Trend reversal for actuators This quarter is the first that we have been able to see a slow-down in the decline in actuators. It is very positive that we have successfully broken the trend that started when we had to the product recall at the end of 2014. We received positive feedback from our customers about how we handled the recall, but it takes a long time to regain trust after a quality defect. Since then we have re-designed the product in order to re-launch a new version. In order not to damage our reputation once more, we have applied incredibly rigid tests and requirements on the product’s quality. Preparations are currently under way for the launch in Q3. Given that we to date have not had a replacement product, we have exceeded our expectations in terms of regaining the trust of our customers. Uncertainty regarding ownership The uncertainty created by the bidding situation is affecting our ability to sign long-term contracts. In the short-term, customers are not terminating signed contracts, but we are hurt during the negotiations of future contracts, i.e. the contracts that will create growth for Haldex in coming years. The long lead times in our industry result in negotiations with the large companies every 5-8 years. During this time, the customer does not normally switch suppliers. It is these long-term contracts that we have either lost or risk losing since the customer does not know who will own the company in the future. Due to dual sourcing, i.e. the practice of having more than one supplier for a single product to reduce risk, it is important for the customer not to end up in a situation where the same supplier is handling all contracts. It is therefore a safer option to place the order with a third company. We still have an opportunity to win a number of contracts where our creative solutions have kept us at the negotiating table, but with each month that passes the chances are shrinking and soon the window will be closed for a number of years in the future. An extension of the bidding process by only a few months therefore risks impairing Haldex’ ability to grow over the next few years. Focus on existing operations The bidding process has been ongoing for a year, and Q2 2017 was very intensive in this respect. Knorr-Bremse began to seriously pursue the European process first in February, and during the spring we have invested several man-years in providing the authorities with information and helping Knorr-Bremse prepare various carve-out scenarios. We have met potential buyers for different product lines and allowed them to conduct due diligence of the different parts. The time plan presented by Knorr-Bremse set a target of having these plans approved during the summer. Going through such an extensive process creates a lot of uncertainty within the company, in addition to the time it takes from running the business. When the European authority announced in June that its criticism was more widespread than the scenarios we prepared together with Knorr-Bremse, Haldex’ Board of Directors chose to withdraw its support for the bid, and I support them in this decision. There is no measured plan for gaining approval and the buyers that were presented were questionable in the opinion of the authorities. It has been extremely challenging to focus on and perform the day-to-day activities while at the same time dedicating large parts of our day to preparing divestitures. I am proud that we did as well as we did during Q2. We surrendered some of our market shares, but we did so under incredibly challenging conditions. We have continued to invest in all strategic projects. Haldex’ strong culture and loyal employees have played a large role in ensuring that we have not lost more employees than what we have so far, but the concern in the organization is noticeable. It will be difficult to successfully run the company much longer under the current conditions. At the same time, I am convinced that the long-term value of Haldex has been strengthened. Our position as a challenger on the market is highly valued by our customers, and the product portfolio that we are now continuing to develop could be a significant part of the technology shift facing the vehicle industry - for example within autonomous driving - where brake functionality naturally becomes a very important part of the solution. Haldex in 2017 The impact of the bidding situation is difficult to assess. Even if there are positive signs on the market, we are choosing to keep our previous forecast for the full year. The assessment of 2017 is that the market could reach last year’s level, but the uncertainty surrounding Haldex’ situation makes it difficult for Haldex to show growth. Our ambition is to continue to ensure good profitability, but due to lower net sales and higher costs from the bidding process, the operating margin for 2017 is forecast to be slightly lower than in 2016.” Åke BengtssonActing President and CEO Full interim report The full interim report is available at http://corporate.haldex.com/en/investors/financialreports or at http://news.cision.com/haldex Press and analyst meeting Media and analysts are invited to a telephone conference at which the report will be presented with comments by Åke Bengtsson, Acting President and CEO. The presentation will also be webcasted live and you can participate with questions by telephone. Date & Time: Tuesday, July 18 at 11.00 CET The press conference is broadcasted at: https://tv.streamfabriken.com/haldex-q2-2017 To join the telephone conference: SE: +46 8 566 426 92 UK: +44 203 00 898 09 US: +1 855 831 59 46 The webcast will also be available afterwards and you can download the Interim report and the presentation from Haldex website: http://corporate.haldex.com/en/investors  

Ericsson reports second quarter results 2017

SECOND QUARTER HIGHLIGHTS · Reported sales decreased by -8% YoY. Sales, adjusted for comparable units and currency, decreased by -13% YoY. The RAN equipment market for 2017 is estimated to show a high single-digit percentage decline compared with previous estimate of -2% to -6%. · Gross margin was 27.9% (32.3%). Gross margin, excluding restructuring charges, was 29.8% (33.2%). · Operating income was SEK -1.2 b. Operating income, excluding restructuring charges was SEK 0.3 b., with a YoY decline in all segments. · Networks operating margin was 7%. Operating margin, excluding restructuring charges, declined to 10% (13%) negatively impacted by continued lower software sales. · IT & Cloud operating income was negatively impacted by less capitalization of development expenses QoQ and YoY. · Planned cost reduction activities will be accelerated, due to current market environment, to achieve an annual run rate reduction of at least SEK 10 b. by mid-2018. · The company sees an increased risk of further market and customer project adjustments with an estimated negative impact on operating income of SEK 3-5 b. for the coming 12 months. · Due to technology and portfolio shifts capitalization of costs will be reduced and is estimated to result in a net negative impact on operating income of SEK -2.9 (1.3) b. in the second half 2017, with no impact on cash. · Cash flow from operating activities was SEK 0.0 (-0.7) b. +-------------------------+------+------+------+------+------+--------+--------+|SEK b. |Q2 |Q2 |YoY |Q1 |QoQ |6 months|6 months|| |2017 |2016 |change|2017 |change|2017 |2016 |+-------------------------+------+------+------+------+------+--------+--------+|Net sales |49.9 |54.1 |-8% |46.4 |8% |96.3 |106.3 |+-------------------------+------+------+------+------+------+--------+--------+|Net sales adjusted for  |49.9  |54.1  |-8%  |47.8  |4%  |97.7  |106.3  ||items affecting | | | | | | | ||comparability in Q1 2017 | | | | | | | |+-------------------------+------+------+------+------+------+--------+--------+|Sales growth adj. for |-  |-  |-13%  |-  |9%  |-15%  |-4%  ||comparable units and | | | | | | | ||currency   | | | | | | | |+-------------------------+------+------+------+------+------+--------+--------+|Gross margin |27.9% |32.3% |- |13.9% |- |21.2% |32.8% |+-------------------------+------+------+------+------+------+--------+--------+|Gross margin excluding |29.8% |33.2% |-  |30.5% |-  |30.1%  |33.6%  ||restructuring charges and| | | | | | | ||adjusted for items | | | | | | | ||affecting comparability | | | | | | | ||in Q1 2017  | | | | | | | |+-------------------------+------+------+------+------+------+--------+--------+|Operating income |-1.2 |2.8 |-145% |-12.3 |-90% |-13.6 |6.2 |+-------------------------+------+------+------+------+------+--------+--------+|Operating income |0.3  |3.8  |-93%  |1.1  |-74%  |1.4  |7.9  ||excluding restructuring | | | | | | | ||charges and adjusted for | | | | | | | ||items affecting | | | | | | | ||comparability in Q1 2017 | | | | | | | |+-------------------------+------+------+------+------+------+--------+--------+|Operating margin |-2.5% |5.1% |- |-26.6%|- |-14.1% |5.9% |+-------------------------+------+------+------+------+------+--------+--------+|Operating margin |0.6%  |7.0%  |-  |2.3%  |-  |1.4%  |7.4%  ||excluding restructuring | | | | | | | ||charges and adjusted for | | | | | | | ||items affecting | | | | | | | ||comparability in Q1 2017 | | | | | | | |+-------------------------+------+------+------+------+------+--------+--------+|Net income |-1.0 |1.6 |-164% |-10.9 |-91% |-11.9 |3.7 |+-------------------------+------+------+------+------+------+--------+--------+|EPS diluted, SEK |-0.30 |0.48 |-163% |-3.29 |-91% |-3.59 |1.08 |+-------------------------+------+------+------+------+------+--------+--------+|EPS (non-IFRS), SEK 1) |0.17 |0.83 |-80% |-2.42 |-107% |-2.25 |1.70 |+-------------------------+------+------+------+------+------+--------+--------+|Cash flow from operating |0.0 |-0.7 |-100% |-1.5 |-100% |-1.5 |-3.1 ||activities | | | | | | | |+-------------------------+------+------+------+------+------+--------+--------+|Net cash, end of period |24.0 |21.0 |14% |28.3 |-15% |24.0 |21.0 |+-------------------------+------+------+------+------+------+--------+--------+ 1) EPS diluted, excl. amortizations and write-downs of acquired intangible assets, and excluding restructuring charges. Non-IFRS financial measures are reconciled to the most directly reconcilable line items in the financial statements at the end of this report. Comments from Börje Ekholm, President and CEO of Ericsson (NASDAQ:ERIC) We are not satisfied with our underlying performance with continued declining sales and increasing losses in the quarter. Execution of our focused business strategy is gaining traction. However, in light of current market conditions, we are accelerating the planned actions to reduce costs. Sales adjusted for comparable units and currency declined by -13%. Based on the development in the first half of the year, our current view of the Radio Access Network (RAN) equipment market outlook is in line with external estimates of a high single-digit percentage decline for the full year 2017. Considering the current market environment, the company position, and the more focused business strategy, we continue to assess risk exposure in ongoing contracts. Depending on the outcome, we see an increased risk of further market and customer project adjustments, which would have a negative impact on results, estimated to SEK 3-5 b. for the coming 12 months, of which 30% is estimated to impact cash. Due to technology and portfolio shifts we will reduce the capitalization of product platform, software release development expenses and hardware costs. Together this is estimated to result in a net negative impact on operating income of SEK -2.9 (1.3) b. in the second half of 2017, with no impact on cash. This is to be compared with SEK -0.3 (1.2) b. of total impact on operating income in the quarter. One key component in our focused business strategy is to reduce costs and increase efficiency. In light of the current market outlook, we will accelerate our actions to ensure that we can meet our target of doubling the 2016 operating margin beyond 2018. Actions will be taken primarily in service delivery and common costs and do not include R&D. Our plan is to implement cost savings with an annual run rate effect of at least SEK 10 b. by mid-2018, of which approximately half will be related to common costs. The decline in the Networks result in the quarter was mainly caused by lower software sales, driven by two key factors; unusually strong software sales in the second quarter last year and cautious mobile broadband investment levels. On the positive side, we were ranked number one in radio by a leading global operator. Performance improvements in Networks will be generated through both the continued ramp-up of Ericsson Radio System (ERS) and cost reductions, mainly in service delivery. The ERS continues to prove its competitiveness and now represents 49% of radio unit deliveries in the quarter. During the quarter, we announced a break-through contract to support Vodafone UK to evolve its 4G network and to provide 5G radio technology. To safeguard a future leading portfolio, we have started to increase R&D investments in Networks with a total increase of SEK 0.2 b. in the quarter. In line with our more focused strategy, we signed an agreement in the quarter to divest the power modules business. The work to refocus our Managed Services business to improve profitability is well underway. So far, we have identified 42 contracts, with sales of SEK 7 b. in 2016, which we will either exit, renegotiate or transform. To date, we have either exited, renegotiated or transformed nine of these contracts resulting in an annualized profit improvement of approximately SEK 140 million going forward. IT & Cloud had another challenging quarter with significant losses. The sequential increase in losses is largely explained by lower capitalization of R&D expenses. Gross margin continued to be negatively impacted by large digital transformation projects. Our IT & Cloud business is of strategic importance as our customers are preparing for 5G and will digitalize their operations and invest in a future network architecture based on software-defined logic. A key driver of performance in the business is the success of our new product portfolio, for which the rolling 12 month sales have grown 7%. We are taking firm actions to improve performance in IT & Cloud, including stabilizing product roadmaps, addressing underperforming customer projects, improving new project delivery scoping and reducing costs, primarily in service delivery. The operating income in our Media business improved sequentially as a result of increased sales, improved business mix and reduced costs. We continue the work to explore strategic opportunities for the Media business. In this report, we have included a table on page 4 to track progress in the execution of our focused business strategy. In light of current market environment and company performance, we are accelerating actions to reduce costs. Our focused business strategy is designed to take us back to technology and market leadership and improve company performance, also in a tough market. We see initial signs of traction in strategy execution including increased investments in R&D in Networks and ramp up of deliveries of Ericsson Radio System, increasing our competitiveness in the market. Planning assumptions going forward Market related                                                           · Based on the development in the first half of the year, the company’s current view of the Radio Access Network (RAN) equipment market outlook is in line with external estimates of a high single-digit percentage decline for the full year 2017. This is to be compared with the company’s previous estimate of -2% to -6%. Ericsson focused strategy related · Addressing low-performing operations in Managed Services and optimizing the offering in Network Rollout are expected to reduce full-year sales by up to SEK 10 b. by 2019. · The plan is to implement cost savings with an annual run rate effect of at least SEK 10 b. by mid-2018, split 50/50 between service delivery and common costs (G&A, IT, real estate etc). · The company aims to increase R&D efficiency. However, R&D expenses will increase short term, primarily in Networks. · Restructuring charges for 2017 are estimated to be in the higher end of the range SEK 6-8 b. · The company sees an increased risk of further market and customer project adjustments, which would have a negative impact on results, estimated to SEK 3-5 b. for the coming 12 months, of which 30% is estimated to impact cash. · Reduced capitalization of development expenses and hardware costs is expected to result in a net negative impact on operating income of SEK -2.9 (1.3) b. in second half 2017, with no impact on cash. Other Ericsson related · The earlier communicated rescoped managed services contract in North America will impact sales negatively YoY in Q3 2017. · Industry trends and business mix in mobile broadband in 2016 are expected to prevail in 2017. NOTES TO EDITORS You find the complete report with tables in the attached PDF or by following this link https://www.ericsson.com/assets/local/investors/documents/financial-reports-and-filings/interim-reports-archive/2017/6month17-en.pdf  or on www.ericsson.com/investors The company will hold two identical conference calls for journalists, financial analysts and investors. President and CEO Börje Ekholm and CFO Carl Mellander will comment on the report and take questions. The first conference call will begin at 0900 CEST (0800 BST in London, 0300 EDT in New York and 1600 JST in Tokyo) and the second at 1400 CEST (1300 BST in London, 0800 EDT in New York and 2100 JST in Tokyo). To join the conference call, please phone one of the following numbers: Sweden: +46 (0) 8 5664 2691 (Toll-free Sweden: 0200 883817) International/UK: +44 203 008 9811 (Toll-free UK: 0808 2370059) US: +1 646 502 5116 (Toll-free US: +1 8557 532236) Please call in at least 15 minutes before the conference calls begin. As there is usually a large number of callers, it may take some time before you are connected. A live audio webcast of the conference call will be available at: www.ericsson.com/investors and at: www.ericsson.com/press REPLAY: Replay of the conference calls will be available from about one hour after it has ended until July 25, 2017. Sweden replay number: +46 (0)85 664 2638 International replay number: +44 (0)20 3426 2807 Conference Number: 689075# (for 0900 call) 689110# (for 1400 call) FOR FURTHER INFORMATION, PLEASE CONTACT Contact person Peter Nyquist, Head of Investor RelationsPhone: +46 10 714 64 49E-mail: peter.nyquist@ericsson.com  Additional contacts Helena Norrman, Senior Vice President, Marketing and CommunicationsPhone: +46 10 719 34 72E-mail: media.relations@ericsson.com Investors Åsa Konnbjer, Director, Investor RelationsPhone: +46 10 713 39 28E-mail: asa.konnbjer@ericsson.com Stefan Jelvin, Director, Investor RelationsPhone: +46 10 714 20 39E-mail: stefan.jelvin@ericsson.com  Rikard Tunedal, Director, Investor RelationsPhone: +46 10 714 54 00E-mail: rikard.tunedal@ericsson.com Media Ola Rembe, Vice President, Head of External CommunicationsPhone: +46 10 719 97 27E-mail: media.relations@ericsson.com  Corporate CommunicationsPhone: +46 10 719 69 92E-mail: media.relations@ericsson.com This information is information that Telefonaktiebolaget LM Ericsson is obliged to make public pursuant to the EU Market Abuse Regulation and the Swedish Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 07:30 CEST on July 18, 2017.

STRONG FIRST HALF-YEAR FOR HiQ

“We make a good start to the year with sales figures and profits for the first six months that are higher than ever before. We are now also more co-workers than ever before that help our clients with innovative solutions that simplify and improve. Obviously, it feels good” says Lars Stugemo, President and CEO of HiQ. Today, HiQ has a clear and strong position in the market. We offer our clients a complete partnership in R&D, IT, digitisation and communication. Together we create smart solutions that make a difference. This is the case when we for example help payment company Bambora. Together we are building the cashless society. HiQ also wins the assignment to make a pre-study for mobile payments in Dubai. Another example is when we together with Husqvarna, create Battery Box, that with help of technology makes it easy to rent tools when you need them. “We at HiQ, and our clients have a driving force to constantly develop ourselves. We now number more than 1,600 co-workers who, with the right skills and an attitude rooted in our corporate values – results, responsibility, simplicity and joy – can make a real difference. With the best team in the industry, an impressive portfolio of clients and strong finances, HiQ is equipped to remain a leading player in the market well into the future,” Lars Stugemo concludes. HiQ President & CEO, Lars Stugemo, presents the company’s interim report today, Tuesday 18 July, at 09:00 (CET) at HiQ’s Stockholm office (address: Regeringsgatan 20).The report can be ordered by phoning +46 8-588 90 000 or downloaded from www.hiq.se. For more information, please contact:Lars Stugemo, President & CEO HiQ. Tel. +46 8-588 90 000Erik Ridman, Head of Communications, HiQ. Tel. +46 70-7508060 This information is information that HiQ International AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person above, at 07.30 CET on 18 July 2017. HiQ helps to make the world a better place by using technology and communication solutions to make people’s lives simpler and better.We are the perfect partner for everyone eager to achieve results that make a difference in a digital world. Founded in 1995, HiQ has more than 1,600 specialists in four countries and is listed on the Nasdaq Stockholm Mid Cap list. For more information and inspiration, please visit www.hiq.se

INTERIM REPORT JANUARY – JUNE 2017

JANUARY – JUNE 2017 · Net sales total SEK 923.9 (846.9) million, an increase with 9.1 per cent · Operating profit (EBIT) is SEK 113.5 (104.5) million, equivalent to an operating margin of 12.3 per cent · Pre-tax profit of SEK 112.9 (104.1) million · Profit after tax of SEK 87.5 (80.9) million · Earnings per share of SEK 1.59 (1.50) · Cash flow from operations of SEK 118.4 (86.4) million · Liquid assets of SEK 163.9 million APRIL – JUNE 2017 · Net sales total SEK 454.3 (442.8) million, an increase with 2.6 per cent · Operating profit (EBIT) is SEK 48.0 (61.4) million, equivalent to an operating margin of 10.6 per cent · Pre-tax profit of SEK 47.5 (61.0) million · Profit after tax of SEK 36.7 (47.5) million · Earnings per share of SEK 0.67 (0.88) · Cash flow from operations of SEK 58.0 (51.1) million SIGNIFICANT EVENTS DURING FIRST SIX MONTHS · Annual General Meeting approves a shareholders’ dividend of SEK 3.10 per share, corresponding to a total of approximately SEK 170 million, through a share split and a redemption programme · HiQ helps Husqvarna launch the first connected tool-shed ever – Battery Box · HiQ and retailer Jula start a digital partnership · HiQ and Länsförsäkringar develop ridesafe.se that prevents smart phone usage while driving · HiQ´s integration platform FRENDS is chosen by Finnish S-Bank · HiQ develops a digital payment service together with Bambora · HiQ wins the assignment to make a pre-study for mobile payments in Dubai · HiQ is appointed digital partner to Awapatent · HiQ and Adalta simplify for newly arrived immigrants to integrate into the Swedish society · HiQ becomes digital partner to bank- and insurance group Skandia AWARDS · HiQ´s team at Great Apes in Helsinki win the European Design Awards for the interface of Quantum Break · The same team win the design category in Finland´s most prestigious advertising-and design award Vuoden Huiput (equivalent to Swedish award Guldägget) · HiQ develops the AR-app “Olof Palme in Almedalen” that wins the Almedalen Innovation Award. FOR FURTHER INFORMATION, PLEASE CONTACT:Lars Stugemo, President and CEO of HiQ, tel. +46 (0)8-588 90 000Erik Ridman, Head of Corporate Communications, HiQ, tel. +46 (0)707-508 060 This information is information that HiQ International AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out, at 07.30 CET on 18 July 2017. HiQ helps to make the world a better place by making people’s lives simpler through technology and communication. We are the perfect partner for everyone eager to achieve results that make a difference in a digital world. Founded in 1995, HiQ has more than 1,600 specialists in four countries and is listed on the Nasdaq Stockholm Mid Cap List. For more information and inspiration, visit www.hiq.se 

Fewer infections in mechanical heart valves

Some 1,500 people undergo aortic valve replacement every year in Sweden, about 75 per cent of whom receive a biological valve (from a pig or calf), the remainder a mechanical one. A complication that carries a high fatality risk is prosthetic valve endocarditis, which occurs when the new valve is infected by bacteria. Until now, there have been no figures on whether the infection frequency differs between the two valve types. It has also been unknown how common infections in an artificial heart valve are. The present study included over 26,500 patients who received a prosthetic heart valve between 1995 and 2012, 940 of whom developed prosthetic valve endocarditis. The risk of infection in the artificial valve was about 50 per cent higher with a biological prosthesis than with a mechanical. The follow-up time was up to 18 years. “We hadn’t expected this large difference,” says Dr Natalie Glaser, doctoral student at Karolinska Institutet’s Department of Molecular Medicine and Surgery. “Our results are important as they tell us more about complications following the surgical replacement of aortic valves.” The current European cardiology guidelines state that there is no difference in the incidence of infection between the two types of implant. Dr Glaser argues that this could be because former studies were too small to reveal any difference and were done on patients who were operated on decades ago.  The present study has also provided updated figures on the commonality of the complication, which affected a total of around 0.5 per cent of patients per year. It also shows that the fatality rate was as high as 16 per cent within a month of diagnosed infection and 50 per cent within five years. “The choice of valve prosthesis is very much decided by the patient’s age,” says principal investigator Ulrik Sartipy, heart surgeon at Karolinska University Hospital and docent at Karolinska Institutet’s Department of Molecular Medicine and Surgery. “Biological valves are usually used for older patients for medical reasons, partly because such valves do not require life-long treatment with anticoagulants. In our study, those who had received biological valves were on average 13 years older than those who were given mechanical ones, but this we’ve compensated for in our comparison.” The study was financed with grants from several bodies, including the Swedish Heart and Lung Foundation, the Mats Kleberg Foundation and the Magnus Bergvall Foundation. Martin Holzmann has reported that he receives a consultancy fee from Actelion and Pfizer. Publication: “Prosthetic valve endocarditis after surgical aortic valve replacement”, Natalie Glaser, Veronica Jackson, Martin Holzmann, Anders Franco-Cereceda and Ulrik Sartipy. Circulation, online 17 July 2017. For more information, please contact:Natalie Glaser, MD, PhD studentDepartment of Molecular Medicine and Surgery, Solna, Karolinska InstitutetPhone: +46 70 591 14 13E-mail: Natalie.Glaser@ki.se Ulrik Sartipy, MD, PhD, Associate ProfessorDepartment of Molecular Medicine and Surgery, Solna, Karolinska InstitutetPhone: +46 8 517 728 94 or +46 70 690 75 61 E-mail: Ulrik.Sartipy@ki.se Press OfficePhone: +46 8 524 860 77E-mail: pressinfo@ki.se 

CEO shift at Dometic

”I would like to thank Roger for his five years with Dometic. Roger has achieved an outstanding transformation of the company, with the IPO in 2015 as an important milestone. Today, the company stands very strong and now enters the next phase. With Juan’s strong business experience and proved leadership, I and the board have found a very suitable leader for the next phase in the company’s development”, says Fredrik Cappelen, Chairman of the Board at Dometic. ”I am leaving Dometic after five intense years. Following an extensive transformation, the company now stands strong. I still have a lot of heart for the company, but now is a good moment for a new leader to continue Dometic’s fantastic journey ahead. I have made this decision as I want to pursue a number of private projects before I decide to take on any new assignments”, says Roger Johansson. ”I have accepted the offer to become the new CEO of Dometic with great humility. I am really looking forward to lead the company to the next level and continue the successful work that Roger and his team has initiated”, says Juan Vargues. Roger Johansson will continue as CEO until the year-end, when Juan Vargues take office as CEO. Juan Vargues, today Head of Entrance Systems at ASSA ABLOY, has previously worked as President and CEO of the Besam Group and has held several positions within the SKF group. For more information, please contact:Johan Lundin, Head of Investor Relations and CommunicationsTel: +46 (0)8 501 025 46Email: ir@dometicgroup.com  This information is information that Dometic Group AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:00 CEST on July 18, 2017. ABOUT DOMETIC GROUPDometic is a global market leader in branded solutions for mobile living in the areas of Climate, Hygiene & Sanitation and Food & Beverage. Dometic operates in the Americas, EMEA and Asia Pacific, providing products for use in recreational vehicles, trucks and premium cars, pleasure and workboats, and for a variety of other uses. Dometic offer products and solutions that enrich people’s experiences away from home, whether in a motorhome, caravan, boat or a truck. Our motivation is to create smart and reliable products with outstanding design. We operate 22 manufacturing/assembly sites in nine countries, sell our products in approximately 100 countries and manufacture approximately 85% of products sold in-house. We have a global distribution and dealer network in place to serve the aftermarket. Dometic employs approximately 6,500 people worldwide, had net sales of SEK 12.4 billion in 2016 and is headquartered in Solna, Sweden.

Interim report January – June 2017

Kai Wärn, President and CEO:“The Husqvarna Group is continuing to implement its profitable growth strategy following the positive execution of its margin improvement activities in recent years. Sales, operating income and margin as well as cash flow increased in the first half of the year. The three divisions with growth targets had a very positive development, effectively capitalizing on an overall good demand in areas such as robotic mowers, battery-powered products and watering products. Going forward we will continue to invest in strategic growth initiatives to further strengthen our position. The Consumer Brands Division continues to focus on margin improvement where cost and efficiency measures, in parallel to increased product development, remain imperative. However due to the challenging U.S. retail market, the previously anticipated margin improvement is now expected to be slower. Group net sales in the second quarter was 8% higher adjusted for currency and increased in all divisions. Operating income increased 16% to SEK 2,002m (1,729) due to the higher volume and a positive currency impact which was partially offset by higher costs for our growth initiatives. The operating margin for the Group continued to improve and was 15.3% (15.0) in the quarter and 9.6% (8.6) for the rolling twelve month period. Sales in the Husqvarna Division increased 5% adjusted for currency, and the operating income rose 15% to SEK 1,186m (1,031). Europe continued as the growth driver largely as a result of good growth in battery-powered products including robotic lawn mowers. The Gardena Division added another quarter of strong performance. Sales increased with 11% adjusted for currency with growth in all product categories, particularly in watering. Operating income rose 26% to 565m (449).  From a sales perspective Consumer Brands also had a favorable development with top-line growth of 9%. Operating income however declined to SEK 80m (147), reflecting a challenging and competitive business environment in the North American retail market, as well as unfavorable product and regional mix. To further improve efficiency in the supply chain footprint, the quarter was impacted by one-time cost items of close to SEK 30m. The Construction Division delivered another strong quarter, with currency adjusted sales growing 16%, whereof organic growth was 2%. Operating income increased 30% to SEK 233m (179). The acquisition of HTC, the floor grinding solutions market leader was finalized in May, further strengthening our product portfolio and ability to better serve our customers in the prioritized concrete surfaces and floors segment.” Second quarter 2017 · Net sales increased to SEK 13,069m (11,504), corresponding to a currency adjusted* growth of 8%. · Operating income increased 16% to SEK 2,002m (1,729), corresponding to a margin of 15.3% (15.0). · Changes in exchange rates, net of raw material costs, positively impacted operating income by around SEK 110m. · Operating working capital* as a percentage of net sales for the last twelve months was 26.8% (27.2). · Earnings per share after dilution increased 11% to SEK 2.43 (2.19). Telephone conferenceA combined press and telephone conference, hosted by Kai Wärn, President and CEO, and Jan Ytterberg, CFO, will be held at Husqvarna Group’s office, Regeringsgatan 28, Stockholm at 10:00 CET on July 18, 2017. To participate, please dial +46 (0) 8 5033 6434 (Sweden) or +44 (0) 8444933800 (UK) ten minutes prior to the start of the conference. The conference call will also be audio cast live on www.husqvarnagroup.com/ir . A replay will be available later the same day.

Interim report January-June 2017: Investments for the future and fewer working days puts pressure on the result for the period

· Divestment of weak businesses in Århus and Helsinki will strengthen the results in coming periods but has a negative one-time effect of SEK -16.3 million on the quarter  · Considerably fewer working days impact the clinics’ results negatively  · Successful start-up of GHP Vård och Hälsa with Trygg Hansa and development of the collaboration with Skandia  · Much greater focus on internal cost control in the clinics in future Second quarter 2017 · Sales revenues decreased to SEK 249.6 million (262.0) · Organic growth amounted to -4.5 percent (22.1) · Adjusted EBITDA amounted to SEK 9.5 million · EBITDA amounted to SEK -6.8 million (31.8) · EBITDA margin amounted to -2.7 percent (12.1) · Result after tax (EAT) amounted to SEK -14.0 million (20.1) · Result per share amounted to SEK -0.21 (0.26) First half year 2017 ·  Sales revenues increased to SEK 510.4 million (493.5) ·  Organic growth amounted to 3.1 percent (13.9) ·  Adjusted EBITDA amounted to SEK 27.7 million ·  EBITDA amounted to SEK 11.4 million (49.9) ·  EBITDA margin amounted to 2.2 percent (10.1) ·  Result after tax (EAT) amounted to SEK -5.7 million (29.5) ·  Result per share amounted to SEK -0.09 million (0.39) CEO’s commentsThe second quarter this year was expected to be a challenge from the point of view of profitability. There were considerably fewer working days than the same period last year, GHP International was not going to be more profitable until the end of the year, we have a couple of start-ups and we have invested in new competencies in the Nordic Region and in International. Despite this knowledge, the quarter was still a step backwards in financial terms. Much can be explained, however, by the fact that we have divested unprofitable units, which will mean improved operational results in the future. We have a strong focus on development of the business, which is something we will draw benefit from later on but it has impacted the result for the quarter negatively. The past quarter we have, for example, started Trygg Hansa health care planning and together with Skandia expanded our collaboration with a new IBS-unit. This strengthens our leading position in the insurance market. We have also entered into a collaboration agreement for a neurorehabilitation hospital in the UAE as part of our continued international expansion and made considerable progress regarding digitalisation in health care. Our clinics in Århus and Helsinki have for us been a challenge for a long time. Together they have made a loss of approximately SEK 3.5 million so far this year and also laid claim to many central resources. We therefore decided to sell both businesses. This gives a negative one-time effect in the quarter but will strengthen the result going forward. The number of working days in each quarter has a great impact on our results. Apart from Collaborative Care and International, our remuneration is based entirely on how many patients we help, at the same time as most of our costs are fixed. During the first quarter this year, there were two working days fewer than during the same period last year and during the second quarter we had six working days fewer. We calculate that these eight days had a negative impact on results of at least SEK 14 million (of which SEK 11 million in Q2). Unfortunately, these working days do not come back during the rest of the year, when there will be more or less the same number of working days as last year. In International we are working according to plan. It is taking a little time to establish processes and improve the hospitals we have just taken over. We therefore anticipate that it will be at the end of the year that we will be up at approximately the same level of profitability as last year in this part of the business. Each year over the past eleven years our remuneration for different measures has fallen and salaries have gone up. Moreover, salaries in the health care sector are increasing faster than in the rest of society. This is not a new challenge for us, but it is a question of being better each year. So far this year we have not carried this out at the pace we would have wanted. A big reason for productivity not increasing as intended is that we are now undergoing a change of generation in the management of many of our clinics (for example, five out of seven CEOs in Stockholm are working their first year for GHP). We also have a new financial organisation in a new structure. The desired change of generation has taken time to implement, however, and we cannot yet see its financial impact. Nevertheless, the underlying situation at our clinics looks good. We have strong patient inflows and a new generation of ambitious employees. In order to manage the challenges that we have encountered as quickly as possible, we are focusing on establishing stricter planning routines and more detailed cost control. By focusing on and taking the appropriate measures, I am confident that we will be able to rapidly improve our profitability. 18 July 2017GothenburgGHP Specialty Care AB (publ) The Board and CEO

SenzaGen recruits Chief Commercial Officer and Chief Scientific Officer

The appointments announced today are the final stage in the work to strengthen SenzaGen's management for the commercialization of the GARD tests and the company's planned listing on Nasdaq First North. The management team has been built up gradually over the past year - at the end of 2016 Marianne Olsson started work as Chief Financial Officer, and in early 2017 Dr Steve Smith was recruited to the post of Intellectual Property Counsel. "We are delighted to have attracted such well-qualified and industrially experienced people to SenzaGen. The company's management now has an optimal composition for our work to establish GARD tests as the new global standard for evaluating the allergy-inducing properties of chemical substances," says SenzaGen CEO Anki Malmborg Hager. Anna Chérouvrier Hansson, Bachelor of Business Administration, and Master of European Business Administration and Business Law, comes most recently from a position as Director of Marketing at the listed drug company Camurus. There she was responsible for the company's marketing department, the development and management of the medical device marketing and sales organisation and for the establishment of distribution partnerships in Asia, the USA and France. She has previously worked as Head of Business Development Life Science at Invest in Skåne, Partner at Zitha Consulting and in a number of senior positions in European pharmaceutical and chemical companies. Henrik Appelgren is a biologist with a PhD in genetic toxicology. He has been working at the Swedish Chemicals Agency for 15 years, where he worked as Sweden's national coordinator in the OECD Test Guideline Programme. Henrik has a deep knowledge in alternative test methods and of regulatory work in the chemical industry - both nationally and internationally. He also has long experience of health risk assessments of chemicals in all European legislation. He is, or has been, a member of several scientific expert councils including FORMAS, the Swedish Research Council, the Swedish Fund for Research Without Animal Experiments, the Scandinavian Society for Cell Toxicology and EUToxRisk. Anna Chérouvrier Hansson takes up her position on 15th August and Henrik Appelgren on 4th September 2017. A complete presentation of SenzaGen's management team will be available on the company's website when the positions are started, www.senzagen.com. For more information: Anki Malmborg Hager, CEO, SenzaGen ABEmail: anki.malmborg.hager@senzagen.comTelephone: +46 768 284822 About GARDGARD is a group of tests for assessing chemical skin sensitizers. The tests make use of genetic biomarkers for more than 200 genes which cover the entire immune reaction and are relevant to predicting the risk of hypersensitivity. The tests have up to 90% reliability. This compares with the current predominant test method, experiments on mice, which has an accuracy of 70-75%. SenzaGen's tests are also capable of measuring the potency of a substance's allergenic properties. Consequently GARD tests provide a much more comprehensive basis for determining whether a substance should be classified as an allergen than current testing methods. About SenzaGenSenzaGen makes it possible to replace animal experiments with in vitro genetic testing to determine the allergenicity of the chemicals we come into contact with in our daily lives, such as for example in cosmetics, pharmaceuticals, food products and dyes. The company's patented tests are the most reliable on the market and provide more information than traditional evaluation methods. We ourselves sell the tests in Sweden and the USA, and we sell through partners in several other countries. Over the next few years the company will expand geographically, make alliances with more distribution partners and launch further unique tests. SenzaGen has its headquarters in Lund in Sweden and a subsidiary in San Francisco, USA. For more information visit www.senzagen.com 

Stadshypotek’s Interim Report January – June 2017

JANUARY – JUNE 2017 COMPARED WITH JANUARY – JUNE 2016 Stadshypotek’s operating profit increased by 5%, or SEK 267m, to SEK 5,817m (5,550). Net interest income grew by SEK 343m to SEK 6,377m (6,034), mainly due to higher lending volumes to the private market in Sweden. However, this change in net interest income was adversely affected by SEK 196m as a result of the doubling of the fee to the Resolution Fund, effective as of 2017. Of the net interest income, SEK 409m (299) was attributable to the branch in Norway, SEK 190m (191) to the branch in Finland and SEK 208m (160) to the branch in Denmark. The increase in net interest income at the Norwegian branch was mainly attributable to a lower funding cost, but also to an increase in lending volumes. Excluding the branches, net interest income increased by SEK 186m. Net gains/losses on financial transactions decreased by SEK 37m to SEK 6m (43). Expenses rose by SEK 37m to -555m (-518). This increase can in part be attributed to an increase in staff costs, largely a consequence of higher pension costs. There was also an increase in the sales compensation paid to the parent company for the services performed by the branch office operations on behalf of Stadshypotek in relation to the administration and sale of mortgage loans. The increase can also be explained by, above all, higher costs of IT development and costs relating to the updating of funding programmes and ratings. Recoveries exceeded new loan losses and the net amount recovered was SEK 2m (5). LENDING Compared with the end of the corresponding period of the previous year, loans to the public increased by 6%, or SEK 65bn, to SEK 1,183bn (1,118). In Sweden, loans to the public increased by 6%, or SEK 57bn, to SEK 1,017bn (960). Loans to the private market in Sweden increased by 6%, or SEK 41bn, to SEK 692bn (651). The credit quality of lending operations remains very good. Impaired loans, before deduction of the provision for probable loan losses, totalled SEK 122m (96). Of this amount, non-performing loans accounted for SEK 57m (50), while SEK 65m (46) related to loans on which the borrowers pay interest and amortisation, but which are nevertheless considered impaired. There were also non-performing loans of SEK 281m (305) that are not classed as being impaired loans. After deductions for specific provisions totalling SEK -35m (-24) and collective provisions of SEK -4m (-3) for probable loan losses, impaired loans totalled SEK 83m (69). FUNDING Issues made under Stadshypotek’s Swedish covered bond programme totalled SEK 49.9bn (61.5) for the first six months of the year. A nominal volume totalling SEK 76.1bn matured or was repurchased. In addition, bonds to the value of EUR 0.5bn (2.25) and USD 1.25bn (-) were issued, while bonds to the value of EUR 1.5bn and NOK 4bn reached maturity. CAPITAL ADEQUACY The total capital ratio according to CRD IV was 55.8% (69.4), while the common equity tier 1 ratio calculated according to CRD IV was 33.2% (38.3). RATING Stadshypotek Covered bonds Long-term Short-termMoody’s Aaa - P-1Standard & Poor’s AA- A-1+Fitch AA F1+  Stockholm, 18 July 2017 Ulrica Stolt KirkegaardChief Executive Stadshypotek discloses the information provided herein pursuant to the Securities Markets Act.Submitted for publication on 18 July 2017, at 11.00 CET.

Interim report  January - June 2017

Continued strong sales growth and increased profitability Second quarter · Net sales amounted to 196.3 MSEK (162.9), which is an increase by 20.5 percent compared to the corresponding quarter last year. At comparable exchange rates net sales increased by 15.9 percent. · Operating profit increased by 54 percent to 37.2 MSEK (24.2). · Result after tax increased by 52 percent to 37.7 MSEK (24.7). · Earnings per share amounted to 0.58 SEK (0.38). · The cash flow from operating activities amounted to 43.1 MSEK (29.1). · Dividends to the shareholders were paid to the amount of 80.9 MSEK (80.9).  · Net cash at June 30 amounted to 101.6 MSEK (99.6), compared to 152.1 MSEK at March 31 and 128.6 at the start of the year. · At the end of the reported period Biotage had no holding of own shares. No shares have been acquired under the repurchasing program resolved at the 2017 Annual General Meeting. Six months, January – June · Net sales amounted to 381.5 MSEK (321.7), which is an increase by 18.6 percent compared to the corresponding period last year. At comparable exchange rates net sales increased by 14.0 percent. · Operating profit increased by 51 percent to 72.1 MSEK (47.8). · Result after tax increased by 53 percent to 73.0 MSEK (47.6). · Earnings per share amounted to 1.13 SEK (0.74). · The cash flow from operating activities amounted to 72.2 MSEK (65.9). Comments by CEO Torben Jörgensen The sales successes of Biotage continue with yet another record quarter. At compar­able exchange rates, sales in the quarter and the half-year increased by 15.9 and 14.0 percent, respectively, which is considerably higher than the average for our markets. The gross margin for the quarter as well as for the six-month period exceeds our strategic 60 percent goal. Higher sales in relation to the fixed cost base contribute significantly to the improved margin. The operating margin (EBIT) is 18.9 percent for the quarter as well as for the half-year, and averages 13.9 percent for the last three years. All our product areas are growing. This quarter we saw especially strong sales in the product areas peptide synthesis, evaporation systems and industrial products. The combination of good system solutions and media for flash purification makes Biotage an attractive partner in the peptide area. For industrial products the sales of systems as well as consumables are increasing and we note that our products are used in a number of new projects among customers in the pharma industry. Also the system sales in organic synthesis are developing well. All geographies show double digit growth in the quarter as well as in the six-month period. Asia is the area showing the strongest growth. Above all South Korea develops strongly, but also Japan had a good quarter. The sales successes are benefiting from the increased direct sales. The latest investments in South Korea and China are good examples of this. The direct sales will now be expanded to Italy, where we from July will be selling out entire product range through our own organization. Our evaluation of the sales strategy for India is now nearing completion and we expect to be operative with our own company in India in 2018. We are using the same approach as in South Korea and China with a combination of direct sales and local distributors. The increasing sales put higher demands on and enable a more efficient production. Great efficiency improvements have been implemented at the plant in Cardiff, Wales, among other things through increased automation. The increased production volumes motivate investments in the production and in the later part of 2017 the production space in Cardiff will be expanded. Access to the new premises enables further automation of the production. The strong sales growth in China is primarily related to systems. In order to better meet the price competition on consumables we have now introduced a locally adapted line of consumables for flash purification. If the locally produced raw material can maintain an even, if not high, quality there is a possibility to introduce these consumables also in other markets. At the end of the quarter two new system launches were made, Biotage Isolera™ Dalton 2000 and a new generation of the evaporation system TurboVap®. Biotage Isolera™ Dalton 2000 is a new mass detection system for flash purification that opens up for a broader functionality with a detection range up to molecular weights of 2000 m/z (mass-to-charge ratio). The new system is integrated with Biotage’s flash system Isolera™ and the software functionality Isolera™ Spektra through Isolera™ Dalton Nanolink. The new TurboVap® system is based on the previous system which has been successful for a number of years, but has increased functionality and improved user friendliness. We are eagerly looking forward to the results of these product launches. Coming financial reportsThe interim report for the third quarter 2017 will be issued on November 2, 2017.The year-end report for 2017 will be issued on February 8, 2018. This report has not been reviewed by the company’s auditor. For further information, please contact:Torben Jörgensen, President and CEO, phone: +46 707 49 05 84Erika Söderberg Johnson, CFO, phone: +46 707 20 48 20 This information is information that Biotage AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 11.00 CET on July 18, 2017. About BiotageBiotage offers efficient separation technologies from analysis to industrial scale and high quality solutions for analytical chemistry from research to commercial analysis laboratories. Biotage’s products are used by government authorities, academic institutions, pharmaceutical and food companies, among others. The company is headquartered in Uppsala and has offices in the US, UK, China, Japan and South Korea. Biotage has approx. 330 employees and had sales of 668 MSEK in 2016. Biotage is listed on NASDAQ Stockholm. Website: www.biotage.com

Interim Report Q2 2017

JANUARY 1 – JUNE 30, 2017 (compared with the corresponding period a year ago) · Net sales increased 9% to SEK 53,423m (49,231) · Organic sales, excluding exchange rate effects, acquisitions and divestments, increased 0.4% · Operating profit before amortization of acquisition-related intangible assets (EBITA) rose 30% to SEK 5,557m (4,283) · Adjusted operating profit before amortization of acquisition-related intangible assets (EBITA) rose 12% to SEK 6,354m (5,683) · Adjusted EBITA margin increased 0.4 percentage points to 11.9% (11.5) · Adjusted profit before tax rose 7% to SEK 5,566m (5,199) · Profit for the period increased 191% to SEK 3,497m (1,200) · Earnings per share amounted to SEK 4.47 (1.54 [1]) · Adjusted earnings per share increased 69% to SEK 5.60 (3.31 [1]) · Cash flow from current operations increased 7% to SEK 3,487m (3,262)  · The acquisition of BSN medical, a leading medical solutions company, was consolidated as of April 3, 2017. Reported net sales for the second quarter of 2017 amounted to SEK 2,096m and adjusted EBITA to SEK 359m. [1] Indicative earnings per share on the assumption that the number of issued shares in Essity as of June 30, 2016 corresponded to the number of issued shares in Essity on June 30, 2017 (702.3 million). (Table included in attached pdf)  SUMMARY OF SECOND QUARTER 2017  Following the split of SCA, the leading global hygiene and health company Essity was listed on Nasdaq Stockholm on June 15, 2017. In the second quarter of 2017, 18 innovations were launched that strengthened Essity’s customer and consumer offerings in all categories. To further improve efficiency and strengthen competitiveness in Professional Hygiene in North America, a production plant in the US was closed during the quarter. The measure is part of Essity’s Tissue Roadmap and is aligned with the company’s strategy to optimize the geographic production footprint to increase cost and capital efficiency for improved profitability. The Group’s net sales for the second quarter of 2017 increased 12.7% compared with the corresponding period a year ago. Organic sales declined by 0.1%. As part of Essity’s focus on profitable growth for increased value creation, the company has discontinued certain underperforming market positions and contracts with unsatisfactory profitability. This has had a negative impact on organic sales. In emerging markets, which accounted for 35% of net sales, organic sales increased 2.9%. Mature markets decreased by 1.5%. The Group’s adjusted EBITA in the second quarter of 2017 increased by 17% compared with the corresponding period a year ago. Excluding currency translation effects and the acquisition of BSN medical the adjusted EBITA was in line with the corresponding period a year ago. A better price/mix, higher volumes, cost savings and other measures to improve profitability offset higher raw material and energy costs. Selling costs were lower. Investments were made in increased marketing activities. The Group’s adjusted EBITA margin increased 0.4 percentage points to 12.2%. Operating cash flow declined 20%. The adjusted return on capital employed was 13.7% (calculated as annualized adjusted EBITA for the second quarter of 2017/capital employed as of June 30, 2017). On April 3, 2017, the Group completed the acquisition of BSN medical, a leading medical solutions company. In the second quarter of 2017, the acquired company’s organic sales declined by 0.7%. The adjusted EBITA margin was 17.1%. Organic sales were negatively impacted by a lower number of invoicing days. Integration costs and operations in Venezuela negatively impacted the EBITA margin by about 1.5 and 1.0 percentage points, respectively. Furthermore, the EBITA margin was negatively impacted by lower absorption of fixed costs as a result of the decline in sales. For further information, please contact:Fredrik Rystedt, CFO and Executive Vice President, +46 8 788 51 31Johan Karlsson, Vice President Investor Relations, Group Function Communications, +46 8 788 51 30Joséphine Edwall-Björklund, Senior Vice President, Group Function Communications, +46 8 788 52 34Media Relations, Group Function Communications, +46 8 788 52 20 NB:Essity discloses the information provided herein pursuant to the EU’s Market Abuse Regulation and the Swedish Securities Market Act. This report has been prepared in both Swedish and English versions. In case of variations in the content between the two versions, the Swedish version shall govern. The information was submitted for publication, through the agency of the contact person set out below, at 12:00 CET on July 18, 2017. This interim report has been reviewed by the company's auditorsKarl Stoltz, Media Relations Manager, +46 8 788 51 55

NeuroVive signs private placement agreement with Esousa Holdings LLC and issues units

Each transaction involves the issue of Units, each Unit consisting of one NeuroVive common share and one warrant. The Board of Directors has approved and authorized the first 4.5 million SEK transaction and issued 1,080,255 Units to Esousa at approximately 4.17 SEK/Unit. The issue of shares and warrants is based on the 2017 annual general meeting's authorization to the Board to issue shares and warrants. The reason for the deviation from shareholders’ pre-emption rights is that the transaction is on favorable terms compared to other available options for capital procurement and the Company gains a new institutional shareholder of strategic importance. The subscription price is approximately SEK 4.17 per share, a 20% discount to the 5 day VWAP (volume-weighted average price) immediately preceding the transaction. The warrants are issued without consideration. Each warrant entitles the holder to acquire an additional common share at 20% discount to the 3 day VWAP for the period prior to the exercise date. The warrants may be exercised from the date of registration for a period of five years. As a result of the first issue, the company’s share capital increases by SEK 54,012.75. If the warrants are exercised, the company’s share capital will increase by not more than SEK 54,012.75. The second 4.5 million SEK tranche will take place by the end of 2017 and have the same terms as the first tranche. Esousa is a life-sciences focused U.S. family office investing in interesting emerging growth companies in a variety of sectors. Esousa has invested in a number of health care companies over the years. Erik Kinnman, CEO of NeuroVive commented: "The fact that Esousa has chosen to invest in NeuroVive as part of its life science directed investment on the back of the addition of the KL1333 mitochondrial disease clinical asset and the recent positive traumatic brain injury project results, is very encouraging. This financing provides us with additional working capital and the development of our clinical project portfolio, leveraging its value, and progressing these new therapeutic opportunities to patients who need them. Following the registration of the new shares, the company will have 50,566,197 shares outstanding. 

ADDvise Signs Letter of Intent Regarding Acquisition of AB Germa

ADDvise Group AB (publ) has signed a Letter of Intent with Ferno Norden AS and Ferno LLC regarding an acquisition of 100 percent of the shares in AB Germa. •    Germa manufactures and sells healthcare products such as vacuum mattresses, child safety solutions, positioning cushions, rehab products and safety products for the military. •    The purchase price amounts to 13.8 MSEK based on cash and debt-free basis. •    In addition, Germa’s production facility will be acquired, with an indicative value of 3.2 MSEK. •    During the fiscal year of 2016, Germa had a turnover of 30.1 MSEK and an EBITDA of 3.4 MSEK. •    The acquisition is expected to have a positive effect on ADDvise Group’s EPS. •    The acquisition is subject to due diligence and that the parties agree to enter into a share purchase agreement. Reasons for the acquisitionGerma is a profitable product company strategically important for ADDvise Group’s business area Healthcare. Germa will contribute with products and knowledge in the field of emergency care and safety products. – To acquire healthcare product companies is in line with our acquisition strategy. Germa is a perfect fit in that strategy. There are clear synergies between Germa and our Healthcare business area, especially in emergency care, says Rikard Akhtarzand, CEO of ADDvise Group. Germa in briefThe company was founded 1925 with headquarters located in the southern parts of Sweden. Germa develops and manufactures healthcare products such as vacuum mattresses, child safety solutions, positioning cushions and rehab products. During the fiscal year of 2016, Germa had a turnover of approximately 30.1 MSEK and generated an EBITDA of 3.4 MSEK.Payment of the purchase price and indicative time scheduleThe purchase price amounts to 17 MSEK based on a cash and debt free basis. Germas production facility is included in the purchase price, with an approximate value of 3.2 MSEK. Share purchase agreement and admission date are scheduled to be completed by the end of Q3 2017. AdvisorMangold Fondkommission AB is ADDvise Group’s financial advisor and Baker & McKenzie is ADDvise Group’s legal adviser in connection to the acquisition. For further information, please contact:Rikard Akhtarzand, CEO +46 765-25 90 71rikard.akhtarzand@addvisegroup.se  Important informationThis information is by ADDvise required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on July 18, 2017 at 16:30 CET.  About ADDvise GroupADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. The Group has sales of about 250 MSEK. ADDvise shares are listed on Nasdaq First North Premier and Mangold Fondkommission AB, 08-503015 50, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.

Citycon Group establishes a EUR 1,500,000,000 EMTN programme

NOT TO BE RELEASED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN OR INTO OR TO ANY PERSON LOCATED IN OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (TOGETHER THE "UNITED STATES"), AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.Citycon Group has established a EUR 1,500,000,000 guaranteed EMTN (“Euro Medium Term Note”) programme (“Programme”). The Central Bank of Ireland has today 18 July 2017 approved the Offering Circular for the Programme which will be available on the website of the Central Bank of Ireland at https://www.centralbank.ie/.The Programme is established by Citycon Treasury B.V. and the notes issued under the Programme will be guaranteed by Citycon Oyj. The Programme will be applied by Citycon Treasury B.V. for its general corporate purposes or to refinance Citycon Group’s existing indebtedness. Notes issued under the Programme may be denominated in any currency. Citycon Treasury B.V. will apply for the notes issued under the Programme, other than notes denominated in Norwegian krone, to be admitted to the Official List of the Irish Stock Exchange and to trading on its regulated market. Possible notes denominated in Norwegian krone will be applied for trading on the main list of the Oslo Stock Exchange.Citycon Group has mandated Nordea Bank AB (publ) to act as the arranger of the Programme.Citycon Group will announce further information when notes are issued under the Programme.Helsinki, 18 July 2017CITYCON OYJFor further information, please contact:Marcel Kokkeel, CEOTel. +358 40 154 6760marcel.kokkeel@citycon.comEero Sihvonen, Executive Vice President and CFOTel. +358 50 557 9137eero.sihvonen@citycon.comCitycon Oyj (Nasdaq Helsinki: CTY1S) is a leading owner, developer and manager of urban grocery-anchored shopping centres in the Nordic and Baltic regions, managing assets that total approximately EUR 5 billion and with market capitalisation of EUR 2 billion. For more information about Citycon, please visit www.citycon.comImportant regulatory noticeThis announcement does not constitute, or form part of, an offer or invitation to sell or issue, or any solicitation of an offer to buy or subscribe for, any securities in the United States or any other jurisdiction nor shall it (or any part of this announcement) or the fact of its distribution form the basis of, or be relied upon in connection with, or act as any inducement to enter into, any contract or commitment.  Recipients of this announcement who intend to purchase any securities are reminded that any such purchase or subscription must be made solely on the basis of the information contained in any final form prospectus and final terms published in connection with any such securities, which if and when published will be available on the website of the Central Bank of Ireland and, regarding notes denominated in Norwegian krone, on the website of the Oslo Stock Exchange.  The Programme described above and the distribution of this announcement and other information in connection with the Programme in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction.  Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.This communication is not an offer of securities for sale in the United States, Australia, Canada, Japan or any other jurisdiction where to do so would be unlawful.  Neither Citycon Oyj nor Citycon Treasury B.V. has registered, or intends to register, securities in any of these jurisdictions or to conduct an offer of securities for sale in any of these jurisdictions.  In particular, no securities of Citycon Oyj or Citycon Treasury B.V. have been or will be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and such securities may not be offered, sold or delivered within the United States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S under the Securities Act) except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.This announcement is directed only at (i) persons who are outside the United Kingdom or (ii) to investment professionals falling within the definition of "investment professionals" in Article 19 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the “Order”) or (iii) high net worth companies, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons in (i), (ii) and (iii) above together being referred to as "relevant persons").

Interim Report Second Quarter 2017

CEO comment: “I am delighted with the strong set of financial results and business momentum that the Tele2 team has delivered in the first half of the year, as we pursue our mission to liberate people to live a more connected life.” Financial highlights                                                         · Tele2 AB’s net sales for the first quarter amounted to SEK 7,988 (6,668) million and EBITDA amounted to SEK 1,631 (1,087) million · Accelerating mobile end-user service revenue growth of 18 percent, or 12 percent on a like-for-like basis · 12 months rolling operating cash flow increased to SEK 3.1 billion, versus SEK 1.1 billion a year earlier · Sweden EBITDA growth of 12 percent including TDC pro forma · Netherlands mobile end-user service revenue growth of 45 percent in local currency · Kazakhstan EBITDA margin expanded further to 22 percent · 2017 financial guidance upgraded for the Group (see p.5 in the report) The report is available on www.tele2.com. Presentation Q2 2017 result Tele2 will host a presentation with the possibility to join through a conference call, for the global financial community at 10:00 am CEST (09:00 am BST/04:00 am EDT) on Wednesday, July 19, 2017. The presentation will be held in English and also made available as a webcast on Tele2’s website: www.tele2.com  Dial-in information:To ensure that you are connected to the conference call, please dial in a few minutes before the start of the conference call to register your attendance. Ask for the Tele2 Q2 Interim Report.   Dial-in numbers:Sweden: +46(0)8 5033 6539United Kingdom: +44(0)20 3427 1901USA: +1646 254 3367 For more information, please contact:Erik Strandin Pers, Head of Investor Relations, Tele2 AB, Phone: +46 733 41 41 88Angelica Gustafsson, Head of Public Relations, Tele2 AB, Phone: +46 704 26 41 42 This information is information that Tele2 AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 07:00 CEST on July 19, 2017. TELE2’S MISSION IS TO FEARLESSLY LIBERATE PEOPLE TO LIVE A MORE CONNECTED LIFE. We believe the connected life is a better life, and so our aim is to make connectivity increasingly accessible to our customers, no matter where or when they need it. Ever since Jan Stenbeck founded the company in 1993, it has been a tough challenger to the former government monopolies and other established providers. Tele2 offers mobile services, fixed broadband and telephony, data network services, content services and global IoT solutions. Every day our 17 million customers across 9 countries enjoy a fast and wireless experience through our award winning networks. Tele2 has been listed on the NASDAQ OMX Stockholm since 1996. In 2016, Tele2 had net sales of SEK 28 billion and reported an operating profit (EBITDA) of SEK 5.3 billion. For definitions of measures, please see the last pages of the Annual Report 2016. Follow @Tele2group on Twitter for the latest updates.

INTERIM REPORT APRIL - JUNE 2017

Satisfactory revenue growth and operating profit Second quarter 2017 ·Revenue in the second quarter was SEK 148.5 (124.1) million, equivalent to a 20 percent increase. ·Operating profit excluding non-recurring costs for the second quarter increased to SEK 31.0 (29.9) million, corresponding to an operating margin excluding non-recurring costs of 20.9 (24.1) percent. ·Operating profit for the second quarter decreased to SEK 22.5 (28.8) million, equivalent to an operating margin of 15.2 (23.2) percent. ·Earnings per share decreased to SEK 0.96 (1.48) for the second quarter. ·Cash flow from operating activities was SEK 38.1 (41.1) million for the quarter. ·Cash and cash equivalents and financial investments amounted to SEK 260.2 (196.6) million at the end of the quarter. ·SEK 2.00 (4.20) per share was disbursed through an automatic redemption program on 12 June, corresponding to a transfer to shareholders of SEK 35.1 (66.8) million. First six months of the year ·Revenue increased to SEK 289.4 (244.9) million for the first six months of the year. ·Operating profit excluding non-recurring costs for the first six months decreased to SEK 56.7 (57.2) million, corresponding to an operating margin excluding non-recurring costs of SEK 19.6 (23.3) percent. ·Operating profit for the first six months of the year decreased to 46.0 (55.8) million, equivalent to an operating margin of 15.9 (22.8) percent. ·Earnings per share decreased to SEK 2.14 (2.86) for the first six months of the year. ·Cash flow from operating activities amounted to SEK 68.5 (79.9) million for the first six months of the year. April to June 2017 (second quarter previous year in brackets) · Revenue, SEK 148.5 (124.1) million · Revenue growth, 20 (3) % · Revenue growth, currency adjusted, 17 (4) % · Operating profit excluding non-recurring costs, SEK 31.0 (29.9) million · Operating profit, SEK 22.5 (28.8) million · Operating margin excluding non-recurring costs,% 20.9 (24.1) · Operating margin, 15.2 (23.2) % · Net profit after tax, SEK 16.8 (23.5) million · Earnings per share, SEK 0.96 (1.48) · Cash flow (from operating activities), SEK 38.1 (41.1) million · Cash and cash equivalents and financial investments, SEK 260.2 (196.6) million Anders Lidbeck, President and CEO comments: Interesting times It is a new Enea that has now put its first half-year behind it. The acquisition of Qosmos last December has complemented the other parts of our business really well, in both hard and soft factors. It is already contributing positively to our business top and bottom line, but has also advanced our market positioning significantly in our focused segments of NFV and cyber security. The acqusition has also strengthened our management and engi­neering capabilities. In overall terms, our second quarter revenue grew by 20 percent year over year. Meanwhile, we are still facing challenges in busi­ness on Key Accounts. Even if, due to the settlement of a previous delivery and the acquisition of Qosmos, we did increase income in the quarter by 22 percent year over year. But the long-term trend remains downward, which is, and will remain, our primary challenge. We need to offset the decline in our current business with major customers, with growth in new segments. Continued trends The second quarter continued the trends we witnessed in the first. Unfortunately, our US service sales continued to make negative progress, with year over year revenues down by more than 20 percent for the third quarter running. The major services deals we projected to close during the first half of 2017 has not materia­lized as expected. It is likely that this trend will continue for the rest of the year, even if the year over year numbers are expected to stabilize by the end of the year. Services sales in Europe made positive progress in the first half-year 2017, as in 2016. We expect this positive trend to also continue in the coming quarters. With the exception of Key Accounts and network intelligence, our glo­bal software operations continued to progress slow in the second quarter 2017 in year over year terms. During the quarter we have executed changes in our sales and marketing organization, to reduce costs and accelerate sales. To spur sales and address new market conditions, we are conti­nuing to develop our product portfolio. In the NFV segment, we announced two new products in the quarter: Enea NFV Core—an NFV platform that builds on our work in the OPNFV project, and Enea NFV Access, a platform optimized for usage cases closest to the subscriber in the network, usually known as customer premi­ses equipment (CPE). We’re now working actively to bring these products to market, and are in promising dialogue with potential customers and partners. We were also able to publicly announce a project that we have ongoing with China Mobile, the world’s largest mobile operator in many respects. Even if the financial value of this project is limited, we attach great strategic significan­ce to this type of project, and the recognition that partnering with China Mobile brings. We’ll keep developing our positioning in the segments where we perceive demand and where the world of tomorrow is being built. Satisfactory margins We have now experienced five years of profit and margin growth, but the coming period will mainly be about realigning our business. During this shift, our focus will be more on establishing a market position than on margin expansion. During this trans­formation process, it will be a challenge to retain the margins generated previously. It should again be noted that the companies acquired in 2016 returned margins well below the 20 percent-plus that Enea has delivered in recent years. Meanwhile, we are retaining our ambition to return to a 20 percent operating margin as early as by year-end 2017. That is why it is very satisfying that we achieved an operating margin of 20.9 percent before non-recurring costs during the second quarter. We will create future margin expansion mainly by focusing on fewer segments and by cutting unprofitable areas that lack clear potential, while continuously reviewing our cost base. During the quarter we decided to put two of our older products in maintenance mode and scale down related resources, while simultaneously focusing nearly all new development on cyber security, and first and foremost, on NFV. Even if our investment in NFV is unprofitable at present, we have also decided to focus here, because these are segments developing rapidly on a global basis, and for the past few years, we have created a unique market positioning here. As a result of these changes, our cost base will reduce by some SEK 20 million for the full year 2018. This program will start to be visible already in the second half-year 2017. The changes were complete during the second quarter, and res­tructuring costs of SEK 4.7 million were charged to second-quarter profit. The significant dispute with a major customer regarding the interpretation of contract terms generated high legal costs in the quarter, which reduced Q2 profit by SEK 3.7 million. We expect legal costs to remain at these levels in the second quarter. Against this background, our operating margin including non-re­curring costs for the second quarter, of just over 15 percent, and our operating profit of 22.5 million, is very satisfactory, even if it was down by SEK 6.3 million year over year. Excluding non-recur­ring costs totaling SEK 8.5 million, operating profit in the second quarter was better than the corresponding period of the previous year. Future prospects We are continuing to build a larger and stronger company with increased values for our customers, employees and shareholders. The transformation process currently underway is fundamentally positive for Enea, and reduces dependence on a single product and a limited number of major customers. Acquisitions that strengthen our market position and long-term earnings ability are a key part of this process, and despite our expectation of redu­ced income from our largest customers, our objective remains to expand with good profitability and sound cash flow. However, we cannot rule out the risk that increasing non-recurring costs associ­ated with this process may be charged to profit for 2017. Our objective for the full year 2017 is to achieve double-digit revenue growth, and improved operating profit compared to 2016 before non-recurring costs. We expect the improvement of opera­ting profit to occur in the second half-year 2017. Press and analyst meeting Press and financial analysts are invited to a press and analyst meeting where Anders Lidbeck, President and CEO, will present and comment on the report. Time: Wednesday July 19 at 08:30 am CEST. Link: https://www.financialhearings.com/event/9845 Phone number: SE: +46856642694 UK: +442030089810 The full report is published at www.enea.com/investors This information is information that Enea AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Swedish Securities Markets Act. The information was submitted for publication, through the agency of the contact person set below, on July 19, 2017 at 7.20 CEST.

Volvo Group – the second quarter 2017

• In Q2 2017 net sales increased by 12% to SEK 88.4 billion (78.9). Adjusted for currency movements and acquired and divested units sales increased by 6%. • Adjusted operating income amounted to SEK 8,540 M (6,130), corresponding to an adjusted operating margin of 9.7% (7.8). • Currency movements had a positive impact on operating income of SEK 350 M. • Operating cash flow in the Industrial Operations amounted to SEK 11.9 billion (6.9). • New Volvo VNL long-haul tractor launched in North America. Press and Analyst Conference. An on-line presentation of the report, followed by a question-and-answer session will be webcast starting at 9.00 CEST. More information under Investors on www.volvogroup.com Aktiebolaget Volvo (publ) 556012-5790                             Contacts Investor Relations:Investor Relations, VHQ                                                     Christer Johansson         +46 31 66 13 34SE-405 08 Göteborg, Sweden                                              Anders Christensson       +46 31 66 11 91Tel +46 31 66 00 00                                                              Anna Sikström                 +46 31 66 13 36www.volvogroup.com For more stories from the Volvo Group, please visit www.volvogroup.com/press. The Volvo Group is one of the world’s leading manufacturers of trucks, buses, construction equipment and marine and industrial engines. The Group also provides complete solutions for financing and service. The Volvo Group, which employs about 95,000 people, has production facilities in 18 countries and sells its products in more than 190 markets. In 2016 the Volvo Group’s sales amounted to about SEK 302 billion (EUR 31,9 billion). The Volvo Group is a publicly-held company headquartered in Göteborg, Sweden. Volvo shares are listed on Nasdaq Stockholm. For more information, please visit www.volvogroup.com.  This information is information that AB Volvo (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 7.20 a.m. CEST on July 19, 2017.

Interim report second quarter and first half year 2017

Second quarter 2017 ·Net sales increased by 7 percent to SEK 6,818 (6,344) million. Organic growth was 8 (7) percent and acquisitions contributed 3 percentage points. Fewer trading days in the quarter had a negative effect of 6 percentage points on sales. ·Operating profit (EBIT) declined by 1 percent to SEK 471 (476) million. Fewer trading days in the quarter had a negative effect of approximately SEK 100 million on gross profit. ·Profit (EBITA) amounted to SEK 558 (560) million, with an EBITA margin of 8.2 (8.8) percent. EBITA includes costs affecting comparability of SEK 11.5 million attributable to the restructuring of the Finnish management and sales organisation. Adjusted EBITA increased by 2 percent to SEK 570 (560) million, with an adjusted EBITA margin of 8.4 (8.8) percent. ·Profit after tax was SEK 308 (155) million. ·Basic and diluted earnings per share were SEK 0.71 (0.55). ·Two acquisitions were made, with a combined annual turnover of approximately SEK 100 million. ·During the quarter, an agreement was signed with Saferoad Holding on the acquisition of their Swedish Water & Sewer business ViaCon VA, with an annual turnover of approximately SEK 320 million. The transaction is subject to approval by the Swedish Competition Authority and closing is scheduled for September 2017. Interim period January - June ·Net sales increased by 13 percent to SEK 13,387 (11,824) million. Organic growth was 8 (6) percent. ·Operating profit (EBIT) increased by 16 percent to SEK 913 (790) million. ·Profit (EBITA) increased by 14 percent to SEK 1,088 (957) million, with an EBITA margin of 8.1 (8.1) percent. Adjusted EBITA increased by 15 percent to SEK 1,099 (957) million, with an adjusted EBITA margin of 8.2 (8.1) percent. ·Profit after tax was SEK 643 (128) million. ·Basic and diluted earnings per share were SEK 1.47 (0.46). ·Three acquisitions were made, with a combined annual turnover of approximately SEK 220 million.   Statement from the CEO Strong growth and continued good profitability Sales increased by 7 percent during the quarter, reflecting a strong first six months period, both in terms of revenue growth and earnings. All markets contributed to the performance and we see continuing good economic growth in our main markets. Gross profit for the quarter was adversely affected by Easter and fewer trading days.  Sales increased by 13 percent during the first half of the year. The solid increase was primarily attributable to organic growth and acquisitions. Our focus on an extended product range, full-range branches and strategic growth initiatives, together with completed acquisitions, has made us more attractive in the market. The positive development is reflected in the fact that we have entered into a number of new agreements with strategically important customers, and have renewed and extended existing agreements with many of our customers. We are increasingly seeing our customer-specific e-commerce solutions, in which efficient and environmentally-optimised logistics are integrated into the service, being well-received by large nationwide customers, irrespective of the market. Looking at results, we succeeded in converting increased sales into improved earnings. To increase sales by SEK 1.6 billion in comparison with the first six months last year means a strong increase in operating activity. It is a mark of strength, then, that we have been able to increase adjusted EBITA by 15 percent, while making significant investments in Norway and Finland. In terms of the individual markets, Ahlsell Sweden continues to deliver both strong sales growth and improved earnings. Operations showed organic growth of 10 percent during the quarter, and we both renewed and extended several nationwide agreements, notably in Construction, Electrical and Water & Sewers. The proportion of large projects continues to grow and we are delivering to most major construction and infrastructure projects in progress around Sweden. Acquisitions in recent years have strengthened Ahlsell’s construction and civil engineering business and made us an even more attractive partner. Internally, we have continued the extensive capacity expansion of the central warehouse in Hallsberg. We have also successfully driven improvement work with a focus on sales efficiency and developing the branch network during the period. Ahlsell Norway achieved organic growth of 6 percent in the quarter. Gross profit was negatively affected by fewer trading days and the Easter effect, which meant that the result for the quarter was unchanged. We saw the strongest development in the Electrical product segment, where we entered into important agreements with electricity grid customers and large installation companies. Sales of Water & Sewer products grew significantly and Ahlsell Norway has successfully aligned itself with municipal operations, resulting in several new transactions. Operations have also continued to focus on strengthening the position in HVAC & Plumbing and increasing cross-selling. The strategy lays the foundation for increased awareness of Ahlsell as a strong integrated supplier with the market’s most extensive range. Development of the branch network is an important part of the position movement and during the quarter we established a new full-range branch and co-located a further two branches. Development of the branch network remains a priority in 2017. Ahlsell Finland still has a relatively unfavourable market situation and organic growth was 4 percent, despite high operational activity. The focus has been on strengthening the market position in HVAC & Plumbing and continuing the growth in Electrical and Tools & Supplies. Work on changing the management and sales organisation for the Finnish operations began during the quarter. The change is expected to bring a clearer focus on Ahlsell’s offering as an integrated supplier, while increasing the organisation’s efficiency. About 30 positions are affected. Extensive work is also in progress in Finland, aimed at developing and strengthening the branch network, with a focus on location, an extended range and Ahlsell’s branch concept. Acquisition opportunities are still favourable Acquisitions are a key element of Ahlsell's business model and growth strategy and there are major synergies inherent in both complementary and strategic acquisitions. With this in mind it is very positive that we presently have a significant pipeline of potential acquisition candidates in all our main markets. During the second quarter, our acquisition efforts resulted in two completed acquisitions and an agreement on the acquisition of ViaCon’s Swedish Water & Sewer opera-tions with an annual turnover of SEK 320 million. The agreement with ViaCon also includes an attractive co-operation agreement for the distribution of their geotechnical products and road signage systems. The acquisition of ViaCon is subject to approval by the Swedish Competition Authority and we expect closing in September. In the year to date, we have made acquisitions, or signed agreements for acquisitions, with a combined annual turnover of approximately SEK 540 million. Outlook I do not expect any major change in the demand situation; in fact, the outlook for the next six months currently appears good, particularly in Sweden, with a construction market that remains strong and positive development in the industrial sector. In the rest of the Nordic region, the outlook also appears positive in, for example, the construction and industrial sector in Norway and we can expect a gradual recovery in Finland. Johan NilssonPresident and CEO This report will be commented upon as follows: Through a webcast today at 10:00 (Europe/Stockholm) under the followinglink: https://tv.streamfabriken.com/ahlsell-q2-2017   You can also participate by calling:   SE: +46 8 566 426 90UK: +44 20 300 898 01US: +1 855 753 22 35 For further information, please contact: Johan Nilsson, President and CEO, telephone +46 705 532 829, e-mail: johan.nilsson@ahlsell.se Kennet Göransson, CFO, telephone +46 706 211 294, e-mail: kennet.goransson@ahlsell.se Anna Oxenstierna, Investor relations, telephone +46 708 158 485, e-mail: anna.oxenstierna@ahlsell.se  +-----------------------------------------------------------------------------+|This  information is information that Ahlsell AB (publ) is obliged to make ||public pursuant to the EU Market Abuse Regulation and the Securities Markets ||Act. The information was submitted for publication, through the agency of the||Johan Nilsson, at 0730 (Stockholm/Europe) on 19 July 2017. |+-----------------------------------------------------------------------------+

TOMRA Q2: Good Activity Level and Strong Sorting Order Intake

Revenues in the second quarter 2017 amounted to 1,972 MNOK compared to 1,769 MNOK in the second quarter last year. This represent an increase of 11%. Organic, currency adjusted revenues were down 12% in TOMRA Collection Solutions and up 8% in TOMRA Sorting Solutions. Gross margin was 42% in the quarter, down from 43% in the same period last year. The decline is explained by the consolidation of Compac.   The Group reported operating expenses of 528 MNOK in the second quarter, unchanged compared to same quarter last year after adjusting for currency and acquisitions. EBITA was 306 MNOK in the second quarter 2016 compared to 319 MNOK in the second quarter 2017. Net finance was positive by 9 MNOK in the quarter, positively influenced by currency gains of 12 MNOK. The cash flow from operations in the second quarter 2017 equaled 170 MNOK, down from 239 MNOK in the second quarter 2016. Collection Solutions:  German Replacement Cycle Maturing Revenues in the business area equaled 975 MNOK in the second quarter, down from 1,089 MNOK in second quarter last year. After adjustment for currency changes, revenues were down 12%. Gross margin was 42%, unchanged from last year. Operating expenses were 220 MNOK, down 2% currency adjusted. As a result of lower revenues in the quarter EBITA declined from 237 MNOK to MNOK 191 compared to the same period last year. “The activity level in Germany is still good due to the ongoing replacement demand, but the very high activity level we saw last year is naturally coming to a lower level as we are further in the replacement cycle”, says Stefan Ranstrand, TOMRA President and CEO. As a part of the announced Container Deposit Scheme in New South Wales, Australia commencing December 1st, TOMRA submitted a tender bid for a role as Network Operator. The bid was made jointly with Cleanaway, the leading waste management company in Australia. A response from the New South Wales Environment Protection Authority is expected during the month of July. Sorting Solutions: Year on Year Improvement in all Business Streams Revenues equaled 997 MNOK in second quarter 2017. This represented an increase of 8% in local currencies, adjusted for acquisitions (Compac). Gross margin was 42%, down from same period last year due to consolidation of Compac. Organic and currency adjusted the operating expenses were unchanged compared to same period last year. EBITA increased from 92 MNOK in second quarter 2016 to 131 MNOK in second quarter 2017, driven by higher volumes and positive contribution from Compac. TOMRA paid at closing a consideration of 70 MNZD for the acquisition of Compac, free of cash and interest-bearing debt. In addition to the initial purchase price, the sellers were entitled to an earn-out linked to the total EBIT for the period July 2016 to June 2019. A financial completion statement was prepared and presented during the second quarter 2017, which was subject to discussions between TOMRA and the vendors. In July 2017, the parties agreed a final settlement where the earn/out was cancelled in exchange for certain upfront agreements regarding warranty clauses and working capital levels. “We are pleased with the overall good momentum in TOMRA Sorting. The order inflow in Food was better than same period last year and we have seen the increased activity level in Recycling continue in the quarter. This leaves us with a solid backlog at the end of this quarter, and we expect the good momentum to continue in the short term”, Ranstrand comments on the outlook for Sorting Solutions. Asker, 19 July 2017 TOMRA Systems ASA For questions, please contact: Espen Gundersen, Deputy CEO/CFO: +47 66 79 92 42 / +47 97 68 73 01 Elisabet V. Sandnes, Vice President Investor Relations/M&A: +47 97 55 79 15 Webcast link: http://webcast.seria.no/webcast/59387985 There will be a Q&A after the presentation and the recorded webcast will be made available on TOMRA’s webpage www.tomra.com after broadcast is concluded.  

REPORT FOR THE SECOND QUARTER 2017 AND THE FIRST HALF YEAR 2017

Financial and operating highlights 2Q 2017 (2Q 2016 in brackets): · Operating revenues were NOK 2 036 million (NOK 3 151 million)  · EBITDA  was NOK 695 million (NOK 1 379 million) · Year on year EBITDA improvement of NOK 254 million, apart from Offshore drilling ·  EBIT (operating result) was NOK - 652 million (NOK -824 million) ·  Net finance was NOK - 61 million (NOK - 9 million).            ·  Net result after tax was NOK -812 million (NOK -1 012 million) Offshore drilling · EBITDA NOK 240 mill. (NOK 1 178 mill.) · Impairment on offshore units NOK 635 mill. (NOK 1 321 mill.) · Bolette Dolphin- termination for convenience against a fee of USD 96 mill. · Bideford Dolphin 100 days contract extension · Borgsten Dolphin to be decomissioned Renewable energy · EBITDA NOK 164 mill. (NOK 84 mill.) · Like-for-like generation up 33% · Compensation for curtailments of NOK 26 million of Crystal Rig II Shipping / Offshore wind · EBITDA NOK 140 mill. (NOK 5 mill.) · Utilization for installation vessels 100% (36%). · Contract pipeline to year end 2019 covered 41% by firm contracts Cruise · EBITDA NOK 139 mill. (NOK 102 mill.) · 11 % weakening of GBP/USD · Net ticket income per diems up 22.5 % Financial information The Group‘s operating revenues amounted to NOK 2 036 million (NOK 3 151 million). Offshore drilling had operating revenues of NOK 466 million (NOK 1 809 million), Renewable energy NOK 253 million (NOK 171 million), Shipping / Offshore wind NOK 401 million (NOK 241 million) and Cruise NOK 574 million (NOK 550 million). Within Other investments NHST Media Group had operating revenues of NOK 335 million (NOK 365 million). EBITDA was NOK 695 million (NOK 1 379 million). Offshore drilling achieved EBITDA of NOK 240 million (NOK 1 178 million), Renewable energy NOK 164 million (NOK 84 million), Shipping/Offshore wind NOK 139 million (NOK 5 million), while Cruise achieved EBITDA of NOK 139 million (NOK 102 million). Within Other investments EBITDA were NOK 12 million (NOK 11 million). Depreciation in the quarter was NOK 713 million (NOK 882 million). Impairment within offshore drilling was NOK 635 million (NOK 1 321 million). EBIT was NOK - 652 million (NOK - 824 million). Net financial items in the quarter were NOK - 61 million (NOK – 9 million). Net interest expenses were NOK 148 million (NOK 176 million) and net currency gain amounted to NOK 45 million (NOK 21 million) Net unrealized loss related to fair value adjustment of financial instruments were NOK 4 million(gain of NOK 36 million). In the quarter Bonheur ASA received NOK 183 million from Koksa Eiendom AS, of which NOK 62 million was recognized as dividend, the rest (NOK 122 million) as repayment on the original investment. Other financial items amounted to NOK - 19 million (NOK - 17 million) Net result in the quarter was NOK - 812 million (NOK - 1 013 million), of which NOK - 325 million are attributable to the shareholders of the parent company (NOK - 494 million). The non-controlling interests´ share of net result in the quarter was thus NOK -487 million (NOK -519 million). Revenues year to date were NOK 4 389 million (NOK 6 440 million) while EBITDA year to date were NOK 1 385 million (NOK 2 665 million). Operating result (EBIT) year to date was NOK - 645 million(NOK - 424 million). Net financial items were NOK - 183 million (NOK - 166 million), and net result after estimated tax was NOK - 960 million (NOK - 802 million), of which NOK - 430 million (NOK - 395 million) are attributable to the shareholders of the parent company.

Another good quarter for ASSA ABLOY

Second quarter · Net sales increased by 8% to SEK 19,387 M (17,894), with organic growth of 2% (4) and acquired growth of 2% (4) · Good growth was shown by EMEA, Americas, Global Technologies and Entrance Systems and negative growth by Asia Pacific · Contracts have been signed for the acquisition of five companies with expected combined annual sales of about SEK 900 M · Operating income (EBIT) increased by 7% to SEK 3,114 M (2,910). The operating margin was 16.1% (16.3) · Net income amounted to SEK 2,179 M (2,026) · Earnings per share increased by 8% and amounted to SEK 1.96 (1.82) · Operating cash flow increased by 2% to SEK 2,575 M (2,519). Sales and income +------------------------------+------+-------+--+------+--------+---+| |Second quarter| |First half-year| |+------------------------------+------+-------+--+------+--------+---+| |  | | | | | |+------------------------------+------+-------+--+------+--------+---+| | 2016| 2017| Δ| 2016| 2017| Δ|+------------------------------+------+-------+--+------+--------+---+|Sales, SEK M |17,894| 19,387|8%|33,785| 37,529|11%|+------------------------------+------+-------+--+------+--------+---+|Of which: | | | | | | |+------------------------------+------+-------+--+------+--------+---+|Organic growth[1] | 602| 344|2%| 1,002| 1,366| 4%|+------------------------------+------+-------+--+------+--------+---+|Acquisitions | 593| 451|2%| 1,083| 900  | 3%|+------------------------------+------+-------+--+------+--------+---+|Exchange-rate effects[1] | -383| 698|4%| -633| 1,478| 4%|+------------------------------+------+-------+--+------+--------+---+|Operating income (EBIT), SEK M| 2,910| 3,114|7%| 5,321| 5,901|11%|+------------------------------+------+-------+--+------+--------+---+|Operating margin (EBIT), % | 16.3%| 16.1%| | 15.7%| 15.7%| |+------------------------------+------+-------+--+------+--------+---+|Income before tax, SEK M | 2,729| 2,944|8%| 4,938| 5,537|12%|+------------------------------+------+-------+--+------+--------+---+|Net income, SEK M | 2,026| 2,179|8%| 3,664| 4,097|12%|+------------------------------+------+-------+--+------+--------+---+|Operating cash flow, SEK M | 2,519| 2,575|2%| 3,017| 3,399|13%|+------------------------------+------+-------+--+------+--------+---+|Earnings per share (EPS), SEK | 1.82| 1.96|8%| 3.30| 3.69|12%|+------------------------------+------+-------+--+------+--------+---+ [1] The sales components Organic growth and Exchange-rate effects have been restated for the first half-year of 2016. No effect on sales figures.  Comments by the President and CEO “The second quarter was another good quarter for ASSA ABLOY,” says Johan Molin, President and CEO. Organic growth was 2% because of the fewer working days resulting from Easter during the quarter. This means that we have an organic growth of 4% for the first half-year. Sales in North America continued to develop well. In Europe the underlying demand is good but we have not seen any appreciable improvement. Sales in China fell once again, and disappointingly they also continued to decrease in Brazil and in the Middle East. “Entrance Systems, Global Technologies and Americas all produced 3% organic growth, while EMEA grew by 2%. However, Asia Pacific showed negative growth because of weak demand in China. “It is pleasing to see that our investments in software solutions to support architects and others who specify door solutions are leading to more inquiries and increased sales. It is also very gratifying that we are launching so many new and exciting products, primarily electronic and digital solutions. One example is a new smart handle for inner doors which provides full RFID compatibility and can be installed and integrated cost-effectively with virtually all access control systems on the market, but can also be used as a freestanding unit. “During the quarter contracts were signed for the acquisition of five companies, including Arjo, a leading supplier of physical and digital identity solutions for national ID documents. The company strengthens our present offering of secure identity solutions and offers complementary growth opportunities. “Operating income for the quarter increased by 7% and amounted to SEK 3,114 M, with an operating margin of 16.1% (16.3). The margin increased in EMEA and Entrance Systems divisions and remained stable for Americas and Global Technologies, but as expected Asia Pacific was weak. The operating cash flow improved by 2%. “My judgment is that the global economic trend has improved to some degree compared with last year. On most markets in North and South America and in parts of Europe there is a positive trend, but on some markets, chiefly in Asia and the Middle East, the trend is weak. However, our strategy of expanding our market presence, even on the emerging markets, remains unchanged. We are also continuing our investments in new products, especially in the growth area of electromechanics.”  Further information can be obtained from:Johan Molin,President and CEO, Tel: +46 8 506 485 42 Carolina Dybeck Happe,Chief Financial Officer, Tel: +46 8 506 485 72 ASSA ABLOY is holding an analysts’ meeting at 10.00 today at Operaterrassen in Stockholm, Sweden. The analysts’ meeting can also be followed on the Internet at www.assaabloy.com.It is possible to submit questions by telephone on: +46 8 5055 6476, +44 203 364 5371 or +1 877 679 2993. This is information that ASSA ABLOY AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 08.00 CEST on 19 July 2017.

Q2 2017: Probi completes integration and ends first half of 2017 with increase in sales and earnings

Highlights and significant events during the second quarter • Robust growth in sales and earnings despite inventory management at one of the largest customers• Successful completion of integration process, strengthening of marketing and sales organization and finalization of purchase price allocation at Probi USA• Several new distribution agreements in EMEA• Launch of research program targeted at next generation probiotics and prebiotics Financial overview MSEK H1 2017 H1 2016 Full -year 2016Net sales 359.4 160.3 443.5Net sales growth, 118.3% 25.3% 103.2%local currency, %Gross margin, % 48.0% 68.8% 60.0%EBITDA 107.1 59.3 152.6EBITDA margin, % 29.8% 37.0% 34.4%Operating profit 79.8 56.0 120.0(EBIT)Net income 59.3 44.0 101.8Earnings per 5.21 4.83 10.73share before andafter dilution,SEKShare price on 580.00 233.98 475.50closing day, SEKMarket cap on 6,608.6 2,132.8 5,417.9closing daySee note 5 fordefinitions ofratios notdefined accordingto IFRS and note4 for adjustmentsmade to full-year2016 Invitation to TeleconferenceDate: 19 July 2017Time: 10:00 a.m.Phone: +46 8 56 64 26 91Participants from Probi: Peter Nählstedt, CEO and Dr. Jörn Andreas, CFO The presentation is available at www.probi.se and www.financialhearings.com ContactsPeter Nählstedt, CEO:Phone: +46 46 286 89 23, E-mail: peter.nahlstedt@probi.comDr. Jörn Andreas, CFO:Phone: +46 46 286 89 41, E-mail: jorn.andreas@probi.com About ProbiProbi AB is a Swedish publicly traded bioengineering company. The vision of Probi is to help people live healthier lives by delivering effective and well-documented probiotics, with proven health benefits based on scientific research.Founded by scientists in Sweden in 1991, Probi is a multinational company with four centres of excellence, active in more than 40 markets around the world and holding over 400 patents worldwide. In 2016, Probi had net sales of MSEK 444. The Probi share is listed on Nasdaq Stockholm, Mid Cap. Probi has about 5,000 shareholders. probi.com This information is information that Probi AB is obliged to make public pursuant to the EU Market Abuse Regulation. Theinformation was submitted for publication, through the agency of the contact person set out above, at 8:00 a.m. CET on 19 July 2017. When in doubt, the Swedish wording prevails.

Interim report January–June 2017

· Orders received amounted to SEK 16,431 M (17,123) in the second quarter and to SEK 27,913 M (27,661) in the first half of the year · Net sales amounted to SEK 13,382 M (13,646) in the second quarter and to SEK 25,188 M (22,843) in the first half of the year · Profit after financial items totaled SEK 522 M (548) for the second quarter and SEK 805 M (240) for the first half of the year · Profit after tax amounted to SEK 435 M (441) for the second quarter and SEK 672 M (197) for the first half of the year · Earnings per share after dilution amounted to SEK 3.99 (66.81*) in the second quarter and to SEK 6.20 (65.61*) for the first half of the year * In this report, Bonava is reported as a discontinued operation according to IFRS 5 (see accounting policies on page 16 and Note 4) and is included in NCC’s income statement up to June 7, 2016. Earnings from discontinued operation comprise Bonava’s profit for the period January 1 to June 7 plus the difference between Bonava’s market capitalization on the listing date and Bonava’s shareholders’ equity on the spinoff date.  Contact information Chief Financial Officer Mattias Lundgren, Tel. +46 70 228 88 81 IR Manager Johan Bergman, Tel. +46 70 354 80 35 Information meetingAn information meeting with an integrated Internet and telephone conference will be held on July 19 at 10:00 a.m. at Tändstickspalatset, Västra Trädgårdsgatan 15 in Stockholm. The presentation will be held in English. To participate in this teleconference, call +46 8 519 993 55 (SE), +44 203 194 05 50 (UK), +1 855 269 26 05 (US) or +49 211 971 900 86 (DE) five minutes prior to the start of the conference. State “NCC.” This is the type of information that NCC AB could be obligated to disclose pursuant to the EU Market Abuse Regulation and the Securites Market Act. The information was issued for publication through the contact person above, on July 19, 2017, at 08:00 CET.

Gunnebo Interim Report January-June 2017

CEO’S COMMENTS ON THE SECOND QUARTER 2017 The second quarter was in line with the same period last year with a turnover of MSEK 1,510 and an operating margin of 6.8% excluding non-recurring items. Growth has been good within both Entrance Security and Cash Management. DEVELOPMENT OF OUR BUSINESSIn region EMEA sales developed well during the second quarter in all sub-regions with the exception of France and South Africa. It is positive that the operating margin in EMEA for the quarter is on the same level as last year, despite organic sales growth of -2%. Excluding France, organic sales growth in EMEA was +4%. In France, which is seeing declining demand from the banking segment, we continue with structural changes. This is in line with our ongoing focus on improving productivity in the European business by expansion in other customer segments and productivity-enhancing activities. Gunnebo's business in South Africa has also seen weaker demand from the banking sector in the past quarters. We have therefore initiated a review of the business to adapt it to new market conditions. In the Middle East, the roll-out of Gunnebo's solutions for efficient cash management in the United Arab Emirates, together with the CIT company, Transguard, is moving forward at a good pace. In the Americas region, sales growth has been good during the second quarter, primarily due to positive developments in North America. During the quarter the Hamilton brand turned 50 which was marked by the introduction of an updated brand identity to the channel partners to further strengthen the brand in North America. In Latin America, sales have developed weaker than expected mainly due to slow investment climate. In region Asia-Pacific, sales growth has been negative. This development is explained by the large OKI project in Indonesia, where sales in the second quarter of 2016 were much higher than this year. The project has been running since the second half of 2015 and is expected to end during the third quarter of 2017. Excluding OKI, growth in the region was flat. Markets in Australia, South-East Asia and China, however, had good sales growth in the quarter. In China, sales of Entrance Security for both subways and public buildings continued to be positive. In India, sales were weaker due to continued low demand from the banking segment. However, our ATM safes business in the country has continued to developed well. We are also working intensively to grow our Indian business into other segments. NEW FINANCINGDuring the quarter we refinanced the Group's long-term borrowing, which resulted in an increased loan facility with improved terms. This gives us better opportunities to invest in profitable growth through increased R&D and acquisitions. QUARTERLY RESULTFor the quarter, we report an operating profit excluding non-recurring costs of MSEK 103 and an operating margin of 6.8%. With a quarterly result in line with the same quarter last year and new loan facilities, we are ready to continue implementing our strategy for profitable growth. Gothenburg, July 19, 2017 Henrik LangePresident and CEO SECOND QUARTER 2017 · Net sales amounted to MSEK 1,510 (1,474), organic growth was -3% · Operating profit (EBIT) amounted to MSEK 92 (80) and the operating margin (EBIT) increased to 6.1% (5.4) · Operating profit (EBIT) excluding non-recurring items amounted to MSEK 103 (103) and the operating margin (EBIT) to 6.8%      (7.0) · Net profit for the period amounted to MSEK 39 (42) · Basic earnings per share amounted to SEK 0.51 (0.55) · Free cash flow amounted to MSEK -76 (27) JANUARY-JUNE 2017 · Net sales amounted to MSEK 2,950 (2,864), organic growth was -1% · Operating profit (EBIT) amounted to MSEK 151 (133) and the operating margin (EBIT) increased to 5.1% (4.6) · Operating profit (EBIT) excluding non-recurring items amounted to MSEK 168 (161) and the operating margin (EBIT) to 5.7% (5.6) · Net profit for the period amounted to MSEK 68 (62) · Basic earnings per share amounted to SEK 0.88 (0.81) · Free cash flow amounted to MSEK -82 (34) Full report is attached to this press release.Invitation to Telephone Conference on July 19, 09.30 (CET)To participate in the conference call, please dial in to one of these numbers: +46 8 5664 2699+44 20 3008 9809 Agenda for the Telephone Conference09:25  Call in09:30  Review of the interim report by Gunnebo’s President and CEO, Henrik Lange, and CFO, Susanne Larsson 09:55  Questions and answers10:15  Closing of telephone conference Copies of the presentation will be available 30 minutes prior to the telephone conference on www.gunnebogroup.com. Attending from Gunnebo AB are President and CEO Henrik Lange, CFO Susanne Larsson and SvP Marketing & Communications Karin Wallström Nordén. A recording of the telephone conference will be available on www.gunnebogroup.com from late afternoon July 19. GUNNEBO AB (publ)Group Communication For more information, please contact:Henrik Lange, President & CEO Gunnebo AB, tel. +46 10 2095 026, orSusanne Larsson, CFO Gunnebo AB, tel. +46 10 2095 026, orKarin Wallström Nordén, SvP Marketing & Communications Gunnebo AB, tel. +46 708 28 33 39  www.gunnebogroup.comThis information is information that Gunnebo AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the contact persons set out above, at 08.01 CET on July 19, 2017.

Electrolux President and CEO Jonas Samuelson’s comments on the results for the second quarter 2017

During the second quarter Electrolux improved its operating income by close to 25%, achieving an operating margin of 6.2%. Profitability increased in most of our business areas. This was driven by continued focus on improving product mix through active portfolio management, and increased cost efficiency within our operations. Cash flow continued to be strong, further strengthening our balance sheet. In EMEA, our premium brands continued to gain market share driven by the built-in kitchen segment. The launch of the new AEG products is ongoing, with strong market impact. We are very pleased that operating margins continue at a high sustained level, reaching 6.2% in the quarter. The European appliance market remains solid, with demand growth in several markets in Western and Eastern Europe, while the UK and the Middle East and Africa continue to be weak. We expect the total European market to be positive and confirm our outlook of around 1% growth in 2017. In our operations in North America, we continued the strong operational performance, improving the mix by focusing on our most competitive products and increasing productivity and cost efficiency. This contributed to achieving an operating margin of 8.4% despite continued price pressure and lower sales volumes under private labels. With a good trend during the first half of the year, the market for appliances in North America remains strong and we see the favorable macro environment continuing to support demand. We therefore increase our outlook for the North American market and now expect the market to grow by 3-4% in 2017. The operations in Latin America faced another quarter with tough market conditions although there were signs of a slow recovery. Market volumes in Brazil, Argentina and Chile improved slightly but the macro and political uncertainty in Brazil remains. Actions to improve the profitability of our business are progressing according to plan. The operations in Asia Pacific, Home Care & SDA and Professional Products all showed strong improvement in earnings compared to the second quarter 2016. We expect the organic sales contribution from volume, price and mix for the full year to be slightly positive, as a result of the supportive market environment, strong mix performance and successful product launches, offsetting continued price pressure. Our efforts to drive cost efficiency continue and we now expect to deliver a net cost efficiency of SEK 2.3bn for the full year of 2017. Price developments in the commodity markets have been neutral on balance, and we confirm our expected negative impact from raw-material costs of SEK 1.4bn for the full year. In early July we announced the agreement to acquire Best, a European manufacturer of innovative and well-designed kitchen hoods. The acquisition enables Electrolux to further drive long-term profitable growth in the built-in-kitchen segment in EMEA. The deal is expected to close within the next quarter and will be our fourth this year, highlighting our ambition to broaden Electrolux product offering and expand in new profitable markets and segments. During the quarter we have also updated our strategic framework, connecting our business model and path to profitable growth to a clear and revised company Purpose – Shape living for the better. We will achieve this by reinventing taste, care and wellbeing experiences for more enjoyable and sustainable living around the world. This will set the direction for Electrolux for years to come.

Interim report January–June 2017

JANUARY – JUNE 2017 (COMPARED WITH JANUARY–JUNE 2016) · Total income increased by 29%, amounting to SEK 911 million (708) · Earnings after tax (EAT) increased by 35%, amounting to SEK 241 million (179) · Return on equity (RoE) was 19% (21) · Earnings per share increased to SEK 2.35 (1.82) · Continued strong growth with increased quality in the credit portfolio, SEK 17,090 million (10,865) +57% · Positive development in credit losses 1.1% (1.2) · Communication from Collector´s Annual General Meeting of 25 April 2017 · Lena Apler – Female Founder of the Year 2017 · Liza Nyberg – new CEO in place from 1 September · Collector Bank successfully issues SEK 500 million of subordinated Tier 2 bonds · Collector issues convertible loans of MSEK 100 to staff* * Completed in July 2017 and affecting the capital base from July 2017 Read more on https://www.collector.se/en/about-collector/investors/financial-information/ Presentations to investors, analysts and mediaA telephone conference with the opportunity to pose questions will be held today, 19 July at 10.00 (CET) am, with Founder & Acting CEO Lena Apler and CFO Pia-Lena Olofsson presenting the report. The telephone conference will be held in Swedish and streamed live on https://tv.streamfabriken.com/collector-q2-2017To join the telephone conference, please call: +46 8 5664 2666 or +44 20 3008 9804. The switchboard will open at 09.55 am CET. For further information, please contact:Lena Apler, Founder & Acting CEO Collector | Phone +46 70-525 65 80 | Email lena.apler@collectorbank.sePia-Lena Olofsson, CFO, Collector | Phone +46 70 858 04 53 | Email pia-lena.olofsson@collectorbank.seÅsa Hillsten, CCO & IR Collector | Phone +46 70 081 81 17 | Email asa.hillsten@collectorbank.se This information is information that Collector AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 08.14 CET on July 19, 2017.

Another preclinical paper on the Episealer implant published

Another preclinical paper has been published that again validates Episurf Medical’s (NASDAQ: EPIS B) patented cartilage repair technology to treat knee pain. The study titled “Cartilage Health in Knees Treated with Metal Resurfacing Implants or Untreated Focal Cartilage Lesions: A Preclinical Study in Sheep” by N. Martinez-Carranza et al. is now available online in the medical journal “Cartilage”. Whilst the paper looks at the positive impact of the Episealer knee implant, it also indicates that the biological coatings applied to the implant maintain the health of the surrounding cartilage, offering an excellent “chondrointegration” of cartilage to the Episealer. “The coatings that are applied to the implant appear to result in the surrounding cartilage being nourished and maintained, which is unique. This is an exciting clinical validation of our technology and more evidence in this area is starting to become available”, comments Prof. Leif Ryd, Senior Medical Advisor, Episurf Medical. For more information, please contact: Pål Ryfors, CEO, Episurf Medical  Tel: +46 (0) 709 62 36 69 Email: pal.ryfors@episurf.com About Episurf Medical Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.

CELLINK publishes quarterly report for the third quarter

CELLINK AB ("CELLINK" or "Company") publishes quarterly report for the period 1st of March 2017 – 31th of May 2017 and the results for the first nine months. The report is available on the company's website: http://cellink.com/investor-relations/. This press release presents a summary of the report. Quarter 3 (Q3), March 1st, 2016 - May 31st, 2017 ·        Operating revenues amounted to 5,162 kSEK ·        Net sales of 3,103 kSEK ·        Operating profit before depreciation, EBITDA amounted to -441 kSEK ·        Operating profit amounted to -537 kSEK ·        Profit before tax amounted to -566 kSEK ·        Earnings per share amounted to -0,082 SEK in the 3rd quarter ·        Cash flow from operating activities in the quarter amounted to -1,460 kSEK 9 months, September 1st, 2016 – May 31st, 2017 ·        Operating income amounted to 13,036 kSEK ·        Net sales of 8 750 kSEK ·        Operating profit before depreciation, EBITDA amounted to 242 kSEK, which corresponds to an EBITDA margin of 1.9% ·        Operating profit amounted to 55 kSEK ·        Profit before tax amounted to -45 kSEK ·        Earnings per share amounted to SEK -0 ·        Cash flow from operating activities during the period amounted to 1,024 kSEK Events in the third quarter (March 2017 - May 2017) · On March 17, the company appointed an Advisory Board to assist the company in strategic matters Events after the end of the period ·        On June 9, the company announced that it received orders in connection with new distribution agreements ·        On July 10, CELLINK signed a distribution agreement with Thermo Fisher Scientific ANZ ·        On July 12, CELLINK conducted a directed share issue of B shares of 30 MSEK         For further information, please contact: Erik Gatenholm, CEO                                     Gusten Danielsson, CFO Phone: +46 73 267 00 00                             Phone: +46 70 991 86 04 E-mail: eg@cellink.com                                E-mail: gd@cellink.com Important information This information is such information as CELLINK AB is required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on July 19, 2017 at. 08:30 CET. About CELLINK CELLINK has created one of the world's first universal Bioinks, today used by many of the world's most well-reputed research institutions. A Bioink can be mixed with living cells to print functional human tissues and if future research is successful, eventually, complete human organs in so-called 3D-Bioprinters. CELLINK's universal Bioink shows excellent results and can be used in both CELLINK's proprietary 3D Bioprinters and in 3D Bioprinters developed by other operators. Mangold Fondkommission AB, tel: +46 (0) 8 5030 1550, is the Company's Certified Adviser.

MTS trials live Licensed Assisted Access

Together with MTS, the largest mobile network operator in Russia, and Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, Ericsson (NASDAQ: ERIC) has conducted the first successful live trial with a commercial small cell product of Rel-13 Licensed Assisted Access (LAA) technology in Russia. The demonstration was conducted in an MTS test lab over a live network and used Ericsson’s Pico RBS 6402 small cell and a Qualcomm® Snapdragon™ X16 LTE mobile test device. With LAA, data speeds are boosted using unlicensed spectrum together with licensed spectrum. The amount of licensed spectrum is limited, and the need for spectrum is huge. The latest Ericsson Mobility Report  forecasts that smartphones will be using 11 Gigabytes of data a month by 2022. This puts enormous strain on operators to meet the demands for performance in mobile connectivity for their subscribers. Andrei Ushatskiy, MTS Vice President, Technology and IT, says: “Delivering the level of mobile connectivity our subscribers expect, across a wide variety of environments, is a primary focus of MTS. This successful demonstration is the first of its kind in Russia, and shows our commitment to exceeding our customers’ expectations with enhanced experiences.” Yulia Klebanova, vice president, business development, Qualcomm Europe Inc., says: “LAA enables more operators globally to offer Gigabit LTE, which is an essential foundation when introducing the 5G mobile experience, and we look forward to working with infrastructure vendors, OEMs, and network operators to advance mobile connectivity for subscribers across the world.” Arun Bansal, Senior Vice President, Europe & Latin America, Ericsson, says: “LAA uses unlicensed spectrum to boost data speeds, offering subscribers the chance to enjoy enhanced LTE experiences on their devices. This technology allows LTE and Wi-Fi users superior performance in both indoor and outdoor environments by sharing the spectrum in unlicensed bands.” Ericsson’s RBS 6402 is a high-performance indoor Pico Cell offering three standards (LTE, WCDMA and Wi-Fi), 10 frequency bands and up to 300 Mbps LTE carrier aggregation. The flexibility, cost-effectiveness and performance in a tablet-sized footprint make it optimal for smaller buildings. NOTES TO EDITORS For media kits, backgrounders and high-resolution photos, please visit www.ericsson.com/press FOLLOW US: www.twitter.com/ericssonwww.facebook.com/ericssonwww.linkedin.com/company/ericssonwww.youtube.com/ericsson  MORE INFORMATION AT: News Center  media.relations@ericsson.com(+46 10 719 69 92) investor.relations@ericsson.com(+46 10 719 00 00) Ericsson is a world leader in communications technology and services with headquarters in Stockholm, Sweden. Our organization consists of more than 111,000 experts who provide customers in 180 countries with innovative solutions and services. Together we are building a more connected future where anyone and any industry is empowered to reach their full potential. Net sales in 2016 were SEK 222.6 billion (USD 24.5 billion). The Ericsson stock is listed on Nasdaq Stockholm and on NASDAQ in New York. Read more on www.ericsson.com. Qualcomm and Snapdragon are trademarks of Qualcomm Incorporated, registered in the United States and other countries. Qualcomm Snapdragon is a product of Qualcomm Technologies, Inc.

OV to evaluate the potential of in-licensing a small molecule compound for development in cancer from a major Pharmaceutical company

“Oncology Venture is excited to explore the opportunity to enhance the development of the molecule. We are confident that by using our Drug Response Predictor (DRPTM) to select patients we will raise the chances of success for the molecule in clinical development. A drug specific DRP biomarker could then be consequentially used as a predictive companion diagnostic to identify likely responders” said Peter Buhl Jensen, M.D., CEO of Oncology Venture. For further information, please contact Ulla Hald Buhl, COO and Chief IR & Or Peter Buhl Jensen, CEOMobile: +45 21CommunicationsMobile: +45 2170 60 89 22E-mail:1049uhb@oncologyventure.com pbj@oncologyventure.com  About the Drug Response Predictor (DRP™) Companion DiagnosticOncology Venture uses the Medical Prognosis Institute (MPI) multi gene DRP™ technology to select those patients that, by the genetic signature in their cancer, is found to have a high likelihood of response to a given drug. The goal is to develop the drug for the right patients by screening patients before treatment, whereby the response rate can be significantly increased. The DRP™ method builds on the comparison of sensitive vs. resistant human cancer cell lines including genomic information from cell lines combined with clinical tumor biology and clinical correlates in a systems biology network. The DRP™ is based on messenger RNA from the patients biopsies.The DRP™ platform (i.e. the DRP™ and the PRP™ biomarkers) can be used in all cancer types, and is patented for more than 70 anti-cancer drugs in the US. The PRP™ is commercialized by MPI for Personalized Medicine. The DRP™ is commercialized by Oncology Venture for drug development. About Oncology Venture Sweden ABOncology Venture Sweden AB is engaged in the research and development of anti-cancer drugs via its wholly owned Danish subsidiary Oncology Venture ApS. Oncology Venture has an exclusive license to use the Drug Response Predictor (DRP™) technology in order to significantly increase the probability of success in clinical trials. DRP™ has proven its ability to provide a statistically significant prediction of clinical outcomes from drug treatment in cancer patients in 29 of the 37 clinical studies that were examined. The Company uses a model that alters the odds in comparison with traditional pharmaceutical development. Instead of treating all patients with a particular type of cancer, patients’ tumors’ genes are screened first with DRP™ and only those who are most likely to respond to the treatment will be treated. Via a more well-defined patient group, the risk and costs are reduced while the development process becomes more efficient.The current product portfolio: LiPlaCis® for Breast Cancer in collaboration with Cadila Pharmaceuticals, Irofulven developed from a fungus for prostate cancer and APO010 – an immuno-oncology product for Multiple Myeloma.Oncology Venture has spun out two companies in Special Purpose Vehicles: 2X Oncology Inc. a US based company focusing on Precision medicine for women’s cancers with a pipeline of three promising phase 2 product candidates and Danish OV-SPV 2 will test and potentially develop the Novartis small molecule kinase inhibitor. This information is that Oncology Venture Sweden AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on July 19th 2017.

Samhällsbyggnadsbolaget i Norden AB (publ) complements the company’s financial targets, issues hybrid bonds of MSEK 300 and issues warrants

"Following successful sales of building rights, we continue our efforts to strengthen the balance sheet and we are very pleased to attract a leading international institution to invest in our hybrid bonds. By this issue we get access to attractively priced equity as a result of a reasonably priced coupon on the bonds and sensible conditions on the warrants, says Ilija Batljan, CEO and Founder of SBB. The hybrid bonds initial issue amounts to MSEK 300 with a coupon of 7.5% per annum within a maximum frame of MSEK 1,000. The bonds are perpetual with a first possible call, from the company, after 5.5 years. The hybrid bonds are subordinated to the Company’s outstanding senior unsecured bonds and is expected to be counted as equity by credit providers and rating agencies. Subscriber to the subordinated unsecured hybrid bonds is Phoenix Insurance Company, a leading insurance company. The board of directors of SBB has also resolved, pursuant to the authority granted by the annual general meeting of shareholders held on 27 April 2017, to issue 35,000,000 warrants. With deviation from the shareholders’ pre-emptive rights, the subscribers to the subordinated unsecured hybrid bonds shall be entitled to receive the warrants free of charge. Each warrant entitles to subscription of one ordinary share of Class B in Samhällsbyggnadsbolaget during the period from and including the date on which the issue of warrants is registered with the Swedish Companies Registration Office up to and including the day five years thereafter, at an exercise price of SEK 7.40. If the warrants are exercised in full, the Company will receive MSEK 259 and the share capital will increase by MSEK 3.5, corresponding to a dilution, based upon the number of outstanding shares as of today, of approximately 4.5 percent of the share capital and approximately 1.3 percent of the votes in the Company. "Applying for an investment grade rating from one of the leading credit rating agencies is a natural step for SBB and a rating would provide yet another seal of approval for our business", says Ilija Batljan, CEO and Founder of SBB. Since earlier, SBB has the following financial targets: · to generate growth in net asset value per ordinary share, excluding dividends on ordinary shares, averaging at least 12% per annum over a five year period, · to generate income from the sale of building rights averaging MSEK 250 to 400 per annum, · to maintain a net LTV below 65%, · to maintain a secured net LTV below 55%, from the second half of 2018 onwards, · to maintain an equity ratio of at least 30% · to maintain an interest coverage ratio of at least 1.5 times · to as long-term target distribute dividends corresponding to 40% of earnings available for distribution (including dividends on preference shares) Advisers: ABG Sundal Collier AB has acted as financial adviser and Advokatfirman Vinge has acted as legal adviser in connection with the issue.

AppSpotr takes the first step on Asia journey

APPTUTTi is a company that offers services to establish apps on the Chinese market. With the agreement APPTUTTi becomes technical partner to AppSpotr with responsibility for, among other things, hosting, integration and customization so that AppSpotr’s web-based application for building apps can be launched in China. Comment from Patric Bottne, CEO of AppSpotr AB: ”I´m very excited to now start our journey with AppSpotr in China and the rest of Asia. A prerequisite for our establishment is that our AppSpotr.com service works technically inside China. There is much required to get a foreign SaaS service like AppSpotr to be online in China. There are different requirements for operation, much need for local technical adaptations and, above all, the challenge of publishing apps to many different local app stores that are only online in China. Without a local partner and expert in the Chinese app market, it would be impossible for AppSpotr to establish itself in China. I am very pleased that we have now signed an agreement with APPTUTTi as our partner. APPTUTTi has the expertise we lack to ensure that AppSpotr.com will work as intended on the Chinese market. APPTUTTi has an impressive technical framework and an established relationship both technically and personally with the largest internet, payment and mobile services in China. It will be very exciting to explore the opportunities for AppSpotr in the Chinese market together with APPTUTTi.” Comment from Dave Wu, Managing Partner of Novel Unicorn Ltd and Chairman of AppSpotr Asia Ltd: ”We love to see the landing of AppSpotr in China and Asia Pacific. We are confident and certainly believe that with APPTUTTi’s assignment and involvement, the undertakings of AppSpotr will become very exhilarating in the near future.”  Comment from Donald Tang, APPTUTTi Ltd: ”APPTUTTi with its operations in Hong Kong, Singapore and Shenzhen is a trusted partner to migrate apps into the world's largest digital marketplace. It is a huge marketplace but with so many publishing stores, complicated channel structure, communication issues arising from different cultures and languages, etc. is quite daunting for foreigners without the help of a local expert.  I am very delighted about the cooperation with AppSpotr which will extend our services to a new group of app owners. Its going to be very exciting to see AppSpotr benefit from the Chinese market.” This information is information that AppSpotr AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication at on July 19th 2017.   About AppSpotr AB AppSpotr democratizes app development worldwide with a platform that lets anyone build native iOS and Android apps without any programming skills. The user easily selects the functionality it needs, customizes the design and content, and then publishes the finished app to App Store and Google Play. AppSpotr have nine employees and is based in Gothenburg, Sweden. About Novel Unicorn Ltd Novel Unicorn is an investment & management company in China and Asia Pacific region. The company’s investments focus on high-growth sectors within the regions, which cover TMT, mobile Internet, consumer products and retail & distributions, while its investment philosophy is to create and realize its investment value through a range of fairly active holding and asset management practices within a mid/long-term time frame. Novel Unicorn was founded in 2010, and is currently based in Hong Kong, with additional offices in Shanghai and Beijing, China. About APPTUTTi Ltd APPTUTTi is the pioneer of app/game launch in China through an online portal. Founded with an objective to help app/game developers around the world to break into a very complicated yet an immensely lucrative market, the company has helped numerous app/game owners get into multiple Chinese app stores by providing localisation, IP registration, monetisation and other necessary services online.

Very strong sales and earnings performance by the Group

Today’s report by Nolato for the first six months of 2017 shows very strong sales performance and good profitability across all business areas, particularly for Integrated Solutions. Adjusted for currency and acquisitions, Group sales growth was a strong 43% in the second quarter and 30% for the first six months. Including acquisitions, the increase in sales was 62% and 48%, respectively. Second quarter in brief: · Sales increased to SEK 1,675 million (1,037) · Operating profit (EBITA) rose to SEK 178 million (110) · The operating margin (EBITA) was 10.6% (10.6) · Profit after tax was SEK 131 million (79) · Earnings per share were SEK 4.98 (3.00) Sales in the Integrated Solutions business area rose to SEK 692 million (311). Adjusted for currency, growth was a very strong 114%. Operating profit (EBITA) was SEK 73 million (28), with an EBITA margin of 10.5% (9.0). "The focus on expanding this business area’s customer and product base has gradually shown very positive development, which is really pleasing and provides us with the diversification we want. High launch volumes in the smoking cessation/e-cigarette segment were delivered in the latter part of the second quarter, and the next months will show how these products have been received on the consumer market," said Nolato President and CEO Christer Wahlquist. Sales in the Medical Solutions business area increased to SEK 498 million (397); adjusted for currency and acquisitions, sales grew by a strong 10%. Operating profit (EBITA) increased to SEK 64 million (53), while the EBITA margin was 12.9% (13.4). "Volumes grew particularly within Medical Devices, in which the ramp-up of new customer projects had a positive impact. The margin was affected by a change in product mix and some impact from acquisitions," said Christer Wahlquist. Industrial Solutions sales increased to SEK 489 million (331); adjusted for currency and acquisitions, sales grew by a strong 16%. Operating profit (EBITA) totalled SEK 48 million (34), with an EBITA margin of 9.8% (10.3). "There was positive development of volumes in most segments, particularly automotive and hygiene. Higher costs associated with the start-up of new projects and fluctuating volumes had a negative effect on the margin," said Christer Wahlquist. Nolato retains a healthy financial position, with an equity/assets ratio of 40% (56) and net financial debt of SEK 639 million (–55). One of the Group’s credit agreements was extended and increased in the second quarter. As a result, Nolato has long-term credit agreements of between four and five years totalling approximately SEK 1.1 billion, and short-term bank overdrafts and similar facilities of around SEK 100 million. ---------For further information, please contact:Christer Wahlquist, President and CEO, +46 705 804848Per-Ola Holmström, CFO, +46 705 763340 Nolato is a Swedish group operating in Europe, Asia and North America. We develop and manufacture products made from polymer materials such as plastic, silicone and TPE for leading customers in medical technology, pharmaceuticals, telecoms, automotive, hygiene and other selected industrial sectors. Nolato shares are listed on Nasdaq Stockholm, where Nolato is a Mid Cap company in the Industrials sector. This information is information that Nolato AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 2.30 pm CET on 19 July, 2017. www.nolato.com   

Second Quarter Results 2017

CEO Casper von Koskull’s comments on the results: “In the second quarter, we have seen evenly distributed growth in our four Nordic home markets. The overall economic situation remains very solid although the geopolitical environment is increasingly unstable. After a period of improved margins, we recently saw a stabilising margin trend, which we expect to continue. We are also seeing continued high activity in corporate advisory services and improved inflow in asset management operations. Customer activities in the capital markets have been lower this quarter due to low volatility. We have had very high activity in the quarter in our simplification and transformation projects, which has impacted the cost development. Credit quality is solid and we expect loan losses below the long-term average in coming quarters. We continue to build up and strengthen our capital position and the Common Equity Tier 1 ratio reached an all-time-high level of 19.2%. As new initiatives have surfaced in Scandinavia about exploring to join the banking union, we would like to process this information before making a final decision in September about our domicile. The transformation programme is progressing according to plan, a key milestone has been reached in the Core Banking Programme, and approximately 28,000 Nordea employees have been engaged in the implementation of the new business culture.”   Second quarter 2017 vs. Second quarter 2016 (Second quarter 2017 vs. First quarter 2017)  · Net interest income EUR 1,175m, 0%; +1% in local currencies (-2%, 0% in local currencies) · Total operating income[1] EUR 2,407m, 0%; +1% in local currencies (-2%, -1% in local currencies) · Total expenses EUR 1,291m, +7%; +8% in local currencies (+4%, +5% in local currencies) · Profit before loan losses EUR 1,116m, -7%; -7% in local currencies (-8%, -7% in local currencies) · Net loan losses EUR 106m, -17%; -15% in local currencies (-6%, -4% in local currencies) · Operating profit[1] EUR 1,010m, -6%; -6% in local currencies (-8%, -8% in local currencies) · Common Equity Tier 1 capital ratio 19.2%, up from 16.8% (up 40 bps from 18.8%) · Cost/income ratio[1] 54% up from 50% (up 3%-points from 51%) · Loan loss ratio of 13 bps, down from 15 bps (down 1 bps from 14 bps) · Return on equity[1] 9.5%, down from 11.4% (down 0.8%-points from 10.3%) · Diluted EPS EUR 0.18 vs. EUR 0.25 (EUR 0.18 vs. EUR 0.21) Exchange rates used for Q2 2017 for income statement items are for DKK 7.4368, NOK 9.1771 and SEK 9.5961.[1] Excl. non-recurring items (Q2 2016: gain related to Visa Inc.’s acquisition of Visa Europe amounting to EUR 151m net of tax) For further information:Casper von Koskull, President and Group CEO, +46 10 157 1020Rodney Alfvén, Head of Investor Relations, +46 72 235 05 15Torsten Hagen Jørgensen, Deputy CEO and Group COO, +45 5547 2200Sara Helweg-Larsen, Head of Group Communications, +45 2214 0000 Latest interim results   The information in this press release is such, which Nordea Bank AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Swedish Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 07.00 CET on 20 July 2017.

Telia Company Interim report January-June 2017

Second quarter summary · As earlier announced former segment region Eurasia is reported as held for sale and discontinued operations. · Net sales in local currencies, excluding acquisitions and disposals, fell 0.4 percent. In reported currency, net sales fell 6.3 percent to SEK 19,801 million (21,130). Service revenues in local currencies, excluding acquisitions and disposals, fell 0.6 percent. · Adjusted EBITDA declined 3.3 percent in local currencies, excluding acquisitions and disposals. In reported currency, adjusted EBITDA, fell 4.6 percent to SEK 6,095 million (6,389). The adjusted EBITDA margin improved to 30.8 percent (30.2). · Adjusted operating income declined 16.7 percent to SEK 3,702 million (4,446). · Total net income attributable to the owners of the parent fell to SEK -397 million (1,439) and earnings per share to SEK -0.09 (0.33). Total net income fell to SEK -308 million (3,902). · Free cash flow, in continuing and discontinued operations, improved to SEK 2,772 million (1,698). · The operational free cash flow outlook for 2017 is improved from above SEK 7.0 billion to above SEK 7.5 billion. First half summary · Net sales in local currencies, excluding acquisitions and disposals, increased 1.2 percent. In reported currency, net sales fell 6.0 percent to SEK 39,053 million (41,524). Service revenues in local currencies, excluding acquisitions and disposals, increased 0.4 percent. · Adjusted operating income declined 13.1 percent to SEK 7,507 million (8,644). · Total net income attributable to owners of the parent improved 26.6 percent to SEK 6,587 million (5,205) and earnings per share to SEK 1.52 (1.20). Total net income fell 12.5 percent to SEK 6,834 million (7,812). Comments by Johan Dennelind, President & CEO   “Dear shareholders and Telia followers, we are now half way through 2017 and have a better visibility on the full year results and our cash flow generation. Even if, frankly speaking, EBITDA in the quarter disappoints for Sweden, we reiterate our EBITDA outlook for the full year based on strong performance elsewhere, notably Norway, and the initiated cost activities that are coming through in second half of 2017. With our other operational free cash flow activities yielding well, we are now able to say that we will be above SEK 7.5 billion for the full year (previously above SEK 7.0 billion). Furthermore, I am very pleased that we managed to secure a dividend decision in Turkcell. Combined with MegaFon associated companies will contribute by around SEK 2.8 billion to our 2017 cash flow. All in all, this means that our free cash flow will be comfortably above SEK 10 billion 2017.   Let us talk more about costs. During the second quarter 2017 we have launched initiatives to reduce our cost base, just as we indicated in the first quarter. The main impact will be in Sweden where the operational expenses are still too high. We plan to reduce our total external and internal resources by roughly 850, around 3 percent of total resources. Of the resources reduced 650 are related to Sweden, equal to 8 percent of the Swedish resources. The initiatives are expected to impact costs already in the second half of 2017 by a reduction of approximately 5 percent in Sweden year on year. We have also initiated medium term structural initiatives that will drive further cost reductions supporting EBITDA in 2018 and 2019. This is expected to result in a reduction of the targeted cost base of at least 3 percent 2018. This is vital for a competitive Telia Company as we still see pressure on our legacy revenues and as anticipated falling one-off revenues from fiber. Our ambition is clear, we aim to grow our operational free cash flow every year in order to support a growing dividend over time.   It is becoming more difficult to deliver on the fiber demand still prevailing, even if our 1.9 million household target is intact for end 2018. We are still the leading and driving force in Sweden for this but we now start to reach the tail of the fiber roll out potential. We struggle with permit and intermediary related issues in connecting households to our fiber network. Some of the roll out challenge is also related to shifts in the market dynamics, which have led to longer delivery processes. Given that the second quarter is traditionally a quarter where many households are connected, these issues had a clear negative impact on revenues and profitability. This, combined with increased operational expenses, are the two main reasons why our EBITDA is declining 3 percent in the second quarter. The main risk on our EBITDA guidance is related to the timing of connecting households to fiber and the related revenues in the fourth quarter.   Norway, yet another proof of our commitment to bring the best quality to our customer by being rewarded the best mobile network for the second consecutive year. We are pleased with the performance in Norway for the second quarter, delivering a continuous strong EBITDA growth, won one of two 900 MHz spectrums, closed the Phonero acquisition adding 246,000 subscriptions and will bear fruit with at least SEK 400 million in synergies in 2018.   In Finland we feel good about the momentum building after the rebranding to Telia, acquisition of Nebula and through the opportunities in creating a great consumer offering with the acquired rights to the Finnish hockey league. We expect Telia Finland to step up to its potential the coming years.   The second quarter of 2017 we increased our execution of the Nordic & Baltic strategy, mainly through M&A. On top of Nebula in Finland we acquired a small but leading Artificial Intelligence company, Humany in Sweden. Further on M&A we have received the needed approvals and finalized the divestment of Sergel. We have reduced our direct ownership in Turkcell, as it has no impact on the overall solution for Turkcell Holding.    Regarding the divestment of the remaining operations in Eurasia there are progress being made in the process. We reiterate that our best estimate is that the assets will be disposed during 2017. We continue our discussions with the DoJ, SEC and the Dutch authorities about our resolution of their investigations and we are hopeful that we will be able to achieve it soon. We remain comfortable that our adjusted provision communicated in our first quarter report is our best estimate of the financial sanction we will be required to pay.    The strong cash flow and the divestments of and dividends from associated companies have strengthened the balance sheet. Our net debt to adjusted EBITDA is now at 1.36x. This is below our target of 2x (+/- 0.5x). If we add upcoming second tranche dividend of SEK 1 per share to be paid and associates’ dividends to be received, known acquisitions as well as the provision for the fine related to Uzbekistan the pro forma number would be 1.8x.    We keep on shaping the new Telia in the Nordics and Baltics, while we work relentlessly to ensure a balanced exit from Eurasia in order to fully focus on the next phase of Telia Company.”   Johan Dennelind, President and CEO           This information is information that Telia Company AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 07:00 CET on July 20, 2017.  For more information, please contact our press office +46 771 77 58 30, visit our Newsroom  or follow us on Twitter @Teliacompany  .   Forward-Looking StatementsStatements made in the press release relating to future status or circumstances, including future performance and other trend projections are forward-looking statements. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There can be no assurance that actual results will not differ materially from those expressed or implied by these forward-looking statements due to many factors, many of which are outside the control of Telia Company.   We’re Telia Company, the New Generation Telco. Our 21,000 talented colleagues serve millions of customers every day in one of the world’s most connected regions. With a strong connectivity base, we’re the hub in the digital ecosystem, empowering people, companies and societies to stay in touch with everything that matters 24/7/365 - on their terms. Headquartered in Stockholm, the heart of innovation and technology, we’re set to change the industry and bring the world even closer for our customers. Read more at http://www.teliacompany.com/.

Saab’s results January-June 2017

Statement by the President and CEO Håkan Buskhe: Continued strong demandDemand for, and interest in, Saab’s product portfolio remains high. This is a result of product development, investment in research and development, and a strong international presence. Growing security concerns around the world seem to have created a state where tensions have now settled at an appreciably higher level. This is reflected in investments in defence and security, as evidenced by the great interest in Saab’s product portfolio. At the same time, the demands faced by suppliers are increasing as well. Solutions and systems have to be cost-efficient, offer strong capabilities, and be delivered quickly. After a number of years of study and political debate in Sweden, updated rules on defense exports were introduced in the second quarter. A long-term regulatory framework is essential for exports to work. We are a company that does business in many countries, and we feel that the new proposed rules will enable us to continue to support our customers with defence and security solutions while achieving growth in line with our goals. Major ordersDuring the first half-year, order bookings increased to MSEK 20,554 (11,462). Major orders were received in several areas, including two in airborne surveillance and one for the Next generation Light Anti-Tank Weapon system (NLAW) to the Swiss Army. Sweden ordered the development and production of the next generation anti-ship missile, the modification and upgrading of the Gävle-class corvettes, a new signal intelligence vessel, and continued support and maintenance of Gripen C/D. We also signed a contract for training systems with the U.S. Army. The order backlog strengthened to MSEK 112,117 at the end of the period. Sales growthSales increased by 11 per cent compared to the same period in 2016. All business areas saw higher sales. Operating income amounted to MSEK 885 (611) with an operating margin of 5.8 per cent (4.4). The improved operating margin is mainly attributable to stronger income in the business area Dynamics and a higher activity level related to airborne surveillance systems. Operational cash flow amounted to MSEK -443 (4,193), which is in line with our expectations, since we had a strong positive cash flow in previous periods due to large advances and milestone payments that have not been repeated now. Earnings per share after dilution amounted to SEK 5.98 (3.71). Successful first flight for Gripen EIn June, Saab completed a successful first flight of the next generation smart fighter, Gripen E. During the flight, the aircraft carried out a number of actions to demonstrate various test criterias and key embedded functions were tested. Since then, further test flights have been conducted, and we are gradually evaluating the aircraft’s various functions as the programme is implemented. Outlook statement for 2017:We estimate that sales growth in 2017 will be higher than Saab’s long-term financial goal: annual organic sales growth of 5 per cent. We expect the operating margin, excluding material non-recurring items, to improve compared to 2016 and thus the company will take a step towards its financial goal: an operating margin of 10 per cent. Financial highlights MSEK  Jan-Jun Jan-Jun Change, Q2 Q2 Full 2017  2016  %  2017  2016  Year 2016 Order bookings 20,554 11,462 79 10,853 6,848 21,828Order backlog 112,117 111,593 - 107,606Sales 15,353 13,854 11 7,923 7,064 28,631Gross income 3,468 3,080 13 1,732 1,569 6,883Gross margin, % 22.6 22.2 21.9 22.2 24.0EBITDA 1,313 1,075 22 614 551 2,743EBITDA margin, % 8.6 7.8 7.7 7.8 9.6Operating 885 611 45 393 317 1,797income (EBIT)Operating margin, % 5.8 4.4 5.0 4.5 6.3Net income 659 414 59 299 191 1,175Earnings per share 5.98 3.71 2.68 1.71 10.60after dilution, SEKReturn on equity, %1) 11.2 13.0 9.0Operational cash flow -443 4,193 -1,429 1,137 2,603Free cash flow -532 4,051 -1,429 1,096 2,359Free cash flow per -4.96 37.91 -13.30 10.25 22.07share after dilution,SEK 1) Return on equity is measured over a rolling 12-month period. For more information and explanations regarding the usage of these key ratios, please see http://saabgroup.com/investor-relations/financial-data/key-ratios/  Press and analyst meeting Saab invites to a press and analyst meeting, where CEO Håkan Buskhe and CFO Magnus Örnberg present the Saab January-June interim report 2017.  Date: Thursday 20 July at 10:00 (CET). Address: Grand Hôtel, Blasieholmshamnen 8, Stockholm, Sweden Venue: New York You are welcome to participate on site at Grand Hôtel, watch the live webcast or dial in to the conference call. It is possible to post questions also over the web and conference call. Live webcast: http://saab-interimreport.creo.se/170720 Conference call: Please, dial in using one of the numbers below. UK: +44 2030089819 SE: +46 856642698 US: +1 8558315948 The interim report, the presentation material and the webcast will be available on http://www.saabgroup.com/en/InvestorRelations. R.S.V.P E-mail: marie.bergstrom@saabgroup.com Tel: +46 8 463 02 45 For further information, please contact: Saab Press Centre, Petter Larsson, Media Relations Manager +46 (0)734 180 018, presscentre@saabgroup.com Ann-Sofi Jönsson, Head of Investor Relations +46 (0) 734 187 214 www.saabgroup.com  www.saabgroup.com/YouTube  Follow us on Twitter: @saab  Saab serves the global market with world-leading products, services and solutions within military defence and civil security. Saab has operations and employees on all continents around the world. Through innovative, collaborative and pragmatic thinking, Saab develops, adopts and improves new technology to meet customers’ changing needs.  The information is such that Saab AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 07.30 CET on 20 July 2017.

Six month report, January–June 2017

Highlights • Revenue amounted to SEK 79.1 billion (72.5); adjusted for currency effects, revenue increased 6 percent. • Operating income amounted to SEK 3.3 billion (3.6); adjusted for currency effects operating income decreased 10 percent. • Earnings per share increased by 7 percent to SEK 7.35 (6.89). • Operating cash flow from operations amounted to SEK –0.3 billion (–1.9). • Operating net financial assets totaled SEK 7.4 billion (March 31, 2017: 12.6). • Order bookings in Construction amounted to SEK 84.5 billion (84.2); adjusted for currency effects, order bookings decreased by 3 percent. The order backlog amounted to SEK 202.2 billion (March 31, 2017: 200.8). • Operating income in Construction amounted to SEK 0.5 billion (1.3), corresponding to an operating margin of 0.7 percent (2.1); adjusted for currency operating income decreased 63 percent. Project write downs taken in the U.S. civil and UK operations affected the operating income by SEK 420 M and SEK 360 M respectively. • Operating income in Project Development amounted to SEK 3.3 billion (2.7); adjusted for currency effects operating income increased by 20 percent. • Return on capital employed in Project Development was 16.5 percent (15.9). • Net investments in Project Development amounted to SEK –0.2 billion (1.4). This report will also be presented via a press conference and audiocast at 10.00 a.m. (CET) on July 20. The telephone conference will be audiocasted live at www.skanska.com/investors, where a recording of the conference will also be available later. To participate in the telephone conference, please dial +46 8 505 564 74, +44 2033 645 374, or +1 855 753 2230. This and previous releases can also be found at www.skanska.com/investors.

Half-year report 2017: Continued earnings improvement

Comments by the CEO SSAB’s operating profit increased to SEK 1,205 million for the second quarter of 2017. The improvement compared with the previous quarter was driven primarily by higher realized prices in SSAB Europe and SSAB Americas. SSAB Special Steels contributed to improved earnings through better capacity utilization and increased shipments, but this was partly offset by production disruptions at the steel mill in Oxelösund. SSAB Special Steels’ shipments continue to grow driven by customer demand for increasingly lighter and stronger products. Demand was good in most segments during the second quarter and the outlook ahead is considered to be stable. SSAB Europe had a strong quarter, with good underlying demand. Realized prices improved and growth within the Automotive segment remained high. Market prices of steel and raw materials weakened during the quarter. Continued good demand is expected during the third quarter. In North America, the realized prices for SSAB Americas increased during the quarter, which resulted in improved margins. The costs of the planned maintenance outage in Mobile impacted negatively on earnings and also resulted in somewhat lower shipments compared to previous quarter, while the underlying demand was relatively stable.  SSAB’s target to reduce net debt by SEK 10 billion between the end of the first quarter of 2016 and the end of 2017 is progressing according to plan. Net cash flow during the quarter was SEK 597 million. An additional SEK 1.7 billion will be achieved during the second half of the year, which is planned to be realized through cash generated from operations and structural reduction in working capital. We have now entered the next phase in our ”Taking the Lead” strategy, having last year created a platform for profitable growth. We have set clear targets for 2020 for our growth initiatives for high-strength steels and service. Development during the second quarter is well in line with our long-term goals. Another focus area is to constantly drive efficiency through continuous improvements in all our operations. Our goal is industry-leading profitability. HYBRIT, our long-term initiative for a sustainable fossil-free steel industry, received financial support during the first quarter from the Swedish Energy Agency and during the second quarter we set up a joint venture with LKAB and Vattenfall to take the project forward. Invitation to SSAB’s second quarter 2017 results briefing SSAB invites you to a presentation of the quarterly report at 10.00am CEST on Thursday July 20, 2017. The press conference will be held in English and live webcast on SSAB’s website www.ssab.com. It is also possible to participate in the briefing via telephone. Venue and time of briefing: World Trade Center (WTC) Stockholm, Kungsbron 1, Conference room Manhattan, 10.00am CEST. Telephone numbers:+46 8 505 564 74 (Sweden),+44 203 364 5374 (UK),+1 855 753 2230 (USA). Link to webcast: Go to webcast  For further information, please contact:Investor Relations: Per Hillström, Head of IR,per.hillstrom@ssab.com, +46 70 2952 912 Media: Viktoria Karsberg, Head of Corporate Communications,viktoria.karsberg@ssab.com, +46 8 454 5734 This information is inside information that SSAB AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 7.30am CEST on July 20, 2017.

Interim report April - June 2017

"Continued good market trend" “During the second quarter of the year, sales increased by 26 percent, of which acquired units contributed 20 percentage points. Organic sales rose 3 percent. Excluding project businesses, comprising mainly offshore oil & gas-related operations – which are currently experiencing a difficult market situation – organic sales rose 5 percent, driven by improved demand in most market segments and in all geographic regions. General industry continued to develop well in all regions, and continued highly favorable organic trend was noted in Asia. Demand for our tires for both the agricultural sector and industrial and construction machinery is continuing to grow. Following a scenario during which the prices for the majority of raw materials dramatically skyrocketed over the course of a few months, these have subsequently fallen to approximately the same levels as during last summer. Our premium position has limited the impact these turbulent movements had on our earnings. We are continuing to work with pricing to offset the effect of this, and the outcome moving forward is largely dependent on how the players in the various stages of the market react. The market for our operations in oil & gas remains weak, which mainly affects the Trelleborg Offshore & Construction business area, which reported a minor loss for the quarter. The market situation is similar to the first quarter, with intense price pressure for the small number of outstanding project transactions. However, this business had only a minor impact on our quarterly earnings from a Group perspective. We are continuing to adapt the oil & gas business to the lower level of activity, and these efforts are aimed at building a long-term attractive structure that will be ready when the market outlook improves. We have completed a number of acquisitions in past year and we are working hard to ensure that the integration of these new units is carried out in a long-term and structured fashion. This could mean that we may decide to recognize costs in individual quarters aimed at generating synergies and thus providing scope for improved earnings in the future. It is also of the utmost importance that, during the integration work, we do not lose focus on the daily sales work, and I believe that we have been successful in that regard. We have talked a lot about digitalization recently, and I can’t emphasize enough how important it is that we are at the forefront of our industry to respond to the changes brought about by new technology in terms of how we do business with customers. A key word we use internally is ‘easy. We want to make it as easy as possible for customers to do business with Trelleborg. If we also combine this with our strong niche positions, and continue to offer the highest product quality and smartest comprehensive solutions, then we as a Group have an exciting future ahead of us. In summary, we saw a general improvement in the demand situation in most of our segments during the quarter. For the third quarter, our overall assessment is that demand will be in line with the second quarter of the year. We are continuing to carefully monitor economic developments and maintain a high level of preparedness to manage fluctuating market conditions”, says Peter Nilsson, President and CEO. Second quarter 2017 Net sales for the second quarter of 2017 rose 26 percent to SEK 8,265 M (6,544). Organic sales increased 3 percent. Excluding project deliveries, the corresponding increase was 5 percent. Effects of structural changes made a positive contribution of 20 percent to net sales, with the acquisition of CGS accounting for the main part of this increase. EBIT, excluding items affecting comparability, rose 21 percent to SEK 1,089 M (899), equivalent to an EBIT margin of 13.2 percent (13.7). Items affecting comparability for the quarter were a negative SEK 76 M (neg: 107), in line with information previously communicated. Earnings per share for continuing operations excluding items affecting comparability totaled SEK 2.92 (2.31), up 26 percent The second quarter of 2016 included net profit for discontinuing operations of SEK 4,369 M related to Vibracoustic. Operating cash flow amounted to SEK 1,096 M (835), up 31 percent. The cash conversion ratio for the most recent 12-month period was 98 percent (83). Market outlook for the third quarter 2017Demand is expected to be in line with the second quarter of 2017, adjusted for seasonal variations. Market outlook from the interim report published on April 27, 2017, relating to the second quarter of 2017Demand is expected to be in line with, or slightly higher than, the first quarter of 2017, adjusted for seasonal variations. For further information, please contact:Media: Vice President Media Relations Karin Larsson, +46 (0)410 67015, +46 (0)733 747015, karin.larsson@trelleborg.comInvestors/analysts: Vice President IR Christofer Sjögren, +46 (0)410 67068, +46 (0)708 665140, christofer.sjogren@trelleborg.com This information is information that Trelleborg AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 07:45 a.m. CET on July 20, 2017. Trelleborg is a world leader in engineered polymer solutions that seal, damp and protect critical applications in demanding environments. Its innovative solutions accelerate performance for customers in a sustainable way. The Trelleborg Group has annual sales of SEK 31 billion and operations in about 50 countries. The Group comprises five business areas: Trelleborg Coated Systems, Trelleborg Industrial Solutions, Trelleborg Offshore & Construction, Trelleborg Sealing Solutions and Trelleborg Wheel Systems, and the operations of Rubena and Savatech. The Trelleborg share has been listed on the Stock Exchange since 1964 and is listed on Nasdaq Stockholm, Large Cap.www.trelleborg.com

Q2 Interim Report for 2017

Q2 2017 · Revenues totalled SEK 11,554 m (9,596) · The operating profit totalled SEK 1,916 m (912) · The operating profit, excluding the revaluation of process inventory, totalled SEK 2,196 m (901)  · Free cash flow totalled SEK 2,152 m (-4,794) · Earnings per share totalled SEK 5.34 (2.26) High mined production and strong cash flow · The operating profit, excluding revaluation of process inventory, increased to SEK 2,196 m (901) due to improved metal prices and high mined production.  · Maintenance shutdowns at the smelters were charged to the profit of SEK 260 m (210) and items affecting comparability impacted the profit with SEK 0 m (209). · The free cash flow totalled SEK 2,152 m (-4,794). The acquisition of the Kevitsa mine affected the cash flow during the second quarter 2016 with slightly below SEK 6 billion. · The net debt/equity ratio decreased during the quarter from 27% to 25%. The dividend paid during the quarter totalled SEK 1,436 m. Please find enclosed the full report. The Interim Report will be presented via a webcast/conference call on Thursday, 20 July at 09:00 (CET). Information is available at www.boliden.com. Contact persons for information: Lennart Evrell, President & CEO Tel: +46 8 610 15 00Håkan Gabrielsson, CFO Tel: +46 8 610 15 00Sophie Arnius, Director Investor Relations       Tel: +46 8 610 15 23       +46 70 590 8072 This information is information that Boliden AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication through the agency of the Director Investor Relations, at 07.45 CET on 20 July 2017.

Boliden’s second quarter: High mined production and strong cash flow

“A quarter of high mined production and good production at copper smelters resulted in a cash flow of over SEK 2 billion. Production in Aitik and the Boliden Area has developed in a particularly positive manner. The high production compensated for maintenance shutdowns and deteriorated market terms compared to previous quarter,” comments Lennart Evrell, President and CEO of Boliden. Production within Boliden’s mines was stable, with the exception of Tara. At Aitik, the milled volume and copper production reached record levels as a result of high grades and increased stability. An unusually favourable ore mix in the Boliden Area, as well as high grades in Kevitsa and Kylylahti, also contributed to the result. Garpenberg continued the strong trend with good stability and a high level of zinc production. Planned maintenance shutdowns took place at Rönnskär, Harjavalta and Kokkola during the quarter. However, the decline in volume compared to the previous quarter was moderate due to higher volumes at zinc smelters and reductions of finished metal stocks. For more information, please contact:Sophie Arnius, Director Investor Relations, tel: +46 8 610 15 23, +46 70 590 8072Klas Nilsson, Director Group Communications, tel: +46 70 453 65 88 Boliden is a metals company with a focus on sustainable development. Scandinavian roots, global market. Our core competence lies within the fields of exploration, mining, smelting and metal recycling. Boliden has more than 5,500 employees and an annual turnover of SEK 40 billion. The stock is listed in the Large Cap segment on NASDAQ OMX Stockholm.  www.boliden.com

Finnair Group Half-Year Report 1 January–30 June 2017

Finnair’s earnings growth continues: all-time high profit for Q2 April–June 2017 · Revenue increased by 11.2% year-on-year to 633.4 million euros (569.6)*. · Available seat kilometres (ASK) grew by 6.8%. · Comparable operating result was 37.5 million euros (3.2). · Operating result was 89.1 million euros (0.2) including i.a. sales gain on an A350 aircraft. · Comparable EBITDAR** was 103.2 million euros (56.3). · Net cash flow from operating activities amounted to 162.2 million euros (119.6), and net cash flow from investing activities to -136.5 million euros (-149.0).*** · Unit revenue (RASK) increased by 4.1% year-on-year. · Unit cost (CASK) decreased by 1.6% and unit cost at constant currency excluding fuel increased by 3.1% year-on-year. · Ancillary and retail revenue per passenger grew by 8.2% year-on-year to 11.8 euros. · Earnings per share were 0.50 euros (-0.04). January–June 2017 · Revenue increased by 7.4% year-on-year to 1,187.7 million euros (1,106.0)*. · Available seat kilometres (ASK) grew by 3.5%. · Comparable operating result was 28.5 million euros (-12.2). · Operating result was 79.1 million euros (-17.4). · Comparable EBITDAR** was 153.3 million euros (92.7). · Net cash flow from operating activities amounted to 186.1 million euros (130.0), and net cash flow from investing activities amounted to 8.6 million euros (-396.3).*** · Unit revenue (RASK) increased by 3.7% year-on-year. · Unit cost (CASK) increased by 0.1% and unit cost at constant currency excluding fuel increased by 2.2% year-on-year. · The 20-million euro cost-efficiency programme was completed in full by the summer. · Ancillary and retail revenue per passenger grew by 8.7% year-on-year to 12.3 euros. · Earnings per share were 0.41 euros (-0.19). * Unless otherwise stated, figures in parentheses refer to the comparison period, i.e. the same period last year. ** Comparable operating result + depreciation + lease payments for aircraft. *** Net cash flow from investing activities includes, in the second quarter, 91 million euros of investments in money market funds and other financial assets maturing after more than three months. In the first year-half, these decreased in net terms by 95 million euros. These investments are part of the Group’s liquidity management.   Outlook Outlook published on 28 April 2017The demand outlook for passenger and cargo traffic in Finnair’s main markets continues to involve uncertainty. Finnair estimates that, in 2017, due to the fleet renewal and introduction of new aircraft, its capacity will grow 8–10 per cent, weighted strongly towards the second half of 2017. Revenue is expected to grow more slowly than our capacity, reflecting increasing capacity in the relevant markets. In keeping with its disclosure policy, Finnair will issue guidance for its expected full-year operational result in connection with the half-year report in July. Outlook on 20 July 2017 The demand outlook for passenger and cargo traffic in Finnair’s main markets continues to involve uncertainty. Finnair reiterates its previous estimate that, in 2017, due to the fleet renewal and introduction of new aircraft, its capacity will grow 8–10 per cent, weighted strongly towards the second half of 2017. Full-year revenue is expected to grow approximately in line with capacity. At current fuel prices and exchange rates, Finnair expects its comparable operating result for 2017 to broadly double year-on-year (2016: 55 million euro) CEO Pekka Vauramo: Finnair is now growing at an accelerated speed: We are opening new routes, adding capacity in existing key routes, and recruiting new employees. Customer satisfaction as measured by Net Promoter Score is at an all-time high. We now provide our passengers, among other things, with wi-fi throughout the wide-body-fleet and new convenient inflight payment solutions in the entire fleet. We also launched a ground transportation service allowing the customer to purchase a complete door-to-door journey connected to a flight ticket. Our sales and marketing efforts in selected target markets are paying off, supporting our market share growth in strategic routes. Market conditions also developed favourably in the second quarter, and hence our growth, helped by successful timing, got a flying start. For the next winter season, we are planning to grow faster than ever before. In the second quarter, Finnair carried a quarterly record number of passengers. This was also shown in our revenue, which grew at a double-digit rate. Sales grew particularly due to the solid demand for the backbone of our network, traffic between Asia and Europe, and our load factors rose. In particular, our sales developed favourably in Japan, Korea and China. Both corporate travel and the materialisation rate of group travel have been clearly stronger than a year ago. Our new destinations, such as San Francisco, have sold well, similarly to the additional frequencies we added to Tokyo. Our expanded range of destinations and increased capacity in Europe matched the needs of our Asian and Finnish passengers. Outbound travel from Helsinki has picked up from a year ago, as has traffic from the United States to the Nordic countries and Russia due to our improved network of connections. On the back of solid demand, our passenger load factor rose considerably in the second quarter, and ticket prices held up well. I am also pleased to see that ancillary revenue per passenger continued to increase, and the expected upturn in cargo materialised. These positive developments were also reflected in our result: our comparable operating profit in the second quarter improved by almost 35 million euros from the slightly positive result a year ago, marking nearly three years of result improvement. It was also particularly encouraging that our customer satisfaction has continued to improve: Finnair’s Net Promoter Score during the quarter was 48, an all-time high. We are focusing on service development and improving the smoothness of the entire passenger journey to offer a unique Nordic experience to our customers. The favourable first half of the year provides a solid foundation for us to build the future Finnair. In the second half of the year, our capacity will grow at a rate of approximately 15 per cent. The third quarter is seasonally the strongest in our business, and favourable market conditions appear likely to continue. Therefore, we anticipate our comparable full-year operating profit to broadly double from last year. Financial reporting The publication dates of Finnair’s remaining financial reports in 2017 are as follows:  Interim Report 1 January – 31 September 2017:                          25 October 2017  FINNAIR PLCBoard of Directors Briefings  Finnair will hold a result press conference on 20 July 2017 at 11:00 a.m. and an analyst briefing at 12:30 p.m. at its office at Tietotie 9. An English-language telephone conference and webcast will begin at 2:30 p.m. Finnish time. The conference may be attended by dialling your local access number 09 7479 0404 (Finland), 0200 883 464 (Sweden), 0800 279 7204 (UK) or +44 (0)330 336 9412 (all other countries). The confirmation code is 750402. To join the live webcast, please register at: https://slideassist.webcasts.com/starthere.jsp?ei=1154164&tp_key=c3de9cad8c  For further information, please contact: Chief Financial Officer Pekka Vähähyyppä, tel. +358 9 818 8550, pekka.vahahyyppa@finnair.comFinancial Communications Manager Ilkka Korhonen, tel. +358 9 818 4705, ilkka.korhonen@finnair.com 

Hansa Medical Interim report April-June 2017

April – June 2017 in brief›› Continued patient enrolment in two ongoing Phase II studies with lead candidate IdeS in highly sensitized patients in the US and Europe. The objective is to have all 40 patients recruited and treated in the two separate studies by the end of 2017. All treated patients will be monitored for six months post treatment. ›› First patient treated in Phase II study with IdeS for acute renal failure in anti-GBM antibody disease. Approximately 15 patients will be recruited in this investigator initiated study at up to 15 clinics in Europe. The primary objective of this study is to evaluate the safety and tolerability of IdeS, as well as efficacy assessed by evaluating renal function at six months after IdeS treatment. ›› Published preclinical results confirm IdeS’ potential in cancer immunotherapy. The published findings demonstrate how pre-treatment with IdeS in tumour animal models can increase the efficacy of currently available antibody based cancer therapies. ›› The European Medicines Agency (EMA) grants access to its Priority Medicines (PRIME) scheme for IdeS in enabling kidney transplantation for highly sensitized patients. Access to PRIME allows for accelerated development of IdeS, a potentially transformative treatment option for patients in need of lifesaving kidney transplantations. ›› Lead candidate IdeS discussed in a two-day workshop titled Antibody Mediated Rejection in Kidney Transplantation, organized by the U.S. Food and Drug Administration (FDA). Transcripts from the workshop have been released and are available on the FDA website. Presenters and audience engaged in extensive discussions around the potential of IdeS in kidney transplantation. Financial summary for the Group (KSEK) +-----------------------------+-------+-------+-------+-------+--------+|KSEK, unless otherwise stated| Q2  | H1  | Year  ||  | | | |+-----------------------------+-------+-------+-------+-------+--------+| | 2017 | 2016 | 2017 | 2016 | 2016 |+-----------------------------+-------+-------+-------+-------+--------+|Net revenue | 693 | 542| 1,751| 1,129| 2,579|+-----------------------------+-------+-------+-------+-------+--------+|Operating profit/loss |-44,901|-30,674|-89,728|-50,619|-111,135|+-----------------------------+-------+-------+-------+-------+--------+|Net profit/loss |-45,151|-30,672|-90,145|-50,647|-111,129|+-----------------------------+-------+-------+-------+-------+--------+|Earnings per share before and| -1.29| -0.94| -2.57| -1.56| -3.39||after dilution (SEK) | | | | | |+-----------------------------+-------+-------+-------+-------+--------+|Shareholders’ equity |198,600|160,201|198,600|160,201| 283,693|+-----------------------------+-------+-------+-------+-------+--------+|Cash flow from operating |-38,797|-22,043|-82,536|-39,603| -94,563||activities | | | | | |+-----------------------------+-------+-------+-------+-------+--------+|Cash and cash equivalents |169,953|133,686|169,953|133,686| 253,578||including short term | | | | | ||investments | | | | | |+-----------------------------+-------+-------+-------+-------+--------+ CEO statementThe first six months of 2017 were characterized by the continued development of our program around novel and innovative immunomodulatory enzymes. As we reached several important milestones during this period, we remained focused on our strategy around our lead candidate IdeS and continue to advance our clinical development. As our program continued to develop according to plan, we noticed an increasing interest by the medical and scientific communities. As a result, principal investigators have been able to present data from our recent studies with IdeS at several renowned scientific and medical meetings. On April 30, top-line clinical results from the ongoing investigator initiated US study with IdeS were presented at the American Transplant Congress (ATC) in Chicago. These encouraging results demonstrate that treatment with IdeS eliminates donor specific antibodies (DSAs) and enables transplantation of HLA incompatible patients. They also support our belief that IdeS has the potential to become the first approved therapy to enable highly sensitized kidney disease patients to be transplanted. IdeS was also in focus at a two-day workshop titled Antibody Mediated Rejection in Kidney Transplantation arranged by the US Food and Drug Administration (FDA). In the workshop, novel opportunities for the treatment and prevention of Antibody Mediated Rejection (ABMR) were discussed. The discussions covered the potential risk-benefit profile of IdeS as a desensitization treatment and the treatment of severe ABMR in kidney transplantation. Presenters and audience engaged in extensive discussions around the potential of IdeS in kidney transplantation. This adds to our firm belief that IdeS has a significant potential to become a novel treatment option to enable patients to receive the lifesaving transplantation they desperately need. We continue to make progress and are committed to spread more knowledge about the profile of IdeS. In May, the European Medicines Agency (EMA) granted access to its Priority Medicines (PRIME) scheme for IdeS. PRIME is intended to enhance support for the development of medicines that target an unmet medical need. The designation was based on data from four independent Phase II studies in the US and Europe, including data from 30 HLA sensitized patients who received IdeS immediately before transplantation. The access to PRIME allows us to continue to accelerate the development of IdeS. In parallel with our pioneering work in organ transplantation, we are also pursuing the therapeutic potential of IdeS in several other indications. We believe that the fast onset and efficacy of IdeS has the potential to bring significant contribution to the critical care in several transplant-related indications and acute autoimmune diseases, including Anti-GBM antibody disease, also known as Goodpasture disease. In June, we announced that the first patient had been treated with IdeS in an investigator-initiated Phase II study in severe anti-GBM antibody disease. In total, approximately 15 patients will be recruited to the study at up to 15 clinics across Europe. We also see opportunities with IdeS as a potential treatment in cancer immunotherapy. Pre-clinical data, published in the peer-reviewed journal Molecular Cancer Therapeutics (Järnum et al., Mol Cancer Ther May 22 2017 DOI: 10.1158/1535-7163.MCT-17-0108), confirm this potential of IdeS and demonstrate how pre-treatment with IdeS in tumor animal models can increase the efficacy of currently available antibody-based cancer therapies. In preparation of the next phase of the company’s growth, we are continuously building a strong, committed team. We are further establishing our footprint in the US via recruitment of two senior medical affairs professionals. In short, encouraged both by the positive development of IdeS and the reception we have so far received from the medical community, I feel that Hansa Medical is in a strong position to continue the journey to become a biopharmaceutical company with important lifesaving products. I look forward to providing further updates about our exciting development. Göran ArvidsonPresident and CEO of Hansa Medical

Evolution Gaming: Interim report January-June 2017

Second quarter of 2017 (Q2 2016) · Operating revenues increased by 56% to EUR 42.3 million (27.1) · EBITDA increased by 81% to EUR 19.2 million (10.6), corresponding to a margin of 45% (39) · Profit for the period amounted to EUR 14.6 million (7.6) · Earnings per share amounted to EUR 0.41 (0.21) The first half of 2017 (1H 2016) · Operating revenues increased by 58% to EUR 82.0 million (51.9) · EBITDA increased by 74% to EUR 36.3 million (20.9), corresponding to a margin of 44% (40) · Profit for the period amounted to EUR 27.4 million (15.3) · Earnings per share amounted to EUR 0.76 (0.42) Events during the second quarter of 2017 · Strong and even growth for all products · Evolution named Live Casino Supplier of the Year for the eighth consecutive year · Change of listing to Nasdaq Stockholm Comments from CEO Martin Carlesund: I am very pleased to be able to sum up an eventful quarter with positive development in several areas. The favourable momentum of the past quarters continued into this period, with a strong and steady growth for all products. It can be noted that gaming revenues generated on our platform using mobiles devices exceeded 50 percent for the first time in this quarter. Compared with the corresponding quarter in 2016, sales rose by 56 percent. EBITDA for the quarter amounted to EUR 19.2 million, equivalent to a margin of 45 percent and an increase of 81 percent on the corresponding quarter last year. The improvement in margin is being driven by high growth among existing customers and in existing environments, supported by a continuously improving and increasingly efficient organisation. We are seeing continued Live Casino initiatives among all of our customers, who are also marketing their offerings towards end users to an increasing extent. Operators’ Live offerings are undergoing constant development and we are working hard to optimise their environments to optimally reflect each brand and various player profiles. For the remainder of the year, we expect an intense period in terms of expansion of new environments. We have previously discussed our strategy to develop Live to include more than traditional tables games. Against this background, it is particularly satisfying that our latest game, Dream Catcher, which represents a completely new category in the Live segment, has quickly become popular among players. Dream Catcher is a clear example of our product innovation and, since its launch, it has developed in line with our high expectations. Another new product is our progressive Jumbo 7 Jackpot, which is now part of Live Casino Hold’em. Evolution has contributed EUR 1 million to the initial winning amount, which is the highest starting level to date for a table game jackpot – a way for us to support our partners and increase the game’s attraction among end users. Land-based casinos continue to show considerable interest for our converging product Dual Play Roulette. Our latest installation, which is available for our entire licensee network, can be found at Grand Casino Bucharest. We are proud of our Dual Play solution, which really fills its purpose as a bridge between online and real-life play. The land-based sector is still clearly larger than the online gaming market, and Evolution shall be the go-to partner for physical casinos seeking to develop their digital brands. Among new customers in the quarter, I want to highlight our agreement with the Netherlands’ largest gaming operator Nederlandse Loterij, which runs a variety of game types and brands in the market. This partnership provides further evidence of Evolution’s leading capabilities to deliver services in regulated markets, and we look forward to the opportunity to build a strong Live Casino product for this state-owned operator. I would also like to mention two events that have contributed to Evolution’s brand and position in the market. In early June, we won the Live Casino Supplier of the Year at the EGR B2B Awards for the eighth consecutive year. Given that there are many new players in the market, more Live Casino suppliers than ever were nominated – making the win particularly gratifying. Competition drives us to work even harder with the aim of continuing to expand our leadership in the segment. In June, we also moved from First North to the main market at Nasdaq Stockholm. It was a special feeling to ring the opening bell and affirm that Evolution has grown to become a large cap company since our IPO slightly more than two years ago. The list change is clear proof that the organisation has matured and professionalised during its time in a public environment. Finally, I am happy to announce that, after the end of the period, we have been given the all-clear to establish our next major studio in Tbilisi in Georgia. From this studio, we will continue to expand, offering our services to additional customers and markets. We view the remainder of the year with confidence and excitement. Presentation for investors, analysts and the media CEO Martin Carlesund and CFO Jacob Kaplan will present the report and answer questions on Thursday, 20 July 2017 at 9:00 a.m. CET via a telephone conference. The presentation will be in English and can also be followed online. Number for participation by telephone: +46 8 566 42 690. Follow the presentation at https://tv.streamfabriken.com/evolution-gaming-group-q2-2017.

Episurf Medical has become an approved supplier to Spire Healthcare, one of the UK’s largest independent hospital providers

Episurf Medical (NASDAQ: EPIS B) has become an approved supplier to Spire Healthcare, one of the UK’s largest independent hospital providers with 39 hospitals, 10 clinics and two specialist cancer care centres across England, Wales and Scotland. The decision has been made following a review process.  “We are very pleased that, with the support from some of the UK’s leading surgeons, Episealer® has received approval from Spire Healthcare as a new treatment method for focal cartilage and bone damages of the knee”, says Pål Ryfors, CEO Episurf Medical. “Spire Healthcare delivers a very high standard of care for both private and NHS patients across the UK. We look forward to offering the Episealer® to suitable patients, enabling them to benefit from our technology which can help them to get back to a pain-free lifestyle”, concludes Ryfors. For more information, please contact: Pål Ryfors, CEO, Episurf Medical  Tel: +46 (0) 709 62 36 69 Email: pal.ryfors@episurf.com About Episurf Medical Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com. This information is information that Episurf Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08.30 CET on 20 July 2017.

Exel Composites Plc’s January–June Half-year Financial Report 2017: “Significant increase in order intake, revenue and operating profit”

Q2 2017 in brief · Order intake increased by 15.5% to EUR 23.4 million (Q2 2016: 20.2). · Revenue increased by 17.4% to EUR 23.2 million (19.7). · Adjusted operating profit improved to EUR 1.7 million (1.2), which is 7.4% of revenue (5.9%). · Net cash flow from operating activities was EUR 1.1 million (0.3). · Earnings per share amounted to EUR 0.09 (0.07). H1 2017 in brief · Order intake increased by 19.8% to EUR 45.8 million (38.3). · Revenue increased by 15.4% to EUR 43.4 million (37.6). · Adjusted operating profit amounted to EUR 3.4 million (1.3), which is 7.8% of revenue (3.5%). · Net cash flow from operating activities was EUR 0.3 million (-0.5). · Earnings per share amounted to EUR 0.18 (0.07). Outlook for full year 2017 Exel Composites reiterates its outlook for 2017 and estimates that revenue with comparable company structure (i.e. without the acquisition of Nanjing Jianhui Composite Material, JHFRP) will increase from previous year level and adjusted operating profit will be higher than previous year level. In 2016, Exel Composites’ revenue was EUR 73.1 million and adjusted operating profit was EUR 2.6 million. President and CEO, Riku Kytömäki In the first half of 2017 order intake, revenue and operating profit continued to develop positively. In the second quarter, the double digit growth was led by volume increase from new customers, and supported by a general market environment recovery. The strong order intake and order backlog in the first quarter also contributed to the significant increase in revenue for the first half of 2017. The Industrial Applications customer segment continued to drive volume growth during the review period. We continued to gain momentum especially in the mid-segment through our efforts and focus on new customer acquisition. Despite lower margin structure, the mid-segment products contributed positively to the operating profit through higher volumes. From a regional perspective Asia – and China in particular – was a major contributor to the increase in revenue in the first half of the year. Volume growth was mainly organic and only partially affected by the newly acquired Nanjing Jianhui Composite Material, JHFRP. Also in Europe revenue has developed well and increased in comparison to the same period last year. Major factors behind the continued improvement in operating profit were the significantly higher revenue and the lower cost base. The cost savings measures from 2016 continued to contribute to an overall reduced cost level. Improvements in operational efficiency, including the downsizing in Australia, also contributed to the improvement in the operating profit. The downsizing of the Australian unit is progressing according to plan and we expect production there to cease by the end of this year. The acquisition of Nanjing Jianhui was successfully completed in April 2017 and was consolidated into Group accounts as of 1 May 2017. The integration process proceeds according to plan. Nanjing Jianhui is an important element of our growth strategy in China as it strengthens our position in the Chinese market and improves our export capacity to other markets. To sum it up; the results of the first half of 2017 reflect good growth in our focus segments and a continued tight cost control. Consolidated key figures EUR 1.4.–30.6. 1.4.–30.6. Change, 1.1–30.6. 1.1.–30.6. Change, 1.1.–31.12.thousand 2017 2016 % 2017 2016 % 2016Order 23,359 20,231 15.5 45,839 38,263 19.8 74,778intakeOrder 19,436 15,799 23.0 19,436 15,799 23.0 16,702backlog¹Revenue 23,150 19,720 17.4 43,447 37,639 15.4 73,079Operating 1,488 1,147 29.8 3,144 1,293 143.2 649profit% of 6.4 5.8 7.2 3.4 0.9revenueAdjusted 1,722 1,167 47.6 3,387 1,316 157.4 2,621operatingprofit²% of 7.4 5.9 7.8 3.5 3.6revenueProfit for 1,060 882 20.2 2,166 880 146.2 198theperiodNet cash 1,101 342 221.9 253 -520 148.7 3,129flow fromoperatingactivitiesReturn on 14.9 11.4 16.0 6.5 1.7capitalemployed,%Net 29.3 18.4 29.3 18.4 12.2gearing, %Earnings 0.09 0.07 0.18 0.07 0.02per shareEquity per 2.3 2.35 -2.1 2.3 2.35 -2.1 2.27share,EUREmployees 534 487 9.7 498 490 1.6 479onaverage ¹ As per the end of the period.² Excluding material items affecting comparability, such as restructuring costs, impairment losses and reversals, and costs related to planned or realized business acquisitions or disposals. For more information, please refer to the paragraph “Change in Exel Composites’ financial reporting terminology” of the Half-year Financial Report published on 21 July 2016. Exel Composites’ half-year financial report January – June 2017 is available in full in pdf format as an attachment to this release. The report and the related presentation are also available at the company’s website under the Investor section. Vantaa, 20 July 2017 Exel Composites PlcBoard of Directors

Episurf Medical reports brief clinical update

Episurf Medical’s (NASDAQ: EPIS B) first 15 patients have now had their Episealer® implants for more than 3 years. Episurf Medical continues to support the collection of clinical data demonstrating the positive impact Episealer patients experience from the company’s unique, personalised solution for the treatment of knee pain. A significant amount of data has been collected on the growing cohort of Episealer patients, with the first patient still performing very well, nearly 5 years since the treatment. Importantly, the data now shows the clinical relevance and benefits patients experience in their quality of life and the associated reduction in pain. These benefits are seen early and the data positively supports that patients already benefit from the technology within 3 months of their procedure, with benefits continuing to improve in the longer term. Episurf Medical currently has 15 patients who have had the implant for more than 3 years and 4 patients have had the implant for more than 4 years. "It is reassuring that as time passes, so far, we do not see any deterioration of patient well-being or increase in the need for implant revision" says Prof. Leif Ryd, Senior Medical Advisor to Episurf Medical. “The results are starting to speak for themselves” concludes Prof. Ryd. For more information, please contact: Pål Ryfors, CEO, Episurf Medical  Tel: +46 (0) 709 62 36 69 Email: pal.ryfors@episurf.com About Episurf Medical Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com. This information is information that Episurf Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 14.30 CET on 20 July 2017.

SKF Half-year report 2017

Gothenburg, 21 July 2017 Alrik Danielson, President and CEO: “The second quarter saw strong organic growth and an improved operating margin. Sales development was positive in all regions, as underlying industrial activity and investments increased. Net sales, at SEK 20.2 billion, increased organically by 7.5% compared to the second quarter last year, with North America and Asia growing by double-digits, 10% and 12% respectively. Improved sales volumes and factory utilization rates contributed to an adjusted operating profit of SEK 2,436 million, 416 million higher than last year and an adjusted operating margin of 12%. The automotive business developed in a solid manner, with a good operational improvement, delivering an adjusted operating margin of 8.1%. The industrial business delivered an adjusted operating margin of 13.8%. Our underlying cash flow generation ability is robust, at SEK 2.3 billion in the quarter. We continued to focus on our core bearing business, with the divestment of Reelcraft completed in June, which impacted cash flow positively by SEK 892 million. In total, we have now raised approximately SEK 5 billion from divestments in the last two years. A few weeks ago we inaugurated the Sven Wingquist Test Center for large-size bearings in Schweinfurt, Germany.  The center is the first in the world that can test large-size bearings – with a diameter of up to six metres – under dynamic loading conditions, simulating actual operating conditions, making customer development processes faster and more reliable. This is just one example of how we are investing in the development of software and hardware that support product and rotating equipment performance, our two value propositions in key industries.  As we move into the second half of the year, we expect to see continued broad-based industrial activity and growth. For the third quarter of 2017, demand for our products and services is expected to be higher compared to the same period last year.” Key figures, SEKm Q2 2017 Q2 2016 H1 2017 H1 2016Net sales* 20,229 18,319 39,830 35,995Adjusted operating 2,436 2,020 4 793 3,992profit**Adjusted operating 12.0 11.0 12.0 11.1margin, %**Items affecting -121 -145 -183 -242comparability**Operating profit 2,315 1,875 4,610 3,750Operating margin, % 11.4 10.2 11.6 10.4Adjusted profit before 2,178 1,801 4,365 3,556taxes**Profit before taxes 2,057 1,656 4,182 3,314Net cash flow after 2,304 4,225 2,368 4,735investments beforefinancing * Cash discounts are from January 1, 2017 classified as a reduction of Net sales. Previously published figures have been restated accordingly.** Please see page 17 of report for definitions  Net sales change y-o-y, % Organic Structure Currency TotalQ2 2017 7.5 -2.0 4.9 10.4H1 2017 7.7 -2.0 5.0 10.7 Organic sales change Europe North Latin Asia Middle Eastin local currencies, America America & Africaper region y-o-y, %Q2 2017 3.1 10.0 9.9 11.7 13.3H1 2017 4.1 8.9 10.6 12.2 11.5 Outlook for the third quarter 2017 Demand compared to the third quarter 2016The demand for SKF’s products and services is expected to be higher for the Group, including Industrial and Automotive. Demand is expected to be higher in Europe, North America and in Asia and significantly higher in Latin America. Demand compared to the second quarter 2017The demand for SKF’s products and services is expected to be lower for the Group and Industrial and slightly lower for Automotive. Demand is expected to be significantly lower in Europe and relatively unchanged in North America, Asia and in Latin America. A teleconference will be held on 21 July 2017 at 09:00 (CET):SE: +46 (0)8 5033 6539UK: +44 (0)20 3427 1912US: +1 646 254 3360 You will find all information regarding the SKF Half year report 2017 on the IR website. Aktiebolaget SKF      (publ) The information in this press release is information which AB SKF is required to disclose under the EU Market Abuse Regulation (EU) No 596/2014. The information was provided by the above contact persons for publication on 21 July 2017 kl. 08.00 CET.

Capio AB (publ) Interim report January – June 2017

April - June 2017 · Net sales MSEK 3,881 (3,573). Organic sales growth 0.5% (4.0) and total sales growth 8.6% (3.8) · EBITDA[1] MSEK 256 (276) and margin 6.6% (7.7). EBITDA decreased by 7.2% · EBITA[1] MSEK 142 (172) and margin 3.7% (4.8). EBITA decreased by 17.4% · Operating result (EBIT) MSEK 108 (157) and margin 2.8% (4.4). EBIT decreased by 31.2% · Profit for the period[2] MSEK 70 (113). Earnings per share after dilution[2] SEK 0.50 (0.80) January - June 2017 · Net sales MSEK 7,795 (7,176). Organic sales growth 1.9% (3.8) and total sales growth  8.6% (3.7) · EBITDA[1] MSEK 598 (572) and margin 7.7% (8.0). EBITDA increased by 4.5% · EBITA[1] MSEK 374 (367) and margin 4.8% (5.1). EBITA increased by 1.9%   · Operating result (EBIT) MSEK 317 (333) and margin 4.1% (4.6). EBIT decreased by 4.8% · Profit for the period[2] MSEK 222 (235). Earnings per share after dilution[2] SEK 1.57 (1.67) [1] Refer to page 33 for definitions of EBITDA and EBITA.[2] Profit for the period refers to profit attributable to parent company shareholders. Refer to note 2 for calculation of earnings per share (before and after dilution). CEO comments:“Nordic develops well while market drop challenges France.” · Acquisitions of more than MSEK 900 in annual sales successfully integrated and the acquisition activity is set to continue · Continued good organic sales growth and acquisitions drive sales and results in Nordic · Digital consultations “Capio Online” and digital support for physical consultations launched in May · Weaker private market in France impacts the result, ongoing work to adjust resources – French Q4 2017 margin to exceed Q4 2016 · Q2 was negatively impacted by fewer working days from Easter and other calendar effects, 1 working day less during the first six months · Full year 2017 Group EBITDA growth is expected to exceed 10% During both Q1 and Q2, the Nordic sales growth was above 13%, driven by the add-on acquisitions and a continued good organic sales growth of 3.6% (3.8) for the first six months. During the same period, the EBITDA result increased by 18% and the margin improved to 6.7% (6.5). The new market entry into Denmark has so far exceeded expectations. The integration of the ten acquired primary care centers in the west of Sweden (Backa) has been successfully completed, as has the integration of the recently acquired eye specialist clinic in Sweden. These acquisitions will give further leverage to both sales and results going forward. As planned, the digital concepts have been under test since May 2017 and the full roll-out to Capio’s 750,000 primary care patients in Sweden starts in September 2017 and continues into 2018. The roll-out includes both digital consultations “Capio Online” and algorithm support “Better Visits” for traditional physical consultations. This is intended to improve availability and lead to more precise diagnoses and better treatments. The length of consultations is also expected to become shorter. We see these digital steps as a start of a new era in healthcare provision. Latest available market statistics from May shows that the private healthcare market in France dropped to a growth of -0.4% during January – May 2017 compared to 2.6% during the same period 2016. Capio’s development has been slightly better than the private market growth. We believe that the slowdown of Capio’s organic sales growth is temporary and will resume, due to the demographic development and our attractive offer in Modern Medicine. However, we now have full focus on adjusting resources to the current volume growth with further staff and cost reductions – also increasing our flexibility to manage variations in patient volumes going forward. On an annualized basis, this will give a result improvement of approximately MEUR 6. The majority of actions will be implemented by the end of Q3 and are expected to impact results and margins positively in Q4 2017, with a full year pace from Q1 2018. Due to the market drop, we no longer expect to reach an unchanged French EBITA margin for the full year, but following the actions taken the EBITA margin in Q4 is expected to exceed the corresponding margin in Q4 2016. Introduction of new specialties and the ongoing procurement program is also expected to contribute to improvements during the second half of 2017. The development is also supported by continuous good reductions of AVLOS with a continued 4% reduction of case mix adjusted AVLOS. In Germany fewer working days compared to 2016 combined with cancellations of planned surgeries at the end of the quarter, burden growth and margins in Q2 2017. This is seen as a temporary drop in volume growth and is expected to recover during the second half of 2017. The recent acquisition of an eye specialist clinic in Bremen will give further leverage to sales and results going forward. Going forward, the top priority is of course to achieve the planned cost adjustments in France and turn the margin trend upwards. We maintain the focus on add-on acquisitions in the Nordics, primarily within primary and specialist care. The digital focus will increase further. For the full year 2017 our expectation is to reach a Group EBITDA growth exceeding 10%. Thomas BerglundPresident and CEO Presentation of the interim reportInvestors, analysts and media are invited to participate in a telephone conference on July 21, 2017 at 09.30 am (CET). President and CEO Thomas Berglund and CFO Olof Bengtsson will present the report and answer questions. The telephone conference will be audio casted live on www.capio.com. To participate in the telephone conference, please register at www.capio.com  and dial in five minutes prior to the start of the conference call. Sweden: +46 8 566 426 92UK: +44 203 008 98 02US: +1 855 753 22 36Finland: +35 898 171 04 93France: +33 170 75 07 12 Prior to the start of the telephone conference, presentation slides will be available at www.capio.com. A recorded version of the audio cast will be available at www.capio.com during the afternoon (CET). For further information Thomas Berglund, President and CEOTelephone: +46 733 88 86 00, E-mail: thomas.berglund@capio.com Olof Bengtsson, CFOTelephone: +46 761 18 74 69, E-mail: olof.bengtsson@capio.com Kristina Ekeblad, Investor Relations ManagerTelephone: +46 708 31 19 40, E-mail: kristina.ekeblad@capio.com Henrik Brehmer, SVP Group Communication and Public AffairsTelephone: +46 761 11 34 14, E-mail: henrik.brehmer@capio.com For further information regarding Capio’s IR activities, refer to www.capio.com  This is information that Capio AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person Henrik Brehmer set out above, at 08.00 (CET) on July 21, 2017. About CapioCapio AB (publ) is a leading, pan-European healthcare provider offering a broad range of high quality medical, surgical and psychiatric healthcare services through its hospitals, specialist clinics and primary care units. Since the Danish operation was acquired at the beginning of 2017, Capio operates in five countries; Sweden, Norway, Denmark, France and Germany. In 2016, Capio’s 12,435 employees provided healthcare services during 4.7 million patient visits across the Group’s facilities, generating net sales of MSEK 14,069. Capio operates across three geographic segments: Nordic (54% of Group net sales 2016), France (38% of Group net sales 2016) and Germany (8% of Group net sales 2016). For more information about Capio, please see www.capio.com .

Interim Report Jan – June, 2017

JANUARY 1 – JUNE 30, 2017(compared with the year-earlier period)  During the period, shares in the discontinued operation Essity (the hygiene business) were distributed to SCA’s shareholders and on June 15, Essity was listed on Nasdaq Stockholm. Net profit for the period mainly comprised an earnings effect of SEK 136,914m from the distribution of Essity shares. The distribution was a non-recurring event. Unless otherwise stated, only SCA’s continuing operations (the forest products business) are described in this report.  · Net sales increased 7% to SEK 8,191m (7,665) · Adjusted EBITDA increased 2% to SEK 1,634m (1,602) · The adjusted EBITDA margin was 19.9% (20.9) · Adjusted operating profit amounted to SEK 1,062m (1,039) · Operating profit amounted to SEK 949m (1,158) · Net profit for the period from continuing operations amounted to SEK 651m (914) · Earnings per share from continuing operations amounted to SEK 0.93 (1.30) · Operating cash flow from continuing operations amounted to SEK 906m (1,340) COMMENTS ON THE FINANCIAL STATEMENTS The Annual General Meeting’s decision to split SCA into two listed companies has been implemented. For every share in SCA, shareholders have received one new share in the global hygiene and health company Essity. SCA is therefore a focused and cost-efficient forest and forest products company. The reported result for the second quarter of 2017 was significantly impacted by extended planned maintenance stops at several of SCA’s mills. Earnings were similarly affected by costs for the recently completed company split, and for the major ongoing investment project at the Östrand pulp mill. Underlying earnings are stable. General market conditions for forest industry products are relatively strong with high demand in China, North America and Europe. The exception is publication papers, which have been adversely impacted by a continued structural decline. Supplies of timber are balanced in SCA’s operating area, creating a stable raw material market. The market balance is strong in the Wood segment, with favorable underlying demand, and prices have gradually risen. The market is driven by continued high levels of construction activity in the US and high demand for wood products in China. The European market is also strong where the building materials trade, in particular, has shown continued positive growth. The market for kraftliner has shown strong growth in recent years and the beginning of 2017 was no exception. Underlying factors include growing online shopping and demands for high quality packaging, which are increasing the preference for kraftliner – a packaging material made from fresh fiber. We have seen stepwise price increases over the past six months and another price increase for unbleached kraftliner has been announced for August. The pulp market developed favorably during the first six months of the year, with strong demand in China and relatively good demand in other markets. Market conditions were characterized by stable prices and volumes, with no significant inventory build-up to date due to increased production capacity. However, a weakened USD has recently resulted in lower delivery prices measured in Swedish kronor. In view of the stable and long-term growing demand for long-fiber pulp, in particular from tissue and packaging producers, SCA decided in August 2015 to invest SEK 7.8bn in the expansion of the Östrand pulp mill. The project will double Östrand’s capacity and make Östrand one of the most cost-efficient mills in the world for long-fiber kraft pulp production. The project is on track in terms of both time and budget. INVITATION TO PRESS CONFERENCE ON THE INTERIM REPORT FOR THE FIRST SIX MONTHS OF 2017 The six-month report will be published on July 21, 2017 at about 8:00 a.m., followed by a press conference at 10:00 a.m. At the press conference, the President and CEO, Ulf Larsson, and CFO, Toby Lawton, will present the report and answer any questions. The press conference will be webcast live at www.sca.com It is also possible to participate by telephone by calling +44 (0) 20 7162 9960 or +1 646 851 2094 or + 46 (0) 8 5052 0337. Ring in good time before the conference commences. Specify “SCA” or conference ID no. 962387. For further information, please contact: Ulf Larsson, President and CEO, tel: +46 (0) 60 19 46 46Toby Lawton, CFO, +46 (0) 60 19 31 09Björn Lyngfelt, Senior Vice President, Group Communications, tel: +46 (0) 60 19 34 98Nils Lindholm, Investor Relations Director, tel: + 46 (0) 70 585 41 05 Please note: SCA discloses the information provided herein pursuant to the EU Market Abuse Regulation. This report has been prepared in both Swedish and English versions. In case of variations in the content between the two versions, the Swedish version shall govern. The information was submitted for publication, through the agency of the contact person set out below, on July 21, 2017 at 8:00 a.m. CET. Björn Lyngfelt, Senior Vice President, Group Communications, tel: +46 (0) 60 19 34 98

Interim report January – June 2017

Challenging market situation  · Net sales increased by 32 % to 407.0 (307.6) MSEK · Operating income increased to 5.5 (4.1) MSEK · Net income amounted to -19.2 (9.8) MSEK · Earnings per share amounted to -0.93 (0.47) SEK · 32 (28) systems were delivered in the period · Order intake amounted to 23 (15) EBM systems For the second quarter: · Net sales increased to 214.8 (147.7) MSEK · Operating income amounted to -1.6 (-4.8) MSEK · Net income amounted to -17.3 (1.5) MSEK · 17 (14) EBM systems were delivered in the second quarter · Order intake amounted to 15 (9) systems Challenging market situation  The Arcam Group continues to grow and during the first six months the increase in sales was 32%. Sales for the period increased to 407.0 (307.6) MSEK and trailing twelve month sales amounts to 747.7 (621.7) MSEK. Operating income for the period was 5.5 (4.1) MSEK and trailing twelve months operating income amounts to -28.4 (30.7) MSEK. In the first 6 months, we delivered 32 (28) EBM systems. The last twelve months we thus delivered 57 systems. We continue to pursue and develop our long-term strategy to industrialize the EBM technology and simultaneously developing the metal powder manufacturing and contract manufacturing business. We invest significantly in technology, marketing and manufacturing capacity to meet our customers’ demands and growing expectations on productivity and reliability. Business status During the period, we delivered 32 EBM systems. The demand for EBM systems is driven by the aerospace industry that is now moving into production, and by the increasing interest for Additive Manufacturing from the orthopedic industry. However, the customers are still hesitant launching large manufacturing projects. We believe that increased product maturity as well as new application areas will drive more production interest. The growth in the period is due to the interest from our largest shareholder GE, in EBM systems for test and evaluation. In the period the order intake from GE was 12 EBM systems and 16 systems were delivered to GE. In the period, we received 23 new orders and the order book by the end of the quarter amounts to 16 EBM systems. The demand of metal powder for Additive Manufacturing continues to grow rapidly. We continue to secure long-term supply agreements to important customers within the orthopedic and the aerospace industries. DTI is increasingly active on the market and continue adding new customers and projects to the EBM part of the contract manufacturing business. However, the business continues to be burdened by weak sales for implants made with traditional technology the conventional part of manufacturing was weak in the period. Hence, we have in the period written down the parent company holding in DTI with 35 MSEK. This has no effect on the consolidated numbers for the group.  Growing organization We continue to build our organization and during the quarter we have strengthened our organization throughout the group. In early April 2017 Karl Lindblom joined as General Manager for Arcam EBM. We have also strengthened our sales organization within Arcam EBM in the USA, and at AP&C and DTI. At AP&C we have expanded the organization to prepare for the opening of our new metal powder manufacturing plant. The expansion of AP&C's new plant is proceeding according to plan and the new facility is expected to be completed in September. With the new facility, we will potentially more than double our capacity for titanium powder atomization. More than adding resources within our companies, we now also access GE's expertise and resources, something that will help us to faster develop our technology and ability both on the EBM side and at AP&C and DTI. With some of the world's largest companies as customers, a strong majority owner with high ambitions and, most important, a team of dedicated and skilled employees, we are well positioned to take advantage of our opportunities on the market for Additive Manufacturing. Mölndal, Sweden, July 21, 2017 Magnus René,President & CEO This information is information that Arcam AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation 596/2014 and the Securities Markets Act (2007:528). The information was submitted for publication, through the agency of the contact person set out above, at 8.30 CET on July 21, 2017.

Klarna and Permira Announce Strategic Equity Investment

Klarna Bank AB is pleased to announce that an investment partnership advised by Permira will acquire a strategic equity stake in the company. Klarna is one of Europe's largest and fastest growing banks, providing easy to use payment solutions and currently serving 60 million consumers and 70.000 merchants. Permira is a global investment firm which advises funds and accounts with a total committed capital of circa €32 billion. Permira focuses on identifying companies for long-term investment, combining local knowledge and global expertise to help them grow sustainably and realise their full potential.  The investment partnership will acquire shares from existing shareholders General Atlantic, DST Global and Niklas Adalberth, upon receipt of approval from the Swedish Financial Supervisory Authority (Finansinspektionen). As a consequence of this transfer, General Atlantic and DST Global will cease to be shareholders in the company, while Niklas Adalberth will retain an equity stake. The investment partnership will become a qualified owner of Klarna.   Sebastian Siemiatkowski, co-founder and CEO of Klarna: "As Klarna continues its journey towards a smoother shopping experience and now as a consumer-oriented and technology intensive bank, this is another exciting step for the company. I am delighted to have a partner like Permira on board with their global footprint and strong expertise in ecommerce and fintech. I look forward to them strategically supporting the future development of Klarna."    Andrew Young, Principal at Permira: “In Klarna we see a unique scale fintech innovator that has successfully improved shopping experiences for both merchants and consumers. We see many vectors that will drive future success and with Sebastian, we look forward to supporting the company’s future organic, geographic, and acquisition growth strategies.”  Ola Nordquist, partner and head of the Nordics at Permira: “Klarna is a truly innovative, founder-led iconic Swedish business and we are pleased to back the company and its management team to advance its leadership position both locally and internationally.”  This investment comes as Klarna has continued to record strong growth in the first half of this year. This is building on the 50% increase in recorded transaction volumes in 2016, in part driven by 17,000 new merchants partnering with Klarna in the last year. Klarna received a full banking licence from the Swedish Financial Supervisory Authority in June 2017.   About KlarnaKlarna is now one of Europe's largest banks, providing easy to use payment solutions for 60 million consumers and 70.000 merchants and working seamlessly across borders.  Klarna is today active in 18 markets with more than 1500 employees. The company was founded in Sweden 2005 with the goal to make online payments safe, simple and smooth. Klarna offers direct payments, pay after delivery options and installment plans in a smooth one-click purchase experience that lets consumers pay when and how they prefer to. When the company acquired SOFORT in 2014 the Klarna Group was formed. Klarna is backed by investors such as Sequoia Capital, Bestseller Group, Atomico and now Permira.   About PermiraPermira is a global investment firm that finds and backs successful businesses with ambition. Founded in 1985, the firm advises funds and accounts with a total committed capital of approximately €32 billion. The Permira funds make long-term investments in companies with the ambition of transforming their performance and driving sustainable growth. In the past 32 years, the Permira funds have made over 200 private equity investments in five key sectors: Consumer, Financial Services, Healthcare, Industrials and Technology. Permira employs over 200 people in 14 offices across North America, Europe and Asia and has had a local presence in the Nordics in Stockholm since 2003. The Permira funds have a long track record of investing in market leading financial services and technology businesses operating in structural growth markets including Magento, TeamViewer, Allegro, Tilney and Tricor. For more information visit:  www.permira.com  Contacts:Klarna                                                                                                 Aoife Houlihan, VP of Communications  +46 (0) 72855 8047  Permira        Noémie de Andia, Head of Communications+44 (0) 207 632 1159           Fogel & PartnersAnders Fogel+46 (0) 722 04 47 50                                

Financial Report April – June 2017

The expectation at the beginning of the quarter was for quarterly organic sales to increase by “around 2%” and an adjusted operating margin of “around 8.5%”. The lower than expected organic sales growth reflects lower customer call-offs due to lower than expected light vehicle production in China and North America. For the third quarter of 2017, the Company expects organic sales to increase in the range of 0-2% and an adjusted operating margin in the 7.5-8.0% range. The indication for the full year remains unchanged for adjusted operating margin at around 8.5% and consolidated sales growth at around 3% while we now expect an organic sales growth of around 2%. (See the “Outlook” section on the next page for further discussion of organic sales and adjusted operating margin, which are forward-looking non-U.S. GAAP measures). Key Figures  For Key Figures summary table, please refer to attached file below.  Comments from Jan Carlson, Chairman, President & CEO"I am pleased that we continue to execute well in Passive Safety and that proactive adjustments to a weaker market in China and North America helped the segment generate another quarter of double digit operating margin, despite continued elevated investments for growth. We managed another quarter with good operating efficiency, and our strong gross margin performance enabled us to meet our adjusted operating margin* expectation although the organic sales growth* was slightly below our expectation due to lower light vehicle production in China and North America. Order intake continued on a high level in Passive Safety in the quarter. We accelerated our efforts to strengthen our foundation in Electronics to capture growth opportunities through the strategic agreements we announced in June and July. The agreements with NVIDIA and Velodyne further improve our capabilities in developing next generation self-driving technologies by accessing NVIDIA’s AI car computing platform and Velodyne’s LiDAR sensing technology while our investment in Autotech provides effective scouting of new technologies in autonomous driving. Electronics booked a handful of smaller orders in Active Safety in the quarter, including one new customer and one vision order. To meet the strong momentum in Passive Safety and Electronics, we continue to invest in competence and capacity, and in the ongoing competition for engineering talent, we have been able to exceed our target of recruiting 1,000 engineers between July 2016 and June 2017. Combined with the formation of the Zenuity joint venture in April and the strategic agreements announced since then, we are continuously strengthening our ability to win new business. We carefully monitor the readiness level for the upcoming increase in new vehicle launches and I am pleased that they are on track. We still see high light vehicle inventories, slow sales momentum and continued uncertainty in China and North America and we expect organic sales growth in the range of 0-2% for the third quarter. Staying focused on quality, innovation and product robustness is more important than ever as we execute on accelerating business volumes and new opportunities, which we will elaborate on at our Capital Markets Day on September 14, 2017.” An earnings conference call will be held at 2:00 p.m. (CET) today, July 21. To follow the webcast or to obtain the pin code and phone number, please access www.autoliv.com. The conference slides will be available on our web site as soon as possible following the publication of this earnings report.

Interim report January-June 2017

April-June 2017• Net sales for the second quarter amounted to SEK 3,408 million (3,403).• Organic growth was 1 per cent (4).• Operating profit amounted to SEK 413 million (420), corresponding to an operating margin of 12.1 per cent (12.3).• Currency losses had an impact of approximately SEK 35 million on the Group’s operating profit, of which SEK 0 million in translation effects and a negative SEK 35 million in transaction effects.• Profit after tax amounted to SEK 314 million (302), corresponding to earnings per share after dilution of SEK 1.86 (1.80).• Operating cash flow amounted to SEK 193 million (238). Consolidated net sales, earnings and cash flowDemand for kitchens in the Nordic region and Central Europe in the second quarter is deemed to have improved year-on-year. In the UK, the kitchen market weakened as the result of heightened macroeconomic uncertainty.Sales increased organically 1 per cent (4), positively impacted by increased sales values and negatively affected by fewer delivery days compared with the preceding year. Currency losses of SEK 12 million (losses: 176) impacted sales.The gross margin amounted to 39.9 per cent (40.1), adversely affected by currency fluctuations and a changed sales mix, which were partly offset by higher sales values.Operating profit declined due to lower volumes and currency losses.The return on operating capital was 32.0 per cent in the past twelve-month period (Jan-Dec 2016: 32.5). The return on equity was 13.9 per cent in the past twelve-month period (Jan-Dec 2016: 13.0).Operating cash flow declined as the result of a negative change in working capital and higher investments compared with the corresponding quarter in 2016.Comments from the CEO“Given the conditions with fewer delivery days than last year, I am pleased with the results for the second quarter. Organic growth in the Nordic region was primarily driven by a strong increase in new housing construction in all Nordic countries. Our project sales in the UK also increased, while sales to consumers declined slightly. Although the operating profit was burdened by currency losses, our profit generation in the first half is ahead of last year’s. We are now working intensively towards our target of growing organically and via acquisitions. Overall, I remain confident in our ambition to deliver profitable growth,” says President and CEO Morten Falkenberg.For further informationContact any of the following on +46 (0)8 440 16 00 or +46 (0)705 95 51 00:• Morten Falkenberg, President and CEO• Kristoffer Ljungfelt, CFO• Lena Schattauer, Head of Communication and Investor RelationsNobia develops and sells kitchens through some twenty strong brands in Europe, including Magnet in the UK; HTH, Norema, Sigdal, Invita, Marbodal in Scandinavia; Petra and A la Carte in Finland and Ewe, FM and Intuo in Austria. Nobia generates profitability by combining economies of scale with attractive kitchen offerings. The Group has approximately 6,000 employees and net sales of about SEK 13 billion. The Nobia share is listed on the Nasdaq Stockholm under the ticker NOBI. Website: www.nobia.com This information is such that Nobia is obliged to made public pursuant to the EU’s Market Abuse Regulation and the Swedish Securities Market Act. The information was submitted for publication, through the agency of the contact person set out above, on 21 July 2017 at 1:00 p.m. CET.